≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Collagenous colitis

Endpoint Browser

COLITCOLLAG

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K52.88
  • Cause of death: ICD-10 — K52.88

2 out of 7 registries used, show all original rules.

4068

4. Check minimum number of events

None

4068

5. Include endpoints

None

4068

6. Filter based on genotype QC (FinnGen only)

3942

Control definitions (FinnGen only)

Control exclude
K11_ENERCOLNONINF

Extra metadata

First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K52
Name in latin
Alia gastroenteritis et/sive colitis non infectiosa specificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 3942 2674 1268
Unadjusted period prevalence (%) 0.83 0.95 0.58
Median age at first event (years) 61.33 59.89 64.35

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
4068
Matched controls
40680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L01BB02
ATC
mercaptopurine; oral
54.1
318.0
181
35
D11
ICPC
Diarrhoea
4.3
317.6
1020
2944
K59.1
ICD-10 Finland
Functional diarrhoea
9.5
307.7
877
1147
C10AC01
ATC
colestyramine; oral
20.8
307.7
685
393
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
59.0
307.7
978
217
L04AX01
ATC
azathioprine; systemic
11.8
307.7
489
465
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.9
307.7
1989
8029
A07EA02
ATC
hydrocortisone; rectal
41.5
307.7
275
71
A06AC01
ATC
ispaghula (psylla seeds); oral
4.3
307.7
1993
7496
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
677.8
307.7
678
12
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
307.7
722
*
K51.5
ICD-10 Finland
Left sided colitis
1937.9
307.7
493
*
UJF92
NOMESCO Finland
Capsular endoscopy
13.9
307.7
332
258
A07EA06
ATC
budesonide; oral, local oral
204.8
307.7
1787
155
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
7.4
307.7
675
1072
UJF32
NOMESCO Finland
Coloscopy
7.1
307.7
2347
6583
A07EC02
ATC
mesalazine; oral, rectal
107.5
307.7
1310
179
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
4503599627370496.0
307.7
4067
66
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.5
307.7
1476
4610
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
229.2
307.7
217
10
UJF30
NOMESCO Finland
Ileoscopy through colon
8.5
307.7
1305
2141
K51.8
ICD-10 Finland
Other ulcerative colitis
1054.6
303.9
294
*
D94
ICPC
Chronic enteritis/ulcerative colitis
59.9
268.8
150
26
H02AB06
ATC
prednisolone; systemic
3.0
246.5
2542
14506
K50.8
ICD-10 Finland
Other Crohn disease
+∞
231.5
220
*
K50.9
ICD-10 Finland
Crohn disease, unspecified
788.3
229.6
224
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
4.4
223.0
633
1637
K50.0
ICD-10 Finland
Crohn disease of small intestine
+∞
213.4
203
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
213.2
2048
10986
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
33.1
185.5
119
37
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
178.9
874
3222
J01MA02
ATC
ciprofloxacin; systemic
2.5
178.3
1962
10964
P01AB01
ATC
metronidazole; oral, rectal
2.5
175.1
2077
11986
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
173.2
165
*
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
1816.7
173.1
167
*
A06AC51
ATC
ispaghula, combinations; oral
4.7
160.8
403
937
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
+∞
158.4
151
*
K50.1
ICD-10 Finland
Crohn disease of large intestine
1582.3
154.1
149
*
A07DA03
ATC
loperamide; oral
5.8
153.9
292
532
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
147.2
2330
14865
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.3
146.7
1808
10375
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.9
144.2
811
3204
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
+∞
142.5
136
*
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
248.7
141.1
144
6
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
239.8
135.9
139
6
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
135.5
609
2113
A02BC02
ATC
pantoprazole; systemic
2.5
132.1
3149
23427
H02AB07
ATC
prednisone; oral
2.8
129.8
775
3147
K51
ICD-10 Finland
Ulcerative colitis
173.1
128.2
134
8
N02AX02
ATC
tramadol; systemic, rectal
2.1
121.1
2023
12831
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
120.6
1150
5815
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
66.0
118.2
65
10
A02BC05
ATC
esomeprazole; systemic
2.1
109.0
1929
12346
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
18.1
108.0
87
49
N03AX16
ATC
[U] pregabalin
2.2
106.0
1179
6306
R19.4
ICD-10 Finland
Change in bowel habit
4.7
105.6
257
580
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
531.5
105.2
104
*
A07EC01
ATC
sulfasalazine; oral, rectal
3.2
104.9
465
1589
N06AX11
ATC
mirtazapine; oral
2.1
104.1
1681
10354
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
101.1
743
3311
ZX120
NOMESCO Finland
Intravenous
2.9
100.3
533
2016
JF1BD
NOMESCO Finland
Very extensive small bowel CT
22.9
98.9
72
32
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
21.5
96.5
72
34
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.1
91.2
1190
6708
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.4
90.4
184
356
L04AB04
ATC
adalimumab; parenteral
5.7
90.0
170
307
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.2
88.6
946
4928
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
4.6
86.8
213
483
WX002
NOMESCO Finland
Sedation and analgesia
2.2
84.5
948
5024
Z01.8
ICD-10 Finland
Other specified special examinations
2.1
83.6
1116
6311
A09AA02
ATC
multienzymes (lipase, protease etc.); oral
5.1
83.6
179
362
A07EA01
ATC
prednisolone; oral, rectal
45.1
82.6
49
11
JF1AD
NOMESCO Finland
Small bowel CT
11.6
82.0
85
75
L04AC05
ATC
ustekinumab; parenteral
30.4
82.0
54
18
A02BC03
ATC
lansoprazole; oral
2.0
81.0
1309
7906
JFF10
NOMESCO Finland
Loop enterostomy
13.2
77.7
74
57
K52
ICD-10 Finland
Other noninfective gastroenteritis and colitis
37.4
77.3
48
13
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
76.9
509
2140
K52.80
ICD-10 Finland
(Hemorrhagic) colitis caused by antibiotics
265.6
76.7
78
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.6
75.8
258
743
N06AX21
ATC
duloxetine; oral
2.3
75.1
648
3072
K90.0
ICD-10 Finland
Coeliac disease
4.2
73.4
202
500
4AA12, ,
NOMESCO Finland
40.4
72.3
44
11
L04AB02
ATC
infliximab; parenteral
27.5
72.0
49
18
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
70.7
1912
13441
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
70.3
1156
6962
R50.9
ICD-10 Finland
Fever, unspecified
2.2
69.9
733
3755
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.2
69.4
299
998
J01MA12
ATC
levofloxacin; systemic
2.1
68.8
841
4563
Z93.2
ICD-10 Finland
Ileostomy status
20.2
67.9
52
26
N05CF01
ATC
zopiclone; oral
1.8
66.7
1419
9241
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.0
65.5
891
5012
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
65.5
1874
13293
N05BA04
ATC
oxazepam; oral
1.9
65.4
1218
7602
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
64.9
705
3652
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
+∞
63.7
61
*
A02BC01
ATC
omeprazole; systemic
1.8
62.6
1208
7604
R11
ICD-10 Finland
Nausea and vomiting
2.4
61.8
478
2150
R53
ICD-10 Finland
Malaise and fatigue
1.8
61.6
1177
7382
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
61.5
430
1847
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
9.4
61.0
73
79
N02BE01
ATC
paracetamol; systemic, rectal
2.6
61.0
3738
33155
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
59.5
57
*
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
+∞
59.5
57
*
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.2
59.3
546
2642
D01
ICPC
Abdominal pain/cramps general
2.1
59.3
625
3191
ZXE00
NOMESCO Finland
One hour or less
1.7
59.2
1637
11402
N05AH04
ATC
quetiapine; oral
2.0
58.9
802
4496
N06AX16
ATC
venlafaxine; oral
2.1
58.6
685
3635
E0000UV, ,
ATC
1.7
58.3
1816
13051
J01DB01
ATC
cefalexin; oral
2.0
58.0
3419
29405
M79.6
ICD-10 Finland
Pain in limb
1.7
57.8
1941
14223
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
+∞
57.4
55
*
R51.80
ICD-10 Finland
Headache
2.0
56.4
757
4215
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.3
56.3
494
2341
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
55.3
1499
10331
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
3.4
54.3
205
630
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
53.6
244
839
L04AX03
ATC
methotrexate; systemic
2.2
53.5
477
2274
D07AC01
ATC
betamethasone; topical
1.7
53.1
1548
10850
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.2
52.9
480
2304
M54.5
ICD-10 Finland
Low back pain
1.7
52.8
1607
11386
J02AC01
ATC
fluconazole; systemic
1.7
52.7
1710
12321
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.5
52.6
349
1460
N02AA05
ATC
oxycodone; systemic
1.9
51.8
816
4779
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
51.8
511
2535
N06AB04
ATC
citalopram; systemic
1.8
50.5
920
5633
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
+∞
50.1
48
*
H02AB09
ATC
hydrocortisone; systemic
3.9
49.8
151
401
AA1AD
NOMESCO Finland
CT of head and brain
1.7
49.4
1246
8366
A07AA09
ATC
vancomycin; oral
5.5
49.1
96
179
S18
ICPC
Laceration/cut
1.6
48.9
1980
14988
A03FA01
ATC
metoclopramide; systemic, rectal
1.8
48.6
992
6273
E87.6
ICD-10 Finland
Hypokalaemia
3.2
48.4
202
660
H02AB04
ATC
methylprednisolone; systemic
2.0
48.3
645
3569
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.4
48.3
355
1555
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
48.0
590
3171
A03CA02
ATC
clidinium and psycholeptics; oral
2.6
47.5
289
1158
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.1
47.4
509
2604
3042, ,
Kela drug reimbursment
+∞
47.0
45
*
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
7.8
46.3
64
83
253, ,
Kela drug reimbursment
+∞
45.9
44
*
K59.9
ICD-10 Finland
Functional intestinal disorder, unspecified
4.4
45.9
117
273
N06AB10
ATC
escitalopram; oral
1.8
45.8
881
5464
Z3231
NOMESCO Finland
Registered nurse
1.7
45.1
1124
7487
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.6
44.8
282
1148
K92.1
ICD-10 Finland
Melaena
2.7
44.8
257
1000
D64.9
ICD-10 Finland
Anaemia, unspecified
2.1
44.5
486
2499
WX402
NOMESCO Finland
General anaesthesia
1.7
44.1
959
6148
B01AB05
ATC
enoxaparin; parenteral
1.6
44.0
1323
9239
R06.0
ICD-10 Finland
Dyspnoea
1.7
43.8
1168
7909
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
10.5
43.8
48
46
M03BX02
ATC
tizanidine; oral
1.6
43.4
2501
20348
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
43.1
489
2549
L04AD01
ATC
ciclosporin; systemic
4.3
42.7
110
259
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
42.2
380
1811
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
4.4
42.1
106
245
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
42.0
1033
6835
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
42.0
1712
12823
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.7
42.0
907
5795
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
+∞
41.7
40
*
N03AX12
ATC
[U] gabapentin; oral
1.8
41.5
708
4223
K56.7
ICD-10 Finland
Ileus, unspecified
4.5
41.3
102
232
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
41.3
1825
13905
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.6
41.3
98
216
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
41.2
476
2494
N05CF02
ATC
zolpidem; oral
1.8
41.2
754
4591
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
41.0
482
2543
WVA20
NOMESCO Finland
Medicine administration
3.3
40.8
157
488
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.0
40.2
460
2402
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
40.1
806
5040
K50
ICD-10 Finland
Crohn disease [regional enteritis]
207.0
39.9
41
*
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.3
39.8
323
1474
A07AA11
ATC
rifaximin; oral
11.2
39.8
42
38
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
6.1
39.7
69
115
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
+∞
39.6
38
*
A02BA02
ATC
ranitidine; systemic
1.7
39.2
784
4891
K29.7
ICD-10 Finland
Gastritis, unspecified
3.0
39.2
183
638
D07AD01
ATC
clobetasol; topical
1.8
39.1
738
4529
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
4.5
39.0
95
214
Z71.8
ICD-10 Finland
Other specified counselling
1.6
38.9
1438
10481
N06AX12
ATC
bupropion; oral
2.3
38.8
325
1503
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
38.6
1215
8521
Z2221
NOMESCO Finland
Medical doctor
1.6
38.6
1107
7590
N06AA09
ATC
amitriptyline; systemic
2.0
38.5
432
2239
P01BA02
ATC
hydroxychloroquine; oral
2.1
38.5
389
1939
A05AA02
ATC
ursodeoxycholic acid; oral
4.3
38.4
99
233
JAH00
NOMESCO Finland
Laparotomy
3.3
38.3
144
441
JN4AD
NOMESCO Finland
Body CT examination
1.9
38.3
503
2754
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
38.3
248
1023
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
38.2
1179
8226
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
38.2
792
4986
SPAT1263
SPAT
Sampling
1.5
37.8
1676
12701
N06AB06
ATC
sertraline; oral
1.9
37.7
506
2789
R19.5
ICD-10 Finland
Other faecal abnormalities
3.8
37.6
116
312
M25.5
ICD-10 Finland
Pain in joint
1.6
37.4
1397
10181
C07AA05
ATC
propranolol; systemic
1.7
37.4
851
5492
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
37.3
2101
16746
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
37.3
844
5439
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
37.3
409
2101
R42
ICD-10 Finland
Dizziness and giddiness
1.6
37.2
987
6629
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
36.9
414
2143
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.1
36.8
370
1839
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.7
36.6
199
752
ZXD05
NOMESCO Finland
Urgent procedure
1.6
36.4
1175
8271
B03BA03
ATC
hydroxocobalamin; parenteral
2.5
36.1
246
1038
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.8
36.0
564
3265
F51.0
ICD-10 Finland
Nonorganic insomnia
1.7
35.9
730
4563
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
35.8
953
6395
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
35.8
540
3090
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.4
35.7
261
1137
JFF13
NOMESCO Finland
Terminal enterostomy
13.9
35.6
33
24
L04AG05
ATC
vedolizumab; parenteral
+∞
35.5
34
*
R10.0
ICD-10 Finland
Acute abdomen
2.9
35.4
172
613
K61.0
ICD-10 Finland
Anal abscess
4.4
35.3
89
206
N02BF01
ATC
gabapentin; oral
1.9
35.3
479
2648
M01AH05
ATC
etoricoxib; oral
1.5
35.0
2488
20705
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
35.0
2886
24802
R4110
NOMESCO Finland
Physiotherapy
1.6
34.8
1140
8035
J01FF01
ATC
clindamycin; systemic
1.6
34.7
1076
7485
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
34.7
621
3740
C07AB07
ATC
bisoprolol; oral
1.5
34.7
1898
14950
R03AC02
ATC
salbutamol; inhalant
1.5
34.7
2213
17992
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
34.5
1514
11382
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
34.5
1477
11047
R15
ICD-10 Finland
Faecal incontinence
2.9
34.4
166
589
D07AC13
ATC
mometasone; topical
1.6
34.3
1149
8136
R52.9
ICD-10 Finland
Pain, unspecified
1.9
34.3
466
2576
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.6
33.8
114
326
N05CD07
ATC
temazepam; oral
1.9
33.7
468
2604
E86
ICD-10 Finland
Volume depletion
3.3
33.7
130
405
K30
ICD-10 Finland
Functional dyspepsia
1.9
33.7
510
2918
J01FA10
ATC
azithromycin; systemic
1.5
33.7
2272
18633
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
+∞
33.4
32
*
R06AE07
ATC
cetirizine; oral
1.5
33.1
1787
13990
UKC02
NOMESCO Finland
Cystoscopy
1.8
32.9
593
3575
A04
ICPC
Weakness/tiredness general
1.7
32.9
703
4446
K83.0
ICD-10 Finland
Cholangitis
4.3
32.8
84
197
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
8.8
32.8
41
47
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.8
32.7
74
157
Z01.2
ICD-10 Finland
Dental examination
1.5
32.7
1881
14904
Z3226
NOMESCO Finland
Physiotherapist
1.7
32.4
742
4776
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
32.3
658
4104
K90.9
ICD-10 Finland
Intestinal malabsorption, unspecified
13.0
32.3
31
24
UJF30, ,
SPAT
5.1
32.3
67
132
D06
ICPC
Abdominal pain localized other
1.9
32.2
414
2245
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.5
32.1
1974
15826
B81
ICPC
Anaemia vit B12/folate deficiency
2.7
32.1
178
680
TGC00
NOMESCO Finland
Bronchial lavation
3.3
32.1
125
392
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
31.9
921
6282
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
31.7
576
3477
N02BF02
ATC
pregabalin; oral
2.1
31.7
315
1557
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
31.5
799
5276
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.4
31.5
216
914
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.8
31.5
166
618
N30.0
ICD-10 Finland
Acute cystitis
1.6
31.4
772
5058
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
31.3
883
5983
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
31.3
686
4361
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.3
31.3
260
1196
R4190
NOMESCO Finland
Nutritional therapy
2.6
31.3
186
736
WZC30
NOMESCO Finland
Teaching
1.7
31.2
685
4358
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.8
31.0
161
594
M48.0
ICD-10 Finland
Spinal stenosis
1.8
30.9
515
3029
J01AA02
ATC
doxycycline; systemic
1.6
30.8
3080
27135
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
30.6
1018
7165
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
30.4
749
4906
C03CA01
ATC
furosemide; systemic
1.5
30.3
1138
8222
256, ,
Kela drug reimbursment
+∞
30.2
29
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
30.2
492
2874
G44.2
ICD-10 Finland
Tension-type headache
1.7
30.2
586
3602
M13.9
ICD-10 Finland
Arthritis, unspecified
2.0
30.1
330
1690
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.9
30.1
411
2271
J01MA14
ATC
moxifloxacin; systemic
2.0
30.1
367
1953
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
4.0
30.0
85
215
JHA00
NOMESCO Finland
Anal or perianal incision
4.3
30.0
77
181
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.6
29.8
172
670
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.8
29.8
519
3092
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.5
29.7
200
839
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
29.7
1233
9094
L03
ICPC
Low back symptom/complaint
1.5
29.7
1226
9032
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.0
29.4
128
429
WX892
NOMESCO Finland
Monitored bed care
2.1
29.4
314
1594
K55.9
ICD-10 Finland
Vascular disorder of intestine, unspecified
11.1
29.3
31
28
D07AB02
ATC
hydrocortisone butyrate; topical
1.5
29.2
1162
8488
SAA01
NOMESCO Finland
Simple examination of mouth
1.5
29.1
2840
24704
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.2
29.1
262
1246
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.8
28.9
144
520
UJF02
NOMESCO Finland
Peroral enteroscopy
7.8
28.9
40
52
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.9
28.6
425
2411
R01AD08
ATC
fluticasone; nasal
1.5
28.6
1116
8112
A07AA02
ATC
nystatin; oral
2.2
28.5
259
1236
A01
ICPC
Pain general/multiple sites
1.8
28.4
461
2687
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
28.4
258
1231
L04AA01
ATC
[U] ciclosporin
4.1
28.3
77
189
M79.1
ICD-10 Finland
Myalgia
1.7
28.3
632
4028
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
28.2
905
6301
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
+∞
28.2
27
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
28.1
1260
9416
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
6.0
28.1
49
82
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
28.0
1388
10584
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.9
27.8
365
1989
XKD00
NOMESCO Finland
Uroflowmetry
1.8
27.8
502
3019
K60.3
ICD-10 Finland
Anal fistula
3.8
27.8
86
232
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
27.8
152
577
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
27.3
1039
7498
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.5
27.1
1084
7902
L17
ICPC
Foot/toe symptom/complaint
1.5
27.1
1252
9401
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
27.1
776
5258
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
27.1
714
4743
TJF80
NOMESCO Finland
Ostomy education
4.6
27.1
64
141
R01AD09
ATC
mometasone; nasal
1.4
27.0
1779
14282
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
26.9
267
1317
N06AB03
ATC
fluoxetine; oral
1.7
26.9
496
2999
L04AA06
ATC
mycophenolic acid; systemic
3.4
26.9
97
290
SPAT1240
SPAT
Therapeutic discussion
1.8
26.8
420
2420
N04BC05
ATC
pramipexole; oral
1.9
26.7
331
1770
M01AE02
ATC
naproxen; oral, rectal
1.4
26.6
2194
18322
S97
ICPC
Chronic ulcer skin
2.1
26.4
265
1314
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.4
26.3
193
842
JAH01
NOMESCO Finland
Laparoscopy
2.3
26.2
197
868
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
26.2
562
3540
JFH10
NOMESCO Finland
Total colectomy and ileostomy
37.0
26.1
33
9
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.0
26.1
118
404
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
26.0
2625
22696
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
26.0
1117
8253
Z01.9
ICD-10 Finland
Special examination, unspecified
2.1
26.0
268
1342
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
25.9
2133
17777
A03FA02
ATC
cisapride; oral, rectal
2.0
25.5
308
1631
M01AB05
ATC
diclofenac; systemic, rectal
1.4
25.5
2544
21905
A01AB09
ATC
miconazole; local oral
1.9
25.5
352
1949
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.6
25.4
149
586
M01AH01
ATC
celecoxib; oral
1.6
25.3
704
4729
N05BA01
ATC
diazepam; systemic, rectal
1.7
25.2
507
3138
M04AA01
ATC
allopurinol; systemic
1.7
25.2
462
2787
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.8
25.1
131
485
G47.3
ICD-10 Finland
Sleep apnoea
1.5
25.1
845
5927
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
25.0
347
1924
R63.4
ICD-10 Finland
Abnormal weight loss
2.3
24.8
190
844
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
24.8
207
954
L01BA01
ATC
methotrexate; systemic
2.5
24.8
165
689
D99
ICPC
Disease digestive system other
4.4
24.8
62
143
A02BC04
ATC
rabeprazole; oral
1.8
24.6
369
2097
D17
ICPC
Incontinence of bowel
4.1
24.6
67
165
6419
FHL
Other measure in this category
43.1
24.5
30
7
J01FA09
ATC
clarithromycin; systemic
1.5
24.4
1187
8962
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
9.4
24.4
29
31
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
24.2
437
2623
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
7.6
24.2
34
45
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.7
24.1
128
479
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
24.0
644
4285
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
24.0
495
3083
N06AX26
ATC
vortioxetine; oral
1.9
23.9
317
1731
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
23.8
1769
14400
N03AE01
ATC
clonazepam; systemic
2.1
23.8
245
1226
F34.1
ICD-10 Finland
Dysthymia
2.4
23.7
166
710
J01CA04
ATC
amoxicillin; systemic
1.5
23.6
3228
29237
3AC01, ,
NOMESCO Finland
4.7
23.6
54
116
K63.9
ICD-10 Finland
Disease of intestine, unspecified
5.9
23.5
42
72
L28
ICPC
Limited function/disability (L)
1.5
23.5
775
5403
D07AB08
ATC
desonide; topical
1.7
23.4
420
2516
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.9
23.2
294
1583
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
2.6
23.2
131
506
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
23.1
241
1211
J01DA01
ATC
[U] cefalexin
1.4
23.0
2345
20084
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.7
23.0
518
3300
N06AX03
ATC
mianserin; oral
2.2
22.9
201
946
A08.5
ICD-10 Finland
Other specified intestinal infections
5.5
22.9
44
81
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.6
22.7
137
546
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.4
22.7
158
674
SFA10
NOMESCO Finland
One-surface restoration
1.4
22.7
2122
17901
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.2
22.6
188
865
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
22.5
979
7215
L04AB06
ATC
golimumab; parenteral
5.0
22.5
48
97
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
8.8
22.4
28
32
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
22.4
395
2355
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.9
22.3
276
1473
F32
ICD-10 Finland
Depressive episode
2.1
22.2
221
1092
R55
ICD-10 Finland
Syncope and collapse
1.7
22.2
427
2608
M79.7
ICD-10 Finland
Fibromyalgia
2.3
22.2
162
706
C05AA08
ATC
fluocortolone; rectal, topical
1.6
22.1
508
3250
N03AX09
ATC
lamotrigine; oral
2.2
22.1
194
913
A04AA01
ATC
ondansetron; systemic, rectal
1.8
22.1
345
1984
SPAT1254
SPAT
Administration of medicine
1.6
22.0
564
3706
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
21.9
379
2246
K52.8
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
+∞
21.9
21
*
R13
ICD-10 Finland
Dysphagia
1.9
21.9
301
1664
ZXA10
NOMESCO Finland
Bilateral
1.5
21.7
699
4837
SPAT1262
SPAT
Handing over of treatment supplies
1.6
21.7
631
4270
B01AB10
ATC
tinzaparin; parenteral
1.7
21.6
439
2720
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
21.6
251
1312
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.2
21.5
190
896
M01AB55
ATC
diclofenac, combinations; oral
1.9
21.5
271
1456
L04AD02
ATC
tacrolimus; systemic
4.2
21.4
56
134
JFB00
NOMESCO Finland
Partial resection of small intestine
3.5
21.4
73
211
R03BB04
ATC
tiotropium bromide; inhalant
1.8
21.4
371
2200
K02.1
ICD-10 Finland
Caries of dentine
1.4
21.3
2246
19229
K58.1
ICD-10 Finland
Irritable bowel syndrome with predominant diarrhoea [IBS-D]
4.5
21.2
52
118
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
21.2
238
1228
D18
ICPC
Change in faeces/bowel movements
2.5
21.2
129
517
K58
ICD-10 Finland
Irritable bowel syndrome
2.6
21.1
123
482
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
21.1
314
1778
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
21.1
1479
11848
J01FA06
ATC
roxithromycin; oral
1.4
21.1
1498
12026
J20
ICD-10 Finland
Acute bronchitis
1.7
21.1
414
2541
E000001, ,
ATC
1.5
21.0
728
5114
D93
ICPC
Irritable bowel syndrome
3.4
21.0
75
223
WX320
NOMESCO Finland
Spinalanesthesy
1.5
21.0
946
7006
A03BA03
ATC
hyoscyamine; oral
4.6
21.0
49
107
K59.09
ICD-10 Finland
Constipation, unspecified
1.9
20.9
287
1585
M05BA04
ATC
alendronic acid; oral
1.7
20.9
368
2191
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
20.9
1117
8537
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
2.5
20.8
128
515
L04AA33
ATC
[U] vedolizumab
+∞
20.8
20
*
M02AA07
ATC
piroxicam; topical
1.4
20.8
1344
10614
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.1
20.8
212
1057
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
20.7
268
1452
R52.2
ICD-10 Finland
Other chronic pain
2.2
20.7
170
779
K62.4
ICD-10 Finland
Stenosis of anus and rectum
8.7
20.6
26
30
RD210, ,
NOMESCO Finland
3.2
20.6
81
256
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.2
20.5
184
873
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
20.5
298
1675
UJD02
NOMESCO Finland
Gastroscopy
2.1
20.5
191
920
1370
FHL
Colonoscopy, whole colon
8.2
20.5
27
33
SPAT1260
SPAT
Consultation of another employee
1.5
20.5
660
4564
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.7
20.5
373
2242
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
20.5
424
2639
SFA20
NOMESCO Finland
Two-surface restoration
1.4
20.4
2226
19099
J05AB01
ATC
aciclovir; systemic
1.5
20.4
845
6152
L04AA13
ATC
[U] leflunomide
2.6
20.4
114
438
J01EA01
ATC
trimethoprim; systemic
1.4
20.4
1017
7669
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.9
20.3
248
1317
WZA90
NOMESCO Finland
Other medical or dental certificate
1.5
20.3
881
6473
SPAT1131
SPAT
Colonoscopy
2.5
20.3
132
546
A46
ICD-10 Finland
Erysipelas
1.6
20.3
536
3544
ZY010
NOMESCO Finland
Hospital outpatient
2.1
20.3
205
1019
4AB02, ,
NOMESCO Finland
16.1
20.1
32
20
M01AC06
ATC
meloxicam; systemic, rectal
1.4
20.0
1366
10874
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.5
19.9
780
5613
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
19.9
371
2243
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.7
19.9
104
386
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
4.4
19.9
49
112
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.6
19.8
117
462
4AA33, ,
NOMESCO Finland
+∞
19.8
19
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.0
19.8
218
1118
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
5.8
19.7
36
63
NF1AA
NOMESCO Finland
Hip X-ray examination
1.7
19.7
365
2204
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
19.7
481
3121
R02
ICPC
Shortness of breath/dyspnoea
1.6
19.6
546
3653
JFH11
NOMESCO Finland
Laparoscopic colectomy
200.9
19.6
20
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.8
19.4
94
335
N06AB05
ATC
paroxetine; oral
1.9
19.4
236
1252
SCA01
NOMESCO Finland
Preventive oral health care, short
1.4
19.4
1071
8213
J05AB11
ATC
valaciclovir; oral
1.6
19.2
565
3824
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
19.2
502
3307
JN4BD
NOMESCO Finland
Extensive body CT
1.7
19.2
375
2296
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.7
19.2
388
2398
C01DA14
ATC
isosorbide mononitrate; oral
1.6
19.1
515
3420
R07.3
ICD-10 Finland
Other chest pain
1.7
19.0
408
2562
M01AH02
ATC
rofecoxib; oral
1.6
18.9
468
3043
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.4
18.9
126
527
JHD00
NOMESCO Finland
Anal dilatation
4.5
18.9
45
100
R35
ICD-10 Finland
Polyuria
1.9
18.8
257
1416
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
4.0
18.8
53
134
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.7
18.7
97
359
R60.0
ICD-10 Finland
Localized oedema
1.6
18.6
496
3283
N07BA03
ATC
varenicline; oral
2.1
18.6
178
867
L13
ICPC
Hip symptom/complaint
1.5
18.5
786
5736
K65.0
ICD-10 Finland
Acute peritonitis
4.0
18.4
52
132
R03DC03
ATC
montelukast; oral
1.5
18.4
634
4441
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
3.0
18.3
81
275
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
18.3
245
1343
R05
ICPC
Cough
1.4
18.3
979
7456
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
18.2
661
4678
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.8
18.0
255
1422
P03
ICPC
Feeling depressed
1.7
18.0
383
2398
R51
ICD-10 Finland
Headache
1.9
18.0
225
1206
P06
ICPC
Sleep disturbance
1.6
17.9
498
3327
A06AD11
ATC
lactulose; oral
1.5
17.9
525
3550
UGC12
NOMESCO Finland
Flexible bronchoscopy
1.8
17.8
271
1544
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
1.8
17.8
273
1559
J02AC02
ATC
itraconazole; systemic
1.5
17.8
654
4636
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
17.8
326
1960
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
17.8
234
1274
D07AA02
ATC
hydrocortisone; topical
1.6
17.8
509
3423
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.9
17.8
84
296
H03AA01
ATC
levothyroxine sodium; systemic
1.4
17.7
918
6946
A28
ICPC
Limited function/disability NOS
1.5
17.7
684
4900
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
17.6
396
2513
J45
ICD-10 Finland
Asthma
1.6
17.6
404
2578
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
36.9
17.6
22
6
K56.0
ICD-10 Finland
Paralytic ileus
4.3
17.6
45
106
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.7
17.6
93
348
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.5
17.6
59
169
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.3
17.5
127
552
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
17.5
1455
11881
R01AD12
ATC
fluticasone furoate; nasal
1.4
17.5
1163
9171
G04CA02
ATC
tamsulosin; oral
1.5
17.5
635
4491
127
Kela drug reimbursment
Transplant complication
3.2
17.5
67
209
S29
ICPC
Skin symptom/complaint other
1.4
17.5
799
5908
J37.0
ICD-10 Finland
Chronic laryngitis
2.3
17.5
139
629
ZXH04
NOMESCO Finland
Procedure performed in other inpatient unit
5.1
17.4
36
71
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.4
17.4
981
7527
L88
ICPC
Rheumatoid/seropositive arthritis
2.1
17.4
174
862
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.7
17.3
361
2247
R05
ICD-10 Finland
Cough
1.4
17.3
834
6223
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
17.3
1573
13012
TPH40
NOMESCO Finland
Insertion of a long peripheral venous catheter
4.1
17.3
47
116
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.9
17.3
216
1157
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
17.2
546
3752
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
17.2
549
3778
R06AX27
ATC
desloratadine; oral
1.4
17.2
1075
8387
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
3.1
17.2
73
242
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.2
17.2
152
718
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
17.1
271
1563
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
17.1
182
922
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.8
17.1
252
1423
N05BA12
ATC
alprazolam; oral
1.6
17.1
376
2374
M01AX17
ATC
nimesulide; oral
1.4
17.0
862
6490
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
17.0
302
1802
SPAT1301
SPAT
No procedures
1.4
16.9
1142
9018
XQ800
NOMESCO Finland
Prick test
1.8
16.9
276
1608
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.5
16.8
540
3720
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
16.8
1496
12324
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
16.8
286
1686
A98
ICPC
Health maint/preventive medicine
2.0
16.8
3915
37690
JK3MN
NOMESCO Finland
Bile absorbtion isotope examination
63.6
16.7
19
*
R01AD58
ATC
fluticasone, combinations; nasal
1.4
16.7
918
7006
A07EC03
ATC
olsalazine; oral
+∞
16.7
16
*
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
+∞
16.7
16
*
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
16.6
451
2993
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
3.1
16.6
70
231
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
4.6
16.6
39
86
D82
ICPC
Teeth/gum disease
1.3
16.6
1388
11324
R4110, ,
SPAT
1.5
16.5
540
3735
SPAT1312
SPAT
General health counselling
1.4
16.5
1153
9149
XF404
NOMESCO Finland
Ambulatory ECG
1.7
16.5
313
1901
Z2446
NOMESCO Finland
Social worker
1.8
16.4
240
1351
M02AA10
ATC
ketoprofen; topical
1.5
16.4
589
4151
J45.1
ICD-10 Finland
Nonallergic asthma
1.8
16.4
276
1620
A41.9
ICD-10 Finland
Sepsis, unspecified
2.2
16.4
132
601
L08
ICPC
Shoulder symptom/complaint
1.4
16.4
885
6732
S06.0
ICD-10 Finland
Concussion
1.6
16.4
405
2631
XF402
NOMESCO Finland
ECG with work load test
1.6
16.4
376
2399
UJF34
NOMESCO Finland
Left colonoscopy
4.7
16.3
37
79
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.1
16.3
44
108
C07AB02
ATC
metoprolol; systemic
1.4
16.3
693
5049
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.1
16.2
150
721
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.9
16.2
201
1074
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.6
16.2
348
2184
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.3
16.2
1860
15864
A03
ICPC
Fever
1.5
16.1
628
4497
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.1
16.1
157
770
JF2AB
NOMESCO Finland
Colongraphy with X-ray
7.1
16.1
24
34
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.6
16.1
90
347
KH1AD
NOMESCO Finland
CT of urinary organs
2.2
16.0
130
593
Z02.7
ICD-10 Finland
Issue of medical certificate
1.7
16.0
289
1731
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
16.0
128
581
C08CA01
ATC
amlodipine; oral
1.3
16.0
1402
11499
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.0
16.0
162
807
K63.3
ICD-10 Finland
Ulcer of intestine
21.0
16.0
23
11
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
15.9
487
3318
J01CA08
ATC
pivmecillinam; oral
1.3
15.9
1628
13647
F32.1
ICD-10 Finland
Moderate depressive episode
1.8
15.9
227
1269
J01MA06
ATC
norfloxacin; oral
1.5
15.9
479
3254
D02AE01
ATC
carbamide; topical
1.8
15.9
234
1321
UJH02
NOMESCO Finland
Anoscopy
2.1
15.9
157
775
G43.9
ICD-10 Finland
Migraine, unspecified
1.8
15.8
232
1308
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.8
15.8
264
1547
UJG02
NOMESCO Finland
Proctoscopy
2.6
15.8
90
350
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.7
15.8
83
310
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
15.8
664
4826
B01AC04
ATC
clopidogrel; oral
1.5
15.7
556
3905
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
6.9
15.7
24
35
K29.0
ICD-10 Finland
Acute haemorrhagic gastritis
4.9
15.7
34
70
U07
ICPC
Urine symptom/complaint other
1.6
15.6
337
2115
6410
FHL
Panprococolectomy and ileostomy
+∞
15.6
15
*
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
17.2
15.6
24
14
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
3.2
15.6
61
193
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
1.9
15.6
196
1053
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
15.5
391
2550
SPAT1153
SPAT
Removal of sutures
1.4
15.5
1128
8989
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
15.5
1151
9203
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.1
15.5
140
668
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
3.8
15.4
46
122
GD1AD
NOMESCO Finland
Thorax CT examination
1.8
15.3
236
1350
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
1.7
15.3
270
1607
Z94.4
ICD-10 Finland
Liver transplant status
6.7
15.3
24
36
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
15.2
1091
8668
SPAT1104
SPAT
Monitoring of emergency patient
1.8
15.2
236
1353
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.7
15.2
296
1809
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
15.2
697
5143
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.1
15.2
146
713
N05BE01
ATC
buspirone; oral
2.3
15.2
114
504
E000006, ,
ATC
1.8
15.1
253
1483
K76.9
ICD-10 Finland
Liver disease, unspecified
3.1
15.1
63
207
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
15.1
187
999
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
20.1
15.1
22
11
N06AG02
ATC
moclobemide; oral
2.0
15.0
159
804
P76
ICPC
Depressive disorder
1.7
15.0
253
1486
SFA30
NOMESCO Finland
Three-surface restoration
1.3
15.0
1541
12895
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.6
15.0
396
2612
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
15.0
565
4019
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.4
14.9
1077
8562
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.4
14.9
104
445
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
14.9
222
1258
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.0
14.9
66
225
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.4
14.8
963
7532
R33
ICD-10 Finland
Retention of urine
1.8
14.8
245
1432
TQW40
NOMESCO Finland
Remowal of suture of skin
1.7
14.8
264
1577
M45
ICD-10 Finland
Ankylosing spondylitis
2.7
14.8
76
281
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.1
14.7
132
628
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.7
14.7
289
1772
A11
ICPC
Chest pain NOS
1.6
14.7
330
2094
Z00.0
ICD-10 Finland
General medical examination
1.4
14.6
711
5297
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
14.6
224
1281
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
80.4
14.6
16
*
P01
ICPC
Feeling anxious/nervous/tense
1.5
14.5
450
3075
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
14.5
763
5766
R21
ICPC
Throat symptom/complaint
1.4
14.4
769
5821
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
14.4
991
7818
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
2.8
14.4
71
257
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
14.3
154
784
WX290
NOMESCO Finland
Other blockage of nerve
1.3
14.3
1718
14654
R07.0
ICD-10 Finland
Pain in throat
1.7
14.3
271
1646
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
2.8
14.2
69
247
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
14.2
137
670
R74
ICPC
Upper respiratory infection acute
1.3
14.2
1196
9715
I50.9
ICD-10 Finland
Heart failure, unspecified
1.5
14.2
455
3130
R51.81
ICD-10 Finland
Facial pain NOS
2.3
14.2
105
462
R20.2
ICD-10 Finland
Paraesthesia of skin
1.7
14.2
262
1580
K86.1
ICD-10 Finland
Other chronic pancreatitis
4.0
14.1
40
102
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
14.1
417
2818
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.0
14.1
152
775
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.0
14.1
158
817
SXC05
NOMESCO Finland
Other oral or dental procedure
1.7
14.0
241
1425
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.1
14.0
125
594
P74
ICPC
Anxiety disorder/anxiety state
1.9
13.9
179
968
WW200
NOMESCO Finland
Immunization
2.3
13.9
100
434
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.1
13.9
131
635
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
13.9
180
976
WW500
NOMESCO Finland
Blood transfusion
2.0
13.9
147
744
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.3
13.8
103
454
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.7
13.8
75
285
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.0
13.8
152
780
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.7
13.8
283
1753
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.3
13.8
1775
15250
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.6
13.8
77
297
N01
ICPC
Headache
1.5
13.7
417
2834
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.4
13.7
695
5210
SPAT1138
SPAT
Guidance concerning bowel function
2.8
13.7
67
241
XX9XE
NOMESCO Finland
Other ultrasound examination
3.7
13.7
43
118
C03DA01
ATC
spironolactone; oral
1.5
13.7
436
2994
I95.1
ICD-10 Finland
Orthostatic hypotension
2.0
13.7
142
714
N03AX11
ATC
topiramate; oral
2.4
13.6
96
413
107
Kela drug reimbursment
Pernicious anaemia
2.8
13.6
69
253
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
13.6
188
1041
EB1VA, ,
NOMESCO Finland
1.4
13.6
652
4841
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
13.6
305
1933
R03BA05
ATC
fluticasone; inhalant
1.4
13.6
646
4791
K08.80
ICD-10 Finland
Toothache NOS
1.6
13.5
328
2118
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
13.5
13
*
M09.2*K51.9
ICD-10 Finland
Juvenile arthritis in ulcerative colitis
+∞
13.5
13
*
K03.66
ICD-10 Finland
Tooth plaque
1.6
13.5
290
1817
JHW96
NOMESCO Finland
Other operation on anus or perianal tissue
5.4
13.5
26
48
L02
ICPC
Back symptom/complaint
1.5
13.5
389
2614
SPAT1255
SPAT
Intravenous administration of medicine
1.7
13.5
237
1409
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.0
13.5
153
794
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
13.5
486
3422
R12
ICD-10 Finland
Heartburn
1.6
13.5
319
2049
D05AX52
ATC
calcipotriol, combinations; topical
1.8
13.5
185
1023
X58
ICD-10 Finland
Exposure to other specified factors
1.5
13.4
521
3720
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
13.4
464
3239
N06AA12
ATC
doxepin; systemic
1.8
13.4
187
1039
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
13.4
319
2052
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.2
13.4
51
159
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
3.3
13.4
49
149
K86.8
ICD-10 Finland
Other specified diseases of pancreas
6.1
13.4
23
38
D07XC01
ATC
betamethasone; topical
1.5
13.4
412
2809
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
1.9
13.4
159
839
N06AX05
ATC
trazodone; oral
2.3
13.3
99
436
U71
ICPC
Cystitis/urinary infection other
1.6
13.3
281
1754
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
1.9
13.3
174
947
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
13.3
970
7703
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.8
13.3
203
1160
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
13.3
678
5089
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.7
13.1
69
258
M54.6
ICD-10 Finland
Pain in thoracic spine
1.6
13.1
277
1730
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.9
13.1
28
57
D29
ICPC
Digestive symptom/complaint other
2.3
13.0
98
434
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.4
13.0
537
3879
D01BA02
ATC
terbinafine; oral
1.4
13.0
869
6807
L86
ICPC
Back syndrome with radiating pain
1.7
13.0
237
1424
R03AK08
ATC
formoterol and beclometasone; inhalant
1.9
12.9
176
970
U02
ICPC
Urinary frequency/urgency
1.4
12.9
579
4246
R03BA02
ATC
budesonide; inhalant
1.4
12.8
641
4790
SHB00
NOMESCO Finland
Preparing and fitting the occlusal splint in the mouth
1.6
12.8
349
2317
R03BA08
ATC
ciclesonide; inhalant
1.6
12.8
322
2099
K20
ICD-10 Finland
Oesophagitis
2.6
12.7
70
268
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
12.7
310
2005
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.8
12.7
180
1005
-54
ICPC
Repair/fix-suture/cast/prosth device
2.4
12.7
85
358
L43.8
ICD-10 Finland
Other lichen planus
2.5
12.7
76
304
N20.1
ICD-10 Finland
Calculus of ureter
2.1
12.6
122
598
A02BA04
ATC
nizatidine; systemic
1.7
12.5
258
1600
K29.6
ICD-10 Finland
Other gastritis
3.0
12.5
53
176
H01
ICPC
Ear pain/earache
1.5
12.5
435
3039
K29.4
ICD-10 Finland
Chronic atrophic gastritis
2.5
12.5
78
318
SPAT1216
SPAT
Assessment of functional ability
1.4
12.5
545
3978
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
12.5
221
1318
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.9
12.5
149
788
SPAT1229
SPAT
Assessment of need for aid
1.6
12.4
272
1713
D09
ICPC
Nausea
1.8
12.4
181
1019
R31
ICD-10 Finland
Unspecified haematuria
1.6
12.4
317
2072
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
12.4
410
2835
120
Kela drug reimbursment
Hypogammaglobulinaemia
13.2
12.4
21
16
S21
ICPC
Skin texture symptom/complaint
1.4
12.4
562
4129
F33
ICD-10 Finland
Recurrent depressive disorder
2.3
12.3
87
375
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.9
12.3
157
848
UJF32, ,
SPAT
2.0
12.3
131
666
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
12.3
279
1775
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.5
12.3
367
2486
D70.82
ICD-10 Finland
Drug-induced neutropenia
2.7
12.3
64
239
R4120
NOMESCO Finland
Occupational therapy
1.7
12.2
240
1471
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
12.2
116
565
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
1.8
12.2
171
952
G01AF05
ATC
econazole; vaginal
1.6
12.1
279
1779
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
12.1
213
1267
L29.9
ICD-10 Finland
Pruritus, unspecified
2.1
12.1
116
567
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
12.4
12.1
21
17
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
4.0
12.1
33
82
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.6
12.0
66
253
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.7
12.0
218
1309
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.0
12.0
135
700
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.4
11.9
77
319
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.6
11.9
289
1867
D16
ICPC
Rectal bleeding
2.2
11.9
95
432
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.8
11.9
60
220
ZX108
NOMESCO Finland
Inhalation
3.8
11.9
35
92
ZXA00
NOMESCO Finland
Right side
1.3
11.9
909
7253
W19
ICD-10 Finland
Unspecified fall
1.5
11.8
347
2340
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.5
11.8
369
2522
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.5
11.8
341
2292
L12
ICPC
Hand/finger symptom/complaint
1.4
11.8
636
4811
A29
ICPC
General symptom/complaint other
1.4
11.8
495
3586
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.3
11.7
1296
10857
E000002, ,
ATC
1.5
11.7
366
2500
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.0
11.7
49
162
R01AD11
ATC
triamcinolone; nasal
1.6
11.7
303
1988
R5110, ,
SPAT
1.5
11.7
332
2224
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
1.6
11.7
252
1583
G44.0
ICD-10 Finland
Cluster headache syndrome
3.1
11.7
47
152
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.5
11.6
325
2168
6525
FHL
Enterostomy occlusion
30.1
11.6
15
5
OAB50, ,
SPAT
1.6
11.6
283
1830
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
1.3
11.6
1179
9769
K90.4
ICD-10 Finland
Malabsorption due to intolerance, not elsewhere classified
12.6
11.6
20
16
N17.8
ICD-10 Finland
Other acute renal failure
2.9
11.6
52
179
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
11.5
259
1642
N06AX22
ATC
agomelatine; oral
2.2
11.5
91
412
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
11.5
236
1462
SDA04
NOMESCO Finland
Demanding periodontal treatment
1.3
11.5
1037
8456
E000003, ,
ATC
1.9
11.5
149
809
J01MA01
ATC
ofloxacin; systemic
1.6
11.5
266
1699
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
11.5
401
2803
KED33
NOMESCO Finland
Transurethral incision of prostate
3.3
11.5
43
133
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
2.1
11.5
107
518
A10AB05
ATC
insulin aspart; parenteral
1.6
11.5
257
1629
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
2.0
11.4
128
662
K29.8
ICD-10 Finland
Duodenitis
3.6
11.4
37
104
R60.9
ICD-10 Finland
Oedema, unspecified
1.7
11.4
208
1250
SPAT1139
SPAT
Nutrition survey
2.0
11.4
125
642
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.4
11.4
75
314
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
1.9
11.4
139
741
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.9
11.3
147
800
H92.0
ICD-10 Finland
Otalgia
1.6
11.3
239
1494
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.3
11.3
773
6064
M10.9
ICD-10 Finland
Gout, unspecified
1.7
11.3
220
1347
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
4.2
11.3
29
69
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.6
11.3
233
1448
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
11.2
104
502
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
2.1
11.2
99
469
Z98.8
ICD-10 Finland
Other specified postsurgical states
2.7
11.2
58
216
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.3
11.2
81
354
B82
ICPC
Anaemia other/unspecified
2.1
11.2
109
537
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
2.3
11.1
86
386
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
2.2
11.1
96
451
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.1
11.1
107
525
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
2.3
11.1
79
343
G54.0
ICD-10 Finland
Brachial plexus disorders
2.2
11.1
94
439
D01AE16
ATC
amorolfine; topical
1.5
11.0
401
2825
Z43.2
ICD-10 Finland
Attention to ileostomy
11.2
11.0
20
18
H53.9
ICD-10 Finland
Visual disturbance, unspecified
1.9
11.0
143
778
D64.8
ICD-10 Finland
Other specified anaemias
2.4
11.0
74
313
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
11.0
939
7599
A99
ICPC
Disease/condition unspecnature/site
1.5
11.0
384
2686
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.8
10.9
160
903
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.7
10.9
207
1257
D72.1
ICD-10 Finland
Eosinophilia
4.7
10.9
25
54
SBA00
NOMESCO Finland
Microbiological examinations
2.1
10.9
99
475
A10AC01
ATC
insulin (human); parenteral
1.6
10.9
240
1516
D02AX
ATC
Other emollients and protectives
2.0
10.8
109
543
J01DA09
ATC
[U] cefadroxil
1.3
10.8
897
7224
N18.8
ICD-10 Finland
Other chronic renal failure
2.3
10.8
77
334
K07.60
ICD-10 Finland
Snapping jaw
1.7
10.8
187
1108
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.8
10.8
170
981
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.5
10.8
371
2586
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.1
10.7
104
511
U01
ICPC
Dysuria/painful urination
1.5
10.7
304
2034
Z93
ICD-10 Finland
Artificial opening status
8.8
10.7
22
25
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.0
10.7
120
621
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.9
10.7
49
171
E83.51
ICD-10 Finland
Hypocalcemia
3.7
10.7
33
90
B80
ICPC
Iron deficiency anaemia
2.1
10.7
102
499
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
10.7
285
1883
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
10.6
281
1854
EBA00
NOMESCO Finland
Extraction of tooth
1.3
10.6
1286
10871
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.5
10.6
369
2579
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.3
10.6
74
319
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.0
10.6
107
535
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.8
10.5
152
855
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
5.0
10.5
22
44
WYA10
NOMESCO Finland
Emergency care or similar visit
1.6
10.5
251
1618
M54
ICD-10 Finland
Dorsalgia
1.4
10.4
443
3213
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
+∞
10.4
10
*
K52.1
ICD-10 Finland
Toxic gastroenteritis and colitis
+∞
10.4
10
*
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.4
10.4
68
284
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.9
10.4
132
713
L20
ICPC
Joint symptom/complaint NOS
1.8
10.4
145
807
C08CA05
ATC
nifedipine; systemic
1.7
10.4
191
1151
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
4.2
10.3
27
65
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.3
10.3
77
341
M01AG02
ATC
tolfenamic acid; oral, rectal
1.4
10.3
518
3866
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
10.3
476
3502
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
10.3
574
4357
L29
ICPC
Musculoskeletal sympt/complt other
1.5
10.3
333
2291
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
2.5
10.3
64
261
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
1.9
10.3
122
644
-1, ,
NOMESCO Finland
1.3
10.3
1143
9550
K59.8
ICD-10 Finland
Other specified functional intestinal disorders
3.9
10.3
29
74
R25.2
ICD-10 Finland
Cramp and spasm
2.1
10.3
92
439
XKC03
NOMESCO Finland
Water cystometry
2.0
10.3
110
561
SPAT1283
SPAT
Restricted health certificate
1.4
10.3
534
4009
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.7
10.3
195
1186
5604
FHL
Vascular preparation or cannulation in the operating room
10.6
10.3
19
18
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
2.8
10.3
49
175
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
2.2
10.3
84
387
JHD20
NOMESCO Finland
Incision of fistula-in-ano
3.3
10.2
38
117
C09CA06
ATC
candesartan; oral
1.3
10.2
860
6933
H57.1
ICD-10 Finland
Ocular pain
1.8
10.2
148
833
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.5
10.2
64
262
00919
ICD-8 Finland
Diarrhoeal disease, Diarrhoea
4.7
10.2
23
49
M05BX04
ATC
denosumab; parenteral
1.6
10.2
242
1555
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.4
10.2
69
293
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
10.2
619
4763
S76
ICPC
Skin infection other
1.7
10.2
190
1150
L43.9
ICD-10 Finland
Lichen planus, unspecified
2.2
10.2
79
356
M01AB01
ATC
indometacin; systemic, rectal
1.6
10.2
224
1415
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.0
10.2
100
495
R05FB02
ATC
cough suppressants and expectorants; systemic
1.3
10.1
1293
10980
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.3
10.1
77
344
SBB00
NOMESCO Finland
Clinical photography of mouth and teeth
1.9
10.1
117
613
R10.2
ICD-10 Finland
Pelvic and perineal pain
2.1
10.1
89
422
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.4
10.1
36
108
M54.1
ICD-10 Finland
Radiculopathy
1.8
10.1
144
807
NA6CG
NOMESCO Finland
Sacro-iliac joint extensive MRI examination with high intensity magnet
5.3
10.1
20
38
R00.2
ICD-10 Finland
Palpitations
1.5
10.1
288
1931
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.7
10.1
182
1092
SHA03
NOMESCO Finland
Stomatognathic treatment, demanding
1.9
10.1
116
607
SHA01
NOMESCO Finland
Stomatognathic treatment, simple
1.5
10.1
373
2637
TK800
NOMESCO Finland
Hemodialysis
2.3
10.1
70
301
M76.0
ICD-10 Finland
Gluteal tendinitis
2.1
10.1
95
463
N03AG01
ATC
valproic acid; systemic, rectal
1.7
10.1
193
1177
M54.2
ICD-10 Finland
Cervicalgia
1.5
10.0
291
1958
J01CF05
ATC
flucloxacillin; systemic
1.6
10.0
242
1563
I95.9
ICD-10 Finland
Hypotension, unspecified
2.5
10.0
61
247
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
10.0
303
2058
R39.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the urinary system
3.2
10.0
38
119
K29.9
ICD-10 Finland
Gastroduodenitis, unspecified
3.3
10.0
36
109
D10
ICPC
Vomiting
1.7
10.0
201
1242
G43
ICD-10 Finland
Migraine
1.7
9.9
174
1036
N94.5
ICD-10 Finland
Secondary dysmenorrhoea
2.4
9.9
63
260
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.5
9.9
62
254
K63.8
ICD-10 Finland
Other specified diseases of intestine
7.6
9.9
22
29
N02CC06
ATC
eletriptan; oral
1.9
9.9
120
640
Z73.6
ICD-10 Finland
Limitation of activities due to disability
3.2
9.8
37
115
UJK12
NOMESCO Finland
Peroral cholangioscopy
12.2
9.8
17
14
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
2.1
9.8
92
447
C10AC02
ATC
colestipol; oral
8.1
9.8
21
26
M01CB01
ATC
sodium aurothiomalate; parenteral
2.6
9.8
55
214
K55.8
ICD-10 Finland
Other vascular disorders of intestine
4.9
9.8
21
43
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.2
9.8
80
369
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
2.7
9.8
49
180
SDA03
NOMESCO Finland
Periodontal treatment
1.2
9.7
1453
12546
TQW99
NOMESCO Finland
Other minor procedure on skin
1.7
9.7
174
1041
L15
ICPC
Knee symptom/complaint
1.3
9.7
931
7628
Z01.7
ICD-10 Finland
Laboratory examination
1.3
9.7
602
4644
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
1.8
9.7
131
722
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.1
9.7
89
429
U13
ICPC
Bladder symptom/complaint other
2.0
9.7
108
559
B37.0
ICD-10 Finland
Candidal stomatitis
2.8
9.7
48
175
J01XX08
ATC
linezolid; systemic
3.7
9.7
30
82
J01FA01
ATC
erythromycin; systemic
1.4
9.7
453
3342
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.3
9.7
67
288
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
1.9
9.6
111
581
N17
ICPC
Vertigo/dizziness
1.4
9.6
478
3560
H66.9
ICD-10 Finland
Otitis media, unspecified
1.6
9.6
221
1411
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
1.9
9.6
109
568
Z00.8
ICD-10 Finland
Other general examinations
1.5
9.6
277
1862
UDC00
NOMESCO Finland
Ear microscopy
1.6
9.6
247
1619
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.4
9.6
486
3632
D02
ICPC
Abdominal pain epigastric
1.6
9.6
231
1491
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
1.9
9.6
119
639
A11CC03
ATC
alfacalcidol; systemic
2.2
9.6
80
372
D01AE15
ATC
terbinafine; topical
1.6
9.6
228
1468
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
9.6
446
3287
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.7
9.5
177
1070
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.4
9.5
367
2614
R39.1
ICD-10 Finland
Other difficulties with micturition
2.0
9.5
102
521
L04AB01
ATC
etanercept; parenteral
2.4
9.5
61
253
G04BD12
ATC
mirabegron; oral
1.4
9.5
430
3152
XW000
NOMESCO Finland
Bone marrow biopsy
1.8
9.5
140
793
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.7
9.5
188
1156
SPAT1125
SPAT
Stoma care and guidance
2.5
9.5
59
241
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.4
9.5
488
3655
G50.1
ICD-10 Finland
Atypical facial pain
2.3
9.5
69
303
SFA00
NOMESCO Finland
Small restoration
1.4
9.4
488
3658
L01
ICPC
Neck symptom/complaint
1.3
9.4
599
4636
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
1.9
9.4
122
664
Z3229
NOMESCO Finland
Other healthcare associate professional
1.5
9.4
268
1796
Z90.4
ICD-10 Finland
Acquired absence of other parts of digestive tract
100.3
9.4
10
*
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
100.3
9.4
10
*
K60.1
ICD-10 Finland
Chronic anal fissure
2.1
9.4
84
401
ZA1.0
ICD-10 Finland
Shoulder region
2.1
9.4
88
428
C08DA01
ATC
verapamil; systemic
1.8
9.4
142
811
WVA30, ,
SPAT
1.6
9.4
226
1459
D19
ICPC
Teeth/gum symptom/complaint
1.3
9.4
1093
9168
5563A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis
+∞
9.4
9
*
6437
FHL
Rectum resection and sphincter-sparing through-anastomosis
+∞
9.4
9
*
ZXA05
NOMESCO Finland
Left side
1.3
9.4
821
6647
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.2
9.4
79
369
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
8.0
9.3
20
25
L11
ICPC
Wrist symptom/complaint
1.5
9.3
343
2422
G04BD08
ATC
solifenacin; oral
1.6
9.3
227
1470
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.7
9.3
180
1101
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
2.2
9.3
77
357
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.7
9.3
171
1032
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.3
9.3
70
312
U05
ICPC
Urination problems other
1.7
9.3
184
1133
K55.2
ICD-10 Finland
Angiodysplasia of colon
3.6
9.3
29
80
L04AF03
ATC
upadacitinib; oral
9.5
9.3
18
19
TQW80
NOMESCO Finland
Local dermatologic skincare
2.0
9.2
96
485
N80.9
ICD-10 Finland
Endometriosis, unspecified
2.3
9.2
64
275
SPAT1211
SPAT
Application of soft bandage
1.5
9.2
297
2042
A01AB04
ATC
amphotericin B; local oral
1.7
9.2
154
905
WVA20, ,
SPAT
1.8
9.2
131
735
SPAT1281
SPAT
Other administrative function
1.5
9.2
261
1749
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
3.2
9.2
35
110
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.9
9.1
111
592
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.5
9.1
263
1767
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.7
9.1
166
999
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.4
9.1
59
246
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.1
9.1
85
413
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
2.9
9.1
41
142
XX2RW, ,
NOMESCO Finland
2.5
9.1
57
234
U04
ICPC
Incontinence urine
1.6
9.1
217
1398
D05BB02
ATC
acitretin; oral
2.1
9.1
78
367
M81.9
ICD-10 Finland
Osteoporosis, unspecified
1.7
9.1
175
1070
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
11.5
9.1
16
14
H60.8
ICD-10 Finland
Other otitis externa
1.9
9.0
110
587
A05
ICPC
Feeling ill
1.6
9.0
205
1305
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.3
9.0
67
297
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
2.1
9.0
79
375
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
9.0
253
1692
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
9.0
122
675
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.5
8.9
302
2097
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
1.7
8.9
152
898
UJK02
NOMESCO Finland
ERCP
2.0
8.9
92
464
SPAT1298
SPAT
Other function in accordance with nutritional therapy nomenclature
3.0
8.9
39
133
J01FA15
ATC
telithromycin; oral
1.5
8.9
322
2266
P29
ICPC
Psychological sympt/compl other
1.5
8.9
255
1712
XKD03
NOMESCO Finland
Urethral pressure profilometry
2.1
8.9
82
397
K29.1
ICD-10 Finland
Other acute gastritis
2.6
8.9
51
201
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
8.9
326
2302
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
1.8
8.8
139
804
I73.0
ICD-10 Finland
Raynaud syndrome
2.3
8.8
64
281
D12
ICPC
Constipation
1.8
8.8
134
767
WX419
NOMESCO Finland
Other general anesthesy
3.1
8.8
36
118
J01XE01
ATC
nitrofurantoin; oral
2.3
8.8
63
275
KCV04
NOMESCO Finland
Distension of bladder with fluid
2.9
8.8
39
134
SCA02
NOMESCO Finland
Preventive oral health care
1.4
8.8
335
2381
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.0
8.8
24
60
WX882
NOMESCO Finland
High dependency care
2.0
8.8
92
467
SAA04
NOMESCO Finland
Special examination of mouth
1.7
8.8
173
1064
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.6
8.8
195
1236
K25.7
ICD-10 Finland
Gastric ulcer, Chronic without haemorrhage or perforation
2.9
8.7
40
140
TNG10
NOMESCO Finland
Puncture of knee
2.7
8.7
45
168
1490
FHL
Sigmoideoscopy (fiberscope)
7.2
8.7
20
28
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
8.7
422
3129
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.4
8.7
57
239
X57
ICD-10 Finland
Unspecified privation
2.1
8.7
79
380
C05AA01
ATC
hydrocortisone; rectal, topical
1.7
8.7
170
1043
I50.0
ICD-10 Finland
Congestive heart failure
1.6
8.7
222
1453
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
2.9
8.7
39
135
TAB22
NOMESCO Finland
Stoppin epidural fluid escape with coagulated blood
2.9
8.7
39
135
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
8.7
696
5565
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
1.9
8.7
103
546
K10.3
ICD-10 Finland
Alveolitis of jaws
1.7
8.6
161
976
ZX114
NOMESCO Finland
Intramuscular
2.5
8.6
51
204
S22.3
ICD-10 Finland
Fracture of rib
1.5
8.6
235
1561
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
1.7
8.6
155
931
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
2.3
8.6
63
278
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
2.2
8.6
68
310
C10AA05
ATC
atorvastatin; oral
1.2
8.6
1461
12752
N05AH03
ATC
olanzapine; systemic
1.6
8.6
207
1338
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
2.1
8.6
75
356
K05.1
ICD-10 Finland
Chronic gingivitis
1.5
8.5
225
1483
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
1.7
8.5
157
948
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.5
8.5
50
199
XG474
NOMESCO Finland
Exhalation nntrogen oxide
2.0
8.5
89
451
E66.8
ICD-10 Finland
Other obesity
1.6
8.5
186
1174
M81.4
ICD-10 Finland
Drug-induced osteoporosis
3.8
8.5
25
66
S16
ICPC
Bruise/contusion
1.9
8.5
111
607
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.6
8.5
178
1112
D05AX02
ATC
calcipotriol; topical
1.8
8.5
115
636
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
8.5
194
1238
N82.2
ICD-10 Finland
Fistula of vagina to small intestine
27.6
8.5
11
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.1
8.5
74
351
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.0
8.5
94
487
B03BA02
ATC
cyanocobalamin tannin complex; parenteral
4.2
8.4
22
53
XG410
NOMESCO Finland
Flow-volume spirometry
1.8
8.4
124
703
K22.8
ICD-10 Finland
Other specified diseases of oesophagus
4.3
8.4
21
49
IGY02
NOMESCO Finland
Psychiatric monitoring contact
1.9
8.4
109
595
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
2.0
8.4
82
406
SPAT1053
SPAT
Memory test
1.4
8.4
441
3315
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
2.7
8.4
44
166
JFA56
NOMESCO Finland
Faecal microbiota transplantation
12.8
8.4
14
11
SPAT1252
SPAT
Overall medication plan or its review
1.6
8.4
216
1418
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
6.7
8.3
20
30
3005
Kela drug reimbursment
Tofacitinib
6.7
8.3
20
30
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.6
8.3
194
1243
6408
FHL
Colectomy and ileostomy
+∞
8.3
8
*
56399
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Other
+∞
8.3
8
*
I84.3
ICD-10 Finland
External thrombosed hemorrhoids
3.0
8.3
36
122
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
8.3
2187
19905
K56.2
ICD-10 Finland
Volvulus
3.3
8.3
30
91
K80
ICPC
Cardiac arrhythmia NOS
1.4
8.3
308
2178
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
8.3
382
2808
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
2.5
8.3
50
202
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
2.7
8.3
44
167
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
1.7
8.3
140
827
K90.8
ICD-10 Finland
Other intestinal malabsorption
9.4
8.3
16
17
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
3.1
8.3
34
112
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.2
8.3
63
283
N05AX12
ATC
aripiprazole; systemic
1.8
8.2
126
723
NG1DA
NOMESCO Finland
X-ray of knees
2.2
8.2
69
322
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
8.2
857
7077
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
3.1
8.2
33
107
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
1.8
8.2
108
592
C01CA24
ATC
epinephrine; parenteral
1.6
8.2
207
1352
PD4AD
NOMESCO Finland
CT of lower extremity arteries
3.0
8.2
35
118
IHZ05, ,
SPAT
1.7
8.2
137
807
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
8.2
2430
22367
D06BX01
ATC
metronidazole; topical
1.4
8.2
365
2670
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
7.5
8.1
18
24
R06.4
ICD-10 Finland
Hyperventilation
2.4
8.1
53
222
SPAT1097
SPAT
Recording of ECG
1.4
8.1
468
3566
D15
ICPC
Melaena
4.4
8.1
20
46
D07AB01
ATC
clobetasone; topical
1.9
8.1
104
565
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
8.1
446
3374
L84
ICD-10 Finland
Corns and callosities
1.8
8.1
121
689
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.5
8.1
247
1680
SPAT1310
SPAT
Counselling related to known health issue
1.2
8.1
1090
9265
H05AA02
ATC
teriparatide; parenteral
3.6
8.1
26
73
M75.9
ICD-10 Finland
Shoulder lesion, unspecified
1.6
8.1
175
1102
R81
ICPC
Pneumonia
1.7
8.1
128
742
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.3
8.1
496
3817
S02.51
ICD-10 Finland
Fracture of tooth, open
1.4
8.1
306
2173
JF1DM
NOMESCO Finland
Very extensive MRI of small bowel (more than 1.5 T)
33.4
8.1
10
*
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
3.8
8.1
24
64
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
4.0
8.1
22
55
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.7
8.1
155
948
SPAT1238
SPAT
Brief therapy
2.3
8.1
57
248
R06.5
ICD-10 Finland
Mouth breathing
1.5
8.0
278
1940
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.2
8.0
62
280
NDL52
NOMESCO Finland
Tenosynovectomy of hand
3.0
8.0
34
114
K03.00
ICD-10 Finland
Approximal wear
1.5
8.0
257
1767
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
1.9
8.0
98
525
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.0
8.0
78
386
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
2.0
8.0
79
393
XJH00
NOMESCO Finland
Transanal ultrasonography
1.7
8.0
146
881
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.5
8.0
259
1785
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.6
8.0
170
1067
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.7
8.0
139
828
A10BH05
ATC
linagliptin; oral
1.6
8.0
161
997
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
2.5
8.0
47
188
K12.00
ICD-10 Finland
Recurrent oral aphthae
2.3
8.0
56
243
M05BB03
ATC
alendronic acid and colecalciferol; oral
2.0
7.9
80
401
ACC51
NOMESCO Finland
Release of median nerve
1.5
7.9
256
1763
F41.8
ICD-10 Finland
Other specified anxiety disorders
1.9
7.9
103
563
N02AC04
ATC
dextropropoxyphene; oral
1.8
7.9
107
592
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
1.7
7.9
132
777
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.8
7.9
110
614
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.6
7.9
170
1070
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
3.7
7.9
24
65
SPAT1325
SPAT
Vaccination
1.2
7.9
1124
9610
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
2.0
7.9
76
375
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
4.6
7.9
18
39
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
2.0
7.9
86
444
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.7
7.8
150
916
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
1.8
7.8
122
704
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.6
7.8
191
1238
R03AC03
ATC
terbutaline; inhalant
1.3
7.8
460
3517
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.0
7.8
76
376
L04AK01
ATC
leflunomide; oral
3.1
7.8
31
100
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
2.5
7.8
45
178
C09AA05
ATC
ramipril; oral
1.3
7.8
789
6488
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.6
7.8
158
979
K13.78
ICD-10 Finland
Other change in the oral mucosa
1.9
7.8
93
494
N06AB08
ATC
fluvoxamine; oral
1.9
7.8
93
494
1410
FHL
Laparoscopy
1.9
7.8
93
494
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.3
7.8
801
6599
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.4
7.8
391
2915
A41.8
ICD-10 Finland
Other specified sepsis
2.2
7.8
61
277
D06AX01
ATC
fusidic acid; topical
1.4
7.8
297
2111
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
1.9
7.8
87
452
L57.0
ICD-10 Finland
Actinic keratosis
1.4
7.8
354
2597
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
2.9
7.8
36
127
L50.9
ICD-10 Finland
Urticaria, unspecified
1.7
7.8
128
751
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.4
7.8
287
2029
62660
ICD-8 Finland
Disorders of menstruation, Intermenstrual bleeding
1.9
7.8
87
453
C10AA01
ATC
simvastatin; oral
1.2
7.7
1363
11904
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.5
7.7
255
1763
NK6PA
NOMESCO Finland
Measurement of bone density from one location with X-ray
4.2
7.7
20
48
H02AA02
ATC
fludrocortisone; oral
3.0
7.7
32
106
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
2.7
7.7
40
150
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.8
7.7
121
700
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
1.6
7.7
157
976
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
7.4
7.7
17
23
L16
ICPC
Ankle symptom/complaint
1.4
7.6
427
3239
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
4.5
7.6
18
40
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
4.5
7.6
18
40
N39.3
ICD-10 Finland
Stress incontinence
1.5
7.6
270
1893
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
2.8
7.6
37
134
QDB10, ,
SPAT
1.9
7.6
90
477
N06AA10
ATC
nortriptyline; systemic
2.0
7.6
75
373
NH1AD
NOMESCO Finland
Ankle and foot CT
2.0
7.6
84
435
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.4
7.6
335
2445
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.1
7.6
69
333
K60.0
ICD-10 Finland
Acute anal fissure
2.6
7.6
43
169
K07.65
ICD-10 Finland
Temporomandibular joint-pain-dysfunction syndrome
2.6
7.6
43
169
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
1.6
7.6
158
987
298, ,
Kela drug reimbursment
6.7
7.6
18
27
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
25.0
7.6
10
*
M13.0
ICD-10 Finland
Polyarthritis, unspecified
2.4
7.6
48
199
K04.1
ICD-10 Finland
Necrosis of pulp
1.4
7.6
351
2584
B02AA02
ATC
tranexamic acid; systemic
1.3
7.6
491
3809
J01DC02
ATC
cefuroxime; systemic
1.6
7.5
175
1122
3029
Kela drug reimbursment
Upadacitinib
6.2
7.5
19
31
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
1.8
7.5
108
609
XQ802
NOMESCO Finland
Epicutan test
1.7
7.5
133
796
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
2.6
7.5
41
158
JFB20
NOMESCO Finland
Ileocaecal resection
3.8
7.5
22
58
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
3.2
7.5
28
87
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
2.1
7.5
71
348
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
1.8
7.5
106
595
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
7.5
750
6158
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
7.5
212
1422
L87
ICPC
Bursitis/tendinitis/synovitis NOS
2.2
7.5
58
263
PEN23
NOMESCO Finland
Plastic repair of femoral artery
3.0
7.5
31
103
XQ820
NOMESCO Finland
Exposure to medicinal substance
3.7
7.5
23
63
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
1.9
7.4
88
467
G04BD09
ATC
trospium; oral
1.9
7.4
83
432
N06AX18
ATC
reboxetine; oral
2.5
7.4
44
177
M19.9
ICD-10 Finland
Arthrosis, unspecified
1.6
7.4
153
954
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
1.8
7.4
106
598
318
Kela drug reimbursment
Teriparatide
3.3
7.4
27
83
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
7.4
571
4540
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.4
7.3
49
208
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.4
7.3
334
2451
K03.64
ICD-10 Finland
Dental calculus supragingival
1.2
7.3
1134
9765
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
1.7
7.3
124
734
Z93.3
ICD-10 Finland
Colostomy status
2.9
7.3
33
115
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
2.2
7.3
61
285
L40.5
ICD-10 Finland
Arthropathic psoriasis
2.2
7.3
61
285
WX723
NOMESCO Finland
CPAP therapy
1.7
7.3
139
849
56908
ICD-8 Finland
Other diseases of intestines and peritoneum, Alii definiti
+∞
7.3
7
*
JGB61
NOMESCO Finland
Laparoscopic excision of rectum and ileoanal anastomosis
+∞
7.3
7
*
K51.4
ICD-10 Finland
Inflammatory polyps
+∞
7.3
7
*
JFG53
NOMESCO Finland
Revision of ileal pelvic pouch
+∞
7.3
7
*
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
3.6
7.3
23
64
R4140
NOMESCO Finland
Psychotherapy
3.6
7.3
23
64
JJC00
NOMESCO Finland
Allogenic transplantation of liver
6.8
7.3
17
25
Z08
ICPC
Social welfare problem
2.4
7.3
48
203
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.4
7.3
48
203
D01AC02
ATC
miconazole; topical
1.5
7.3
231
1587
R25.1
ICD-10 Finland
Tremor, unspecified
1.8
7.3
105
594
WX610
NOMESCO Finland
Patient controlled analgesia
3.2
7.2
28
89
N02AJ13
ATC
tramadol and paracetamol; systemic
2.0
7.2
79
408
A10AE04
ATC
insulin glargine; parenteral
1.4
7.2
295
2124
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
2.5
7.2
44
179
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
2.3
7.2
54
241
XCK00
NOMESCO Finland
Perimetry
1.5
7.2
194
1286
B34.9
ICD-10 Finland
Viral infection, unspecified
1.9
7.2
91
493
R03BA01
ATC
beclometasone; inhalant
1.3
7.2
457
3532
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
7.2
3454
33137
Z94.0
ICD-10 Finland
Kidney transplant status
2.6
7.2
39
150
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
1.3
7.2
736
6057
K02.0
ICD-10 Finland
Caries limited to enamel
1.3
7.2
662
5379
B35.3
ICD-10 Finland
Tinea pedis
1.6
7.2
149
930
K03.0
ICD-10 Finland
Excessive attrition of teeth
1.8
7.2
95
523
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.4
7.2
47
198
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
1.9
7.2
89
480
J34.2
ICD-10 Finland
Deviated nasal septum
1.6
7.2
153
962
FN2BA
NOMESCO Finland
Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)
1.6
7.1
181
1185
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
20.0
7.1
10
5
L14
ICPC
Leg/thigh symptom/complaint
1.4
7.1
284
2037
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
1.4
7.1
310
2259
M43.1
ICD-10 Finland
Spondylolisthesis
1.7
7.1
133
809
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
6.6
7.1
17
26
M05BA07
ATC
risedronic acid; oral
1.8
7.1
105
598
K07
ICPC
Swollen ankles/oedema
1.6
7.1
164
1051
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.5
7.1
240
1669
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
1.9
7.1
80
418
N94.1
ICD-10 Finland
Dyspareunia
2.4
7.1
46
193
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.2
7.1
854
7159
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
2.1
7.1
63
302
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
1.7
7.1
127
764
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.9
7.0
80
419
N30
ICD-10 Finland
Cystitis
1.4
7.0
291
2101
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.1
7.0
63
303
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
2.6
7.0
39
152
G56.2
ICD-10 Finland
Lesion of ulnar nerve
1.7
7.0
111
645
S04
ICPC
Lump/swelling localized
1.4
7.0
381
2878
GD1AA, ,
SPAT
1.3
7.0
530
4199
F29
ICPC
Eye symptom/complaint other
1.4
7.0
359
2687
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.5
7.0
43
176
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.5
7.0
42
170
C10AA07
ATC
rosuvastatin; oral
1.2
7.0
1159
10043
R52.1
ICD-10 Finland
Chronic intractable pain
2.7
7.0
36
135
WPB10
NOMESCO Finland
Making a convalescent care decision
3.5
7.0
23
66
B01AF02
ATC
apixaban; oral
1.3
7.0
438
3381
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.5
7.0
188
1248
M77.1
ICD-10 Finland
Lateral epicondylitis
1.5
7.0
241
1684
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
2.6
7.0
37
141
N02CC03
ATC
zolmitriptan; nasal, oral
1.6
7.0
171
1112
TND10
NOMESCO Finland
Joint puncture, wrist or finger joint
4.4
7.0
17
39
UJC12
NOMESCO Finland
Flexible oesophagoscopy
3.0
7.0
30
102
PD5AD
NOMESCO Finland
CT of aorta
1.9
7.0
78
407
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
1.9
6.9
88
478
UDM02
NOMESCO Finland
Sinoscopy
2.0
6.9
69
345
F61.0
ICD-10 Finland
Mixed personality disorders
2.2
6.9
53
239
OAA81, ,
SPAT
1.7
6.9
111
647
R14
ICD-10 Finland
Flatulence and related conditions
2.6
6.9
39
153
D50
ICD-10 Finland
Iron deficiency anaemia
1.9
6.9
77
401
C10AA03
ATC
pravastatin; oral
1.5
6.9
225
1554
K64.9
ICD-10 Finland
Haemorrhoids, unspecified
1.6
6.9
135
831
G03DB01
ATC
dydrogesterone; oral
1.3
6.9
404
3087
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.1
6.9
61
292
N82.3
ICD-10 Finland
Fistula of vagina to large intestine
7.5
6.9
15
20
T89
ICPC
Diabetes insulin dependent
1.7
6.9
126
762
ZZH40
NOMESCO Finland
Substitute of bone
2.7
6.9
36
136
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.4
6.9
267
1906
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.9
1369
12068
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.4
6.9
268
1915
V252A
ICD-9 Finland
Contraceptive management, Sterilisation
1.4
6.9
263
1873
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
6.8
127
771
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.3
6.8
721
5952
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
2.8
6.8
32
114
K66.0
ICD-10 Finland
Peritoneal adhesions
3.4
6.8
23
67
M01AX05
ATC
glucosamine; oral
1.3
6.8
657
5365
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
2.5
6.8
41
166
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.7
6.8
129
787
R06AX22
ATC
ebastine; oral
1.3
6.8
571
4583
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
6.8
371
2803
N06AA04
ATC
clomipramine; systemic
2.2
6.8
57
267
WX780
NOMESCO Finland
Remote monitoring CPAP
1.6
6.8
139
865
NA3SA
NOMESCO Finland
Lumbar spine X-ray examination in standing position
3.0
6.8
29
98
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
6.8
505
3991
WZC00, ,
SPAT
1.3
6.8
507
4009
M54.8
ICD-10 Finland
Other dorsalgia
1.6
6.8
156
999
L95
ICPC
Osteoporosis
1.6
6.8
149
944
K92.0
ICD-10 Finland
Haematemesis
2.0
6.8
71
362
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.3
6.8
407
3122
R09
ICPC
Sinus symptom/complaint
1.4
6.7
280
2023
E27.4
ICD-10 Finland
Other and unspecified adrenocortical insufficiency
4.3
6.7
17
40
6253A
ICD-9 Finland
Pain and other symptoms associated with female genital organs, Dysmenorrhoea
3.6
6.7
21
58
WZA10
NOMESCO Finland
Extensive medical or dental certificate
2.3
6.7
47
204
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
6.7
30
104
1470
FHL
Rectoscopy
3.1
6.7
27
88
ZZA00
NOMESCO Finland
Split skin graft
1.8
6.7
87
476
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.1
6.7
61
295
K05.18
ICD-10 Finland
Chronic gingivitis
1.4
6.7
244
1721
NHQ40
NOMESCO Finland
Amputation of toe
2.4
6.7
45
192
I81
ICD-10 Finland
Portal vein thrombosis
3.9
6.7
19
49
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.0
6.7
68
343
K03.2
ICD-10 Finland
Erosion of teeth
2.1
6.7
57
269
K59.0
ICD-10 Finland
Constipation
1.5
6.7
181
1203
M75.5
ICD-10 Finland
Bursitis of shoulder
1.9
6.7
81
434
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.0
6.7
69
350
I50.1
ICD-10 Finland
Left ventricular failure
1.6
6.7
131
807
R52.0
ICD-10 Finland
Acute pain
1.7
6.7
114
677
N19
ICD-10 Finland
Unspecified kidney failure
1.7
6.7
112
662
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
2.8
6.7
31
110
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
2.1
6.7
61
296
WX600
NOMESCO Finland
Single shot through catheter
2.1
6.7
56
263
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
1.7
6.7
109
640
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
3.7
6.6
20
54
K07.61
ICD-10 Finland
Cracking jaw joint
2.0
6.6
70
358
7200A
ICD-9 Finland
Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis
6.4
6.6
16
25
R03AC13
ATC
formoterol; inhalant
1.6
6.6
156
1005
R07.2
ICD-10 Finland
Precordial pain
2.0
6.6
71
365
M77.4
ICD-10 Finland
Metatarsalgia
1.5
6.6
207
1418
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
2.9
6.6
30
105
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
2.9
6.6
30
105
WX202
NOMESCO Finland
Supraclavicular plexus blockade
2.2
6.6
53
244
SBB10
NOMESCO Finland
Dental impressions
1.5
6.6
205
1402
KMAK, ,
NOMESCO Finland
1.2
6.6
1765
15957
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.4
6.6
245
1735
R06AE09
ATC
levocetirizine; oral
1.3
6.6
460
3604
R83
ICPC
Respiratory infection other
1.2
6.6
842
7098
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.5
6.6
227
1586
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
2.9
6.6
29
100
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.1
6.6
60
291
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
2.7
6.6
34
128
KCW96
NOMESCO Finland
Other operations on bladder
3.2
6.6
25
79
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.2
6.6
53
245
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.6
6.6
152
976
L30.8
ICD-10 Finland
Other specified dermatitis
1.8
6.5
93
524
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
4.2
6.5
17
41
F43.29
ICD-10 Finland
Adaptation disorder UNS
1.9
6.5
77
409
-48
ICPC
Clarification/discussion RFE/demand
1.9
6.5
76
402
Z2445
NOMESCO Finland
Psychologist
1.7
6.5
114
682
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
1.8
6.5
93
525
H00.00
ICD-10 Finland
Hordeolum
1.6
6.5
149
954
L60.0
ICD-10 Finland
Ingrowing nail
1.6
6.5
160
1042
EBA15
NOMESCO Finland
Extraction of multiple teeth
1.7
6.5
116
698
G25.0
ICD-10 Finland
Essential tremor
1.8
6.5
87
482
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
1.7
6.5
113
676
R4180
NOMESCO Finland
Podiatric therapy
2.3
6.5
47
208
N05AA02
ATC
levomepromazine; systemic
1.7
6.5
116
699
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.0
6.4
68
348
N05CD02
ATC
nitrazepam; oral
2.2
6.4
53
247
JFA76
NOMESCO Finland
Closure of fistula of small intestine
70.0
6.4
7
*
S22
ICPC
Nail symptom/complaint
1.5
6.4
226
1585
G04CA01
ATC
alfuzosin; oral
1.4
6.4
292
2144
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
1.5
6.4
212
1469
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.1
6.4
60
294
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
2.2
6.4
50
228
N05AF03
ATC
chlorprothixene; systemic
1.9
6.4
77
412
TKC22
NOMESCO Finland
Catheterisation instruction
2.0
6.4
68
349
G03DC03
ATC
lynestrenol; oral
2.0
6.4
68
349
M77.9
ICD-10 Finland
Enthesopathy, unspecified
1.7
6.4
103
603
C03AA03
ATC
hydrochlorothiazide; oral
1.4
6.4
289
2121
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.6
6.4
139
880
A04.5
ICD-10 Finland
Campylobacter enteritis
2.8
6.4
31
113
U08
ICPC
Urinary retention
2.1
6.4
59
288
G03CA04
ATC
estriol; systemic, vaginal
1.4
6.4
226
1588
K81.9
ICD-10 Finland
Cholecystitis, unspecified
2.6
6.4
35
136
U29
ICPC
Urinary symptom/complaint other
1.7
6.4
106
626
E34.9
ICD-10 Finland
Endocrine disorder, unspecified
4.1
6.3
17
42
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
4.1
6.3
17
42
ZX100
NOMESCO Finland
Oral
2.3
6.3
45
197
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.0
6.3
68
350
N06AA06
ATC
trimipramine; systemic
1.8
6.3
81
442
YHMAS, ,
NOMESCO Finland
3.0
6.3
26
86
S02
ICPC
Pruritus
1.7
6.3
118
718
K04.0
ICD-10 Finland
Pulpitis
1.4
6.3
274
1995
E83.4
ICD-10 Finland
Disorders of magnesium metabolism
6.5
6.3
15
23
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.7
6.3
108
642
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
8.1
6.3
13
16
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.3
6.3
439
3438
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.0
6.3
64
323
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.8
6.3
30
108
JAD10
NOMESCO Finland
Repair of incisional hernia
2.8
6.3
30
108
Z49.2
ICD-10 Finland
Other dialysis
3.1
6.3
25
81
B03XA02
ATC
darbepoetin alfa; parenteral
2.0
6.3
67
344
Z71.9
ICD-10 Finland
Counselling, unspecified
1.4
6.3
266
1930
D73
ICPC
Gastroenteritis presumed infection
1.7
6.3
101
591
N20.0
ICD-10 Finland
Calculus of kidney
2.0
6.3
64
324
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.3
6.3
394
3043
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.0
6.3
59
290
XQ855
NOMESCO Finland
Skin temperature measurement
3.8
6.3
18
47
5586X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]
+∞
6.2
6
*
56902
ICD-8 Finland
Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)
+∞
6.2
6
*
LEE20
NOMESCO Finland
Closure of urovaginal fistula using graft or flap
+∞
6.2
6
*
H26.4
ICD-10 Finland
After-cataract
1.4
6.2
338
2552
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.2
6.2
955
8195
K04.08
ICD-10 Finland
Other specified pulpit
1.4
6.2
236
1678
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.7
6.2
32
120
XLA10, ,
NOMESCO Finland
1.6
6.2
156
1020
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.5
6.2
169
1125
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
3.0
6.2
26
87
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
1.9
6.2
76
409
TLC02
NOMESCO Finland
Simple extraction of IUD
1.6
6.2
120
738
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.5
6.2
199
1372
J01
ICD-10 Finland
Acute sinusitis
1.5
6.2
185
1257
H20.1
ICD-10 Finland
Chronic iridocyclitis
2.5
6.2
37
150
WX006
NOMESCO Finland
Intravenous sedation or analgesia without general anesthesia
1.4
6.2
230
1631
F51.9
ICD-10 Finland
Nonorganic sleep disorder, unspecified
1.9
6.2
75
403
N02CC07
ATC
frovatriptan; oral
1.6
6.2
120
739
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.2
92
527
1412
FHL
Laparoscopy and sterilization
1.5
6.1
203
1407
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.3
6.1
45
200
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
3.2
6.1
23
72
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
3.4
6.1
21
62
WGA11
NOMESCO Finland
Planning of pain management
3.3
6.1
22
67
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
1.7
6.1
97
565
Y60
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
2.6
6.1
33
127
JG1JB
NOMESCO Finland
Defekography with X-ray
2.6
6.1
33
127
G44.8
ICD-10 Finland
Other specified headache syndromes
2.1
6.1
51
239
I84.4
ICD-10 Finland
External hemorrhoids with other complications
2.4
6.1
40
169
5790A
ICD-9 Finland
Intestinal malabsorption, Coeliac disease
7.7
6.1
13
17
G03FB05
ATC
norethisterone and estrogen; systemic
1.3
6.1
372
2859
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
1.7
6.1
112
679
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
1.4
6.1
232
1651
T91
ICPC
Vitamin/nutritional deficiency
2.6
6.1
34
133
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.4
6.1
218
1534
A10AB04
ATC
insulin lispro; parenteral
1.8
6.1
91
521
R07.1
ICD-10 Finland
Chest pain on breathing
2.1
6.1
52
246
D70.89
ICD-10 Finland
Neutropenic splenomegaly
2.3
6.1
43
188
IHZ04, ,
SPAT
2.1
6.1
55
266
Z51.5
ICD-10 Finland
Palliative care
1.4
6.1
278
2043
R30.0
ICD-10 Finland
Dysuria
1.6
6.1
140
898
ND1DG
NOMESCO Finland
Wrist and hand very extensive MRI examination with high intensity magnet
4.1
6.1
16
39
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
1.8
6.1
87
492
A07AA12
ATC
fidaxomicin; oral
12.5
6.1
10
8
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
12.5
6.1
10
8
G04BD04
ATC
oxybutynin; oral, transdermal
1.5
6.1
168
1123
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.5
6.1
185
1262
R29
ICPC
Respiratory symptom/complaint other
1.4
6.1
227
1611
D09AB01
ATC
zinc bandage without supplements; topical
2.0
6.1
62
314
K04.09
ICD-10 Finland
Pulpit UNS
1.6
6.1
138
883
K59
ICD-10 Finland
Other functional intestinal disorders
3.0
6.1
25
83
-31
ICPC
Medical examin/health eval partial
1.5
6.1
212
1486
ZX112
NOMESCO Finland
Subcutaneous
1.9
6.1
68
356
AN1
HP
Coronary angiography
1.4
6.0
308
2304
S93.4
ICD-10 Finland
Sprain and strain of ankle
1.3
6.0
351
2679
OAB93, ,
SPAT
1.5
6.0
192
1321
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
3.6
6.0
19
53
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
10.0
6.0
11
11
K11.2
ICD-10 Finland
Sialoadenitis
1.7
6.0
108
651
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
2.5
6.0
36
146
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
1.9
6.0
71
378
K59.4
ICD-10 Finland
Anal spasm
3.5
6.0
20
58

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
budesonide; oral, sublingual
A07EA06 [21600658]
3.9e+00
5.0e+00
5.6e+00
—
6.3e+00
5.9e+00
4.8e+00
cases:7.07%
controls:0.16%
cases:10.57%
controls:0.08%
cases:3.33%
controls:0.01%
—
—
cases:12.34%
controls:0.02%
cases:22.54%
controls:0.08%
cases:22.05%
controls:0.22%
287
63
3772
40526
429
31
3631
40568
135
5
3924
40594
—
499
10
3546
40492
864
31
2970
38963
685
71
2421
31711
Gastroenterology
10 [38004455]
1.4e+00
2.7e+00
4.1e+00
8.6e+00
4.6e+00
3.6e+00
2.2e+00
cases:18.06%
controls:5.02%
cases:21.40%
controls:1.85%
cases:12.76%
controls:0.25%
cases:47.99%
controls:0.01%
cases:18.15%
controls:0.23%
cases:37.19%
controls:1.67%
cases:35.19%
controls:5.75%
733
2039
3326
38550
869
751
3191
39848
518
100
3541
40499
1948
6
2111
40593
734
93
3311
40409
1426
652
2408
38342
1093
1828
2013
29954
Other specified noninfective gastroenteritis and colitis
K52.88 [2000502923]
4.8e+00
5.8e+00
1.0e+50
1.0e+50
—
8.1e+00
6.6e+00
cases:2.73%
controls:0.02%
cases:4.14%
controls:0.01%
cases:2.86%
controls:0.00%
cases:98.89%
controls:0.00%
—
—
cases:41.63%
controls:0.02%
cases:33.42%
controls:0.07%
111
9
3948
40580
168
5
3892
40594
116
0
3943
40599
4014
0
45
40599
—
1596
9
2238
38985
1038
22
2068
31760
mesalazine; oral, rectal
A07EC02 [21600664]
4.4e+00
5.7e+00
—
—
1.0e+50
6.0e+00
5.7e+00
cases:8.23%
controls:0.11%
cases:8.79%
controls:0.03%
—
—
—
—
cases:7.12%
controls:0.00%
cases:13.64%
controls:0.04%
cases:16.29%
controls:0.07%
334
44
3725
40545
357
13
3703
40586
—
—
288
0
3757
40502
523
16
3311
38978
506
21
2600
31761
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
1.7e+00
3.6e+00
5.2e+00
1.0e+50
4.9e+00
3.3e+00
2.3e+00
cases:10.59%
controls:2.02%
cases:20.44%
controls:0.72%
cases:11.43%
controls:0.07%
cases:1.03%
controls:0.00%
cases:6.08%
controls:0.05%
cases:15.81%
controls:0.68%
cases:21.99%
controls:2.85%
430
819
3629
39770
830
294
3230
40305
464
28
3595
40571
42
0
4017
40599
246
20
3799
40482
606
267
3228
38727
683
907
2423
30875
Functional diarrhoea
K59.1 [45543327]
1.9e+00
3.9e+00
5.6e+00
1.0e+50
3.6e+00
2.4e+00
1.7e+00
cases:3.57%
controls:0.57%
cases:8.33%
controls:0.18%
cases:3.18%
controls:0.01%
cases:0.64%
controls:0.00%
cases:0.62%
controls:0.02%
cases:1.96%
controls:0.18%
cases:3.38%
controls:0.63%
145
232
3914
40357
338
72
3722
40527
129
5
3930
40594
26
0
4033
40599
25
7
4020
40495
75
70
3759
38924
105
201
3001
31581
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
1.7e+00
3.2e+00
4.7e+00
—
4.8e+00
2.6e+00
1.9e+00
cases:5.69%
controls:1.10%
cases:8.42%
controls:0.37%
cases:5.32%
controls:0.05%
—
—
cases:5.02%
controls:0.04%
cases:5.84%
controls:0.45%
cases:9.92%
controls:1.61%
231
446
3828
40143
342
150
3718
40449
216
21
3843
40578
—
203
17
3842
40485
224
174
3610
38820
308
512
2798
31270
Ova and parasites identified in Stool by Light microscopy
10704-5 [3003327]
1.6e+00
3.5e+00
4.3e+00
1.0e+50
5.0e+00
2.4e+00
1.5e+00
cases:2.88%
controls:0.60%
cases:6.13%
controls:0.21%
cases:2.39%
controls:0.03%
cases:0.32%
controls:0.00%
cases:1.83%
controls:0.01%
cases:1.98%
controls:0.18%
cases:3.54%
controls:0.79%
117
243
3942
40346
249
84
3811
40515
97
13
3962
40586
13
0
4046
40599
74
5
3971
40497
76
71
3758
38923
110
252
2996
31530
Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
92695-6 [37019628]
1.8e+00
3.5e+00
4.4e+00
1.0e+50
4.5e+00
2.5e+00
1.6e+00
cases:2.04%
controls:0.36%
cases:4.06%
controls:0.12%
cases:1.58%
controls:0.02%
cases:0.79%
controls:0.00%
cases:1.33%
controls:0.01%
cases:1.59%
controls:0.13%
cases:2.96%
controls:0.63%
83
145
3976
40444
165
50
3895
40549
64
8
3995
40591
32
0
4027
40599
54
6
3991
40496
61
50
3773
38944
92
200
3014
31582
loperamide; oral
A07DA03 [21600646]
2.1e+00
3.0e+00
3.5e+00
—
3.7e+00
3.0e+00
2.6e+00
cases:7.88%
controls:1.09%
cases:9.90%
controls:0.55%
cases:4.26%
controls:0.13%
—
—
cases:4.50%
controls:0.11%
cases:10.35%
controls:0.58%
cases:14.13%
controls:1.25%
320
442
3739
40147
402
225
3658
40374
173
52
3886
40547
—
182
45
3863
40457
397
225
3437
38769
439
398
2667
31384
loperamide oxide; oral
A07DA05 [21600648]
2.1e+00
3.0e+00
3.5e+00
—
3.7e+00
3.0e+00
2.6e+00
cases:7.88%
controls:1.09%
cases:9.90%
controls:0.55%
cases:4.26%
controls:0.13%
—
—
cases:4.50%
controls:0.11%
cases:10.35%
controls:0.58%
cases:14.13%
controls:1.25%
320
442
3739
40147
402
225
3658
40374
173
52
3886
40547
—
182
45
3863
40457
397
225
3437
38769
439
398
2667
31384
Noninfective gastroenteritis and colitis, unspecified
K52.9 [45572215]
3.8e+00
5.3e+00
—
1.0e+50
—
4.9e+00
3.8e+00
cases:3.84%
controls:0.09%
cases:6.85%
controls:0.04%
—
—
cases:1.33%
controls:0.00%
—
—
cases:4.12%
controls:0.03%
cases:4.99%
controls:0.12%
156
37
3903
40552
278
15
3782
40584
—
54
0
4005
40599
—
158
12
3676
38982
155
39
2951
31743
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
8.9e-01
1.9e+00
2.9e+00
5.6e+00
3.0e+00
2.1e+00
1.3e+00
cases:11.04%
controls:4.83%
cases:8.05%
controls:1.35%
cases:2.19%
controls:0.13%
cases:3.23%
controls:0.01%
cases:2.22%
controls:0.11%
cases:8.66%
controls:1.16%
cases:14.42%
controls:4.47%
448
1962
3611
38627
327
548
3733
40051
89
51
3970
40548
131
5
3928
40594
90
44
3955
40458
332
451
3502
38543
448
1420
2658
30362
colestyramine; oral
C10AC01 [21601876]
2.6e+00
3.7e+00
3.8e+00
1.0e+50
—
4.0e+00
3.3e+00
cases:2.73%
controls:0.20%
cases:3.52%
controls:0.09%
cases:1.01%
controls:0.02%
cases:0.79%
controls:0.00%
—
—
cases:4.49%
controls:0.08%
cases:5.70%
controls:0.23%
111
81
3948
40508
143
36
3917
40563
41
9
4018
40590
32
0
4027
40599
—
172
33
3662
38961
177
72
2929
31710
Ileoscopy through colon
UJF30 [2001305028]
1.5e+00
3.0e+00
4.7e+00
1.0e+50
3.6e+00
2.7e+00
1.8e+00
cases:4.61%
controls:1.04%
cases:5.20%
controls:0.29%
cases:3.23%
controls:0.03%
cases:7.66%
controls:0.00%
cases:1.51%
controls:0.04%
cases:3.57%
controls:0.25%
cases:6.31%
controls:1.05%
187
422
3872
40167
211
116
3849
40483
131
12
3928
40587
311
0
3748
40599
61
17
3984
40485
137
99
3697
38895
196
335
2910
31447
Bacteria identified in Stool by Culture
625-4 [3025941]
1.6e+00
3.2e+00
4.1e+00
1.0e+50
5.0e+00
1.8e+00
1.4e+00
cases:5.17%
controls:1.04%
cases:6.01%
controls:0.26%
cases:2.44%
controls:0.04%
cases:1.26%
controls:0.00%
cases:2.20%
controls:0.01%
cases:1.62%
controls:0.28%
cases:4.48%
controls:1.18%
210
423
3849
40166
244
104
3816
40495
99
17
3960
40582
51
0
4008
40599
89
6
3956
40496
62
110
3772
38884
139
375
2967
31407
Colonoscopy Study observation
28023-0 [3022145]
1.5e+00
3.0e+00
4.5e+00
—
4.0e+00
2.2e+00
1.8e+00
cases:7.22%
controls:1.73%
cases:11.16%
controls:0.63%
cases:4.83%
controls:0.05%
—
—
cases:4.10%
controls:0.08%
cases:5.71%
controls:0.64%
cases:12.27%
controls:2.28%
293
701
3766
39888
453
257
3607
40342
196
22
3863
40577
—
166
33
3879
40469
219
249
3615
38745
381
724
2725
31058
Norovirus RNA [Presence] in Stool by NAA with probe detection
7974-9 [3008909]
1.5e+00
2.6e+00
4.6e+00
1.0e+50
4.6e+00
1.9e+00
1.6e+00
cases:1.85%
controls:0.41%
cases:2.32%
controls:0.17%
cases:1.23%
controls:0.01%
cases:1.18%
controls:0.00%
cases:1.88%
controls:0.02%
cases:1.36%
controls:0.21%
cases:3.35%
controls:0.70%
75
168
3984
40421
94
68
3966
40531
50
5
4009
40594
48
0
4011
40599
76
8
3969
40494
52
82
3782
38912
104
222
3002
31560
Upper gastrointestinal surgery
106 [44777669]
8.8e-01
1.5e+00
2.4e+00
6.2e+00
2.3e+00
1.6e+00
1.2e+00
cases:21.51%
controls:10.18%
cases:14.58%
controls:3.77%
cases:5.67%
controls:0.57%
cases:8.99%
controls:0.02%
cases:5.54%
controls:0.59%
cases:15.52%
controls:3.58%
cases:26.66%
controls:10.00%
873
4131
3186
36458
592
1532
3468
39067
230
231
3829
40368
365
8
3694
40591
224
237
3821
40265
595
1397
3239
37597
828
3177
2278
28605
Coloscopy
UJF32 [2001305029]
1.1e+00
2.7e+00
4.4e+00
1.0e+50
3.7e+00
2.1e+00
1.4e+00
cases:10.30%
controls:3.86%
cases:13.08%
controls:0.98%
cases:6.55%
controls:0.08%
cases:10.22%
controls:0.00%
cases:3.46%
controls:0.09%
cases:7.30%
controls:0.95%
cases:13.88%
controls:3.70%
418
1566
3641
39023
531
396
3529
40203
266
34
3793
40565
415
0
3644
40599
140
36
3905
40466
280
372
3554
38622
431
1176
2675
30606
azathioprine; oral, parenteral
L04AX01 [21603927]
2.2e+00
2.0e+00
2.1e+00
—
3.0e+00
3.0e+00
3.0e+00
cases:2.69%
controls:0.29%
cases:1.45%
controls:0.21%
cases:0.49%
controls:0.06%
—
—
cases:1.01%
controls:0.05%
cases:3.73%
controls:0.20%
cases:6.18%
controls:0.31%
109
119
3950
40470
59
84
4001
40515
20
24
4039
40575
—
41
20
4004
40482
143
77
3691
38917
192
99
2914
31683
Flexible sigmoidoscopy with biopsy
UJF45 [2001305031]
1.4e+00
2.2e+00
3.5e+00
1.0e+50
3.4e+00
2.9e+00
1.9e+00
cases:3.05%
controls:0.74%
cases:1.80%
controls:0.21%
cases:0.47%
controls:0.01%
cases:1.75%
controls:0.00%
cases:0.62%
controls:0.02%
cases:2.58%
controls:0.14%
cases:4.54%
controls:0.69%
124
301
3935
40288
73
85
3987
40514
19
6
4040
40593
71
0
3988
40599
25
8
4020
40494
99
55
3735
38939
141
218
2965
31564
Internal Medicine
11 [38004456]
7.7e-01
1.3e+00
2.2e+00
6.3e+00
2.2e+00
1.6e+00
1.1e+00
cases:36.51%
controls:21.05%
cases:25.07%
controls:8.04%
cases:9.90%
controls:1.25%
cases:26.21%
controls:0.07%
cases:9.57%
controls:1.19%
cases:27.78%
controls:7.40%
cases:39.21%
controls:18.18%
1482
8545
2577
32044
1018
3266
3042
37333
402
508
3657
40091
1064
27
2995
40572
387
483
3658
40019
1065
2884
2769
36110
1218
5778
1888
26004
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
7.2e-01
1.7e+00
2.8e+00
5.4e+00
2.4e+00
1.2e+00
9.1e-01
cases:13.48%
controls:7.04%
cases:13.10%
controls:2.77%
cases:5.20%
controls:0.34%
cases:4.07%
controls:0.02%
cases:3.76%
controls:0.35%
cases:8.56%
controls:2.73%
cases:20.96%
controls:9.66%
547
2856
3512
37733
532
1126
3528
39473
211
139
3848
40460
165
8
3894
40591
152
140
3893
40362
328
1063
3506
37931
651
3069
2455
28713
metronidazole; oral, rectal
P01AB01 [21604857]
8.3e-01
1.5e+00
2.7e+00
4.0e+00
3.3e+00
1.4e+00
9.9e-01
cases:15.59%
controls:7.47%
cases:8.69%
controls:2.00%
cases:2.73%
controls:0.19%
cases:1.18%
controls:0.02%
cases:4.80%
controls:0.19%
cases:7.64%
controls:2.01%
cases:15.97%
controls:6.58%
633
3032
3426
37557
353
811
3707
39788
111
78
3948
40521
48
9
4011
40590
194
78
3851
40424
293
782
3541
38212
496
2090
2610
29692
Irritable bowel syndrome with diarrhoea
K58.0 [45596336]
1.8e+00
3.3e+00
4.8e+00
1.0e+50
—
2.6e+00
2.0e+00
cases:3.33%
controls:0.55%
cases:4.66%
controls:0.18%
cases:1.77%
controls:0.01%
cases:0.96%
controls:0.00%
—
—
cases:2.19%
controls:0.16%
cases:4.60%
controls:0.67%
135
224
3924
40365
189
73
3871
40526
72
6
3987
40593
39
0
4020
40599
—
84
62
3750
38932
143
212
2963
31570
Enterocolitis due to Clostridium difficile
A04.7 [45552153]
1.2e+00
1.9e+00
3.2e+00
1.0e+50
4.0e+00
2.7e+00
1.6e+00
cases:0.44%
controls:0.14%
cases:0.52%
controls:0.08%
cases:0.30%
controls:0.01%
cases:0.30%
controls:0.00%
cases:0.67%
controls:0.01%
cases:0.86%
controls:0.06%
cases:1.13%
controls:0.24%
18
56
4041
40533
21
33
4039
40566
12
5
4047
40594
12
0
4047
40599
27
5
4018
40497
33
23
3801
38971
35
76
3071
31706
Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
72493-0 [43055120]
1.3e+00
2.0e+00
3.4e+00
1.0e+50
3.8e+00
2.0e+00
1.9e+00
cases:1.16%
controls:0.32%
cases:1.21%
controls:0.17%
cases:0.64%
controls:0.02%
cases:0.12%
controls:0.00%
cases:1.71%
controls:0.04%
cases:1.54%
controls:0.21%
cases:2.38%
controls:0.35%
47
128
4012
40461
49
67
4011
40532
26
9
4033
40590
5
0
4054
40599
69
15
3976
40487
59
83
3775
38911
74
112
3032
31670
Elastase.pancreatic [Mass/mass] in Stool
25907-7 [3000570]
1.6e+00
3.4e+00
4.8e+00
—
—
2.8e+00
1.8e+00
cases:2.41%
controls:0.52%
cases:5.39%
controls:0.18%
cases:2.34%
controls:0.02%
—
—
—
—
cases:2.43%
controls:0.16%
cases:4.06%
controls:0.69%
98
211
3961
40378
219
74
3841
40525
95
8
3964
40591
—
—
93
61
3741
38933
126
219
2980
31563
Bacteria identified in Blood by Culture
600-7 [3023368]
5.9e-01
1.1e+00
2.5e+00
5.7e+00
2.4e+00
1.2e+00
8.0e-01
cases:9.16%
controls:5.28%
cases:6.55%
controls:2.25%
cases:3.25%
controls:0.28%
cases:4.11%
controls:0.01%
cases:3.41%
controls:0.33%
cases:7.36%
controls:2.43%
cases:15.45%
controls:7.59%
372
2142
3687
38447
266
912
3794
39687
132
113
3927
40486
167
6
3892
40593
138
134
3907
40368
282
948
3552
38046
480
2412
2626
29370
Diarrhoea
D11 [2002000310]
1.2e+00
2.9e+00
4.1e+00
1.0e+50
2.7e+00
1.7e+00
1.6e+00
cases:5.25%
controls:1.66%
cases:6.82%
controls:0.42%
cases:1.87%
controls:0.03%
cases:0.30%
controls:0.00%
cases:0.62%
controls:0.04%
cases:2.37%
controls:0.44%
cases:7.89%
controls:1.72%
213
675
3846
39914
277
171
3783
40428
76
13
3983
40586
12
0
4047
40599
25
17
4020
40485
91
170
3743
38824
245
546
2861
31236
ispaghula (psylla seeds); oral
A06AC01 [21600555]
1.1e+00
1.6e+00
1.9e+00
4.1e+00
2.2e+00
1.8e+00
1.4e+00
cases:12.37%
controls:4.60%
cases:11.38%
controls:2.56%
cases:2.91%
controls:0.46%
cases:1.06%
controls:0.02%
cases:3.88%
controls:0.43%
cases:14.35%
controls:2.70%
cases:19.58%
controls:5.73%
502
1869
3557
38720
462
1039
3598
39560
118
188
3941
40411
43
7
4016
40592
157
176
3888
40326
550
1054
3284
37940
608
1820
2498
29962
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
88518-6 [36304997]
1.5e+00
1.4e+00
2.9e+00
—
4.1e+00
2.3e+00
1.7e+00
cases:1.77%
controls:0.40%
cases:0.79%
controls:0.19%
cases:0.37%
controls:0.02%
—
—
cases:0.99%
controls:0.02%
cases:1.72%
controls:0.17%
cases:3.03%
controls:0.56%
72
163
3987
40426
32
78
4028
40521
15
8
4044
40591
—
40
7
4005
40495
66
66
3768
38928
94
177
3012
31605
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
6.0e-01
1.3e+00
2.7e+00
3.9e+00
2.6e+00
1.6e+00
1.2e+00
cases:17.37%
controls:10.33%
cases:16.82%
controls:5.32%
cases:11.51%
controls:0.84%
cases:1.13%
controls:0.02%
cases:8.97%
controls:0.73%
cases:21.80%
controls:5.37%
cases:34.29%
controls:14.02%
705
4192
3354
36397
683
2160
3377
38439
467
343
3592
40256
46
9
4013
40590
363
296
3682
40206
836
2094
2998
36900
1065
4457
2041
27325
Coeliac disease
K90.0 [45586745]
1.5e+00
2.0e+00
3.5e+00
1.0e+50
2.6e+00
2.3e+00
1.6e+00
cases:1.92%
controls:0.44%
cases:1.48%
controls:0.20%
cases:0.74%
controls:0.02%
cases:1.43%
controls:0.00%
cases:0.49%
controls:0.04%
cases:2.19%
controls:0.22%
cases:2.74%
controls:0.55%
78
179
3981
40410
60
82
4000
40517
30
9
4029
40590
58
0
4001
40599
20
15
4025
40487
84
85
3750
38909
85
176
3021
31606
Granulocytes [#/volume] in Blood
30394-1 [3035715]
7.9e-01
1.8e+00
3.3e+00
—
3.3e+00
2.2e+00
2.0e+00
cases:1.06%
controls:0.48%
cases:0.81%
controls:0.13%
cases:0.42%
controls:0.01%
—
—
cases:0.42%
controls:0.01%
cases:0.83%
controls:0.10%
cases:2.00%
controls:0.28%
43
196
4016
40393
33
53
4027
40546
17
6
4042
40593
—
17
6
4028
40496
32
38
3802
38956
62
88
3044
31694
Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
43730-1 [3043849]
1.0e+00
2.1e+00
3.5e+00
—
3.6e+00
1.6e+00
1.5e+00
cases:0.69%
controls:0.25%
cases:0.91%
controls:0.12%
cases:0.42%
controls:0.01%
—
—
cases:0.72%
controls:0.02%
cases:0.81%
controls:0.16%
cases:1.26%
controls:0.29%
28
102
4031
40487
37
47
4023
40552
17
5
4042
40594
—
29
8
4016
40494
31
61
3803
38933
39
92
3067
31690
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
1.4e+00
2.4e+00
3.9e+00
—
2.8e+00
1.4e+00
1.3e+00
cases:8.35%
controls:2.21%
cases:7.66%
controls:0.72%
cases:3.77%
controls:0.08%
—
—
cases:1.46%
controls:0.09%
cases:3.21%
controls:0.82%
cases:9.47%
controls:2.82%
339
899
3720
39690
311
291
3749
40308
153
33
3906
40566
—
59
36
3986
40466
123
318
3711
38676
294
896
2812
30886
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
5.9e-01
1.3e+00
2.2e+00
4.9e+00
2.1e+00
1.1e+00
9.3e-01
cases:20.84%
controls:12.75%
cases:21.18%
controls:6.76%
cases:10.77%
controls:1.30%
cases:6.48%
controls:0.05%
cases:9.34%
controls:1.27%
cases:18.00%
controls:6.58%
cases:34.51%
controls:17.21%
846
5175
3213
35414
860
2746
3200
37853
437
529
3622
40070
263
21
3796
40578
378
513
3667
39989
690
2567
3144
36427
1072
5469
2034
26313
Salmonella sp identified in Stool by Organism specific culture
20955-1 [3004716]
1.1e+00
2.6e+00
4.1e+00
1.0e+50
3.5e+00
9.7e-01
8.8e-01
cases:3.23%
controls:1.13%
cases:3.50%
controls:0.26%
cases:0.89%
controls:0.01%
cases:0.44%
controls:0.00%
cases:0.72%
controls:0.02%
cases:0.78%
controls:0.30%
cases:2.51%
controls:1.06%
131
459
3928
40130
142
104
3918
40495
36
6
4023
40593
18
0
4041
40599
29
9
4016
40493
30
116
3804
38878
78
337
3028
31445
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
7.2e-01
1.7e+00
3.3e+00
—
3.4e+00
2.1e+00
1.8e+00
cases:1.16%
controls:0.56%
cases:0.89%
controls:0.16%
cases:0.47%
controls:0.02%
—
—
cases:0.57%
controls:0.02%
cases:0.89%
controls:0.11%
cases:2.25%
controls:0.37%
47
229
4012
40360
36
65
4024
40534
19
7
4040
40592
—
23
8
4022
40494
34
43
3800
38951
70
118
3036
31664
Emergency Room Visit
ER [9203]
7.0e-01
1.0e+00
1.9e+00
5.7e+00
1.6e+00
1.0e+00
8.3e-01
cases:51.52%
controls:34.58%
cases:26.58%
controls:11.37%
cases:9.14%
controls:1.41%
cases:12.52%
controls:0.05%
cases:6.28%
controls:1.33%
cases:23.89%
controls:10.37%
cases:47.36%
controls:28.24%
2091
14037
1968
26552
1079
4618
2981
35981
371
573
3688
40026
508
19
3551
40580
254
538
3791
39964
916
4044
2918
34950
1471
8976
1635
22806
Capsular endoscopy
UJF92 [2001305032]
1.9e+00
2.8e+00
1.0e+50
1.0e+50
—
4.6e+00
3.6e+00
cases:0.86%
controls:0.14%
cases:0.79%
controls:0.05%
cases:0.25%
controls:0.00%
cases:0.37%
controls:0.00%
—
—
cases:2.69%
controls:0.03%
cases:2.90%
controls:0.08%
35
55
4024
40534
32
19
4028
40580
10
0
4049
40599
15
0
4044
40599
—
103
11
3731
38983
90
27
3016
31755
infliximab; parenteral
L04AB02 [21603909]
2.3e+00
2.7e+00
—
—
—
3.9e+00
3.9e+00
cases:0.54%
controls:0.05%
cases:0.34%
controls:0.02%
—
—
—
—
—
—
cases:1.10%
controls:0.02%
cases:2.54%
controls:0.05%
22
22
4037
40567
14
9
4046
40590
—
—
—
42
9
3792
38985
79
17
3027
31765
Emergency Room and Inpatient Visit
ERIP [262]
4.8e-01
9.6e-01
2.0e+00
5.9e+00
2.0e+00
9.4e-01
5.1e-01
cases:8.97%
controls:5.73%
cases:8.05%
controls:3.24%
cases:3.15%
controls:0.45%
cases:6.21%
controls:0.02%
cases:3.54%
controls:0.51%
cases:8.71%
controls:3.61%
cases:17.87%
controls:11.59%
364
2327
3695
38262
327
1317
3733
39282
128
181
3931
40418
252
7
3807
40592
143
206
3902
40296
334
1408
3500
37586
555
3682
2551
28100
Endomysium IgA Ab [Titer] in Serum
10863-9 [3020961]
9.7e-01
2.1e+00
3.6e+00
—
3.9e+00
1.3e+00
8.0e-01
cases:2.59%
controls:1.00%
cases:2.49%
controls:0.31%
cases:1.26%
controls:0.03%
—
—
cases:0.87%
controls:0.02%
cases:1.10%
controls:0.30%
cases:2.61%
controls:1.19%
105
404
3954
40185
101
125
3959
40474
51
14
4008
40585
—
35
7
4010
40495
42
117
3792
38877
81
377
3025
31405
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
5.5e-01
1.3e+00
2.3e+00
4.4e+00
2.0e+00
1.2e+00
9.8e-01
cases:34.34%
controls:23.22%
cases:36.87%
controls:13.82%
cases:21.21%
controls:2.51%
cases:7.49%
controls:0.10%
cases:15.43%
controls:2.41%
cases:33.96%
controls:13.93%
cases:54.06%
controls:30.59%
1394
9425
2665
31164
1497
5612
2563
34987
861
1019
3198
39580
304
42
3755
40557
624
975
3421
39527
1302
5432
2532
33562
1679
9722
1427
22060
Office Visit
OMOP4822458 [581477]
6.4e-01
9.6e-01
1.8e+00
4.9e+00
2.3e+00
1.2e+00
9.0e-01
cases:15.42%
controls:8.76%
cases:5.67%
controls:2.26%
cases:1.60%
controls:0.27%
cases:1.92%
controls:0.01%
cases:3.09%
controls:0.31%
cases:5.89%
controls:1.94%
cases:12.75%
controls:5.58%
626
3554
3433
37035
230
917
3830
39682
65
111
3994
40488
78
6
3981
40593
125
127
3920
40375
226
756
3608
38238
396
1775
2710
30007
Extensive abdominal CT
JN3BD [2001305556]
9.1e-01
1.7e+00
3.8e+00
1.0e+50
2.5e+00
1.8e+00
1.5e+00
cases:3.45%
controls:1.41%
cases:1.75%
controls:0.31%
cases:0.86%
controls:0.02%
cases:2.12%
controls:0.00%
cases:0.35%
controls:0.03%
cases:1.36%
controls:0.23%
cases:3.51%
controls:0.81%
140
573
3919
40016
71
126
3989
40473
35
8
4024
40591
86
0
3973
40599
14
11
4031
40491
52
90
3782
38904
109
256
2997
31526
Thorax X-ray examination
GD1AA [2001303617]
6.9e-01
9.4e-01
1.7e+00
5.4e+00
1.4e+00
1.1e+00
8.6e-01
cases:17.54%
controls:9.62%
cases:8.82%
controls:3.64%
cases:2.12%
controls:0.41%
cases:2.78%
controls:0.01%
cases:1.76%
controls:0.43%
cases:9.55%
controls:3.44%
cases:21.38%
controls:10.31%
712
3906
3347
36683
358
1477
3702
39122
86
167
3973
40432
113
5
3946
40594
71
175
3974
40327
366
1342
3468
37652
664
3277
2442
28505
Cholangitis
K83.0 [45552955]
2.3e+00
3.6e+00
—
1.0e+50
—
3.3e+00
2.8e+00
cases:0.64%
controls:0.06%
cases:0.52%
controls:0.01%
—
—
cases:0.30%
controls:0.00%
—
—
cases:0.70%
controls:0.03%
cases:1.26%
controls:0.08%
26
26
4033
40563
21
6
4039
40593
—
12
0
4047
40599
—
27
10
3807
38984
39
24
3067
31758
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
64084-7 [40766800]
1.6e+00
1.7e+00
—
—
3.5e+00
3.0e+00
2.3e+00
cases:0.67%
controls:0.14%
cases:0.22%
controls:0.04%
—
—
—
—
cases:0.40%
controls:0.01%
cases:0.97%
controls:0.05%
cases:1.29%
controls:0.13%
27
57
4032
40532
9
17
4051
40582
—
—
16
5
4029
40497
37
19
3797
38975
40
41
3066
31741
Inpatient Hospital
21 [8717]
5.5e-01
8.6e-01
1.7e+00
5.4e+00
1.7e+00
9.0e-01
7.3e-01
cases:42.89%
controls:30.30%
cases:19.06%
controls:9.05%
cases:6.36%
controls:1.18%
cases:11.14%
controls:0.05%
cases:6.06%
controls:1.19%
cases:17.66%
controls:8.00%
cases:34.29%
controls:20.04%
1741
12298
2318
28291
774
3675
3286
36924
258
480
3801
40119
452
22
3607
40577
245
482
3800
40020
677
3119
3157
35875
1065
6368
2041
25414
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
8.3e-01
2.2e+00
3.5e+00
—
3.1e+00
1.4e+00
8.9e-01
cases:9.09%
controls:4.17%
cases:11.72%
controls:1.47%
cases:3.97%
controls:0.13%
—
—
cases:2.65%
controls:0.13%
cases:5.29%
controls:1.31%
cases:11.88%
controls:5.26%
369
1692
3690
38897
476
596
3584
40003
161
53
3898
40546
—
107
51
3938
40451
203
511
3631
38483
369
1671
2737
30111
Outpatient Visit
OP [9202]
9.4e-01
9.6e-01
1.1e+00
5.0e+00
1.3e+00
1.2e+00
1.3e+00
cases:89.92%
controls:77.71%
cases:76.67%
controls:55.76%
cases:27.54%
controls:11.25%
cases:45.48%
controls:0.54%
cases:30.43%
controls:11.11%
cases:80.13%
controls:54.83%
cases:94.27%
controls:82.46%
3650
31541
409
9048
3113
22640
947
17959
1118
4568
2941
36031
1846
220
2213
40379
1231
4500
2814
36002
3072
21382
762
17612
2928
26209
178
5573
Epstein Barr virus Ab [Presence] in Serum
49178-7 [3048929]
7.1e-01
1.5e+00
2.8e+00
—
3.8e+00
1.6e+00
1.3e+00
cases:1.23%
controls:0.61%
cases:0.84%
controls:0.20%
cases:0.25%
controls:0.01%
—
—
cases:0.54%
controls:0.01%
cases:0.73%
controls:0.15%
cases:2.12%
controls:0.58%
50
247
4009
40342
34
80
4026
40519
10
6
4049
40593
—
22
5
4023
40497
28
60
3806
38934
66
184
3040
31598
adalimumab; parenteral
L04AB04 [21603911]
1.8e+00
1.8e+00
1.5e+00
—
2.0e+00
2.2e+00
2.3e+00
cases:1.08%
controls:0.18%
cases:0.84%
controls:0.13%
cases:0.30%
controls:0.06%
—
—
cases:0.42%
controls:0.06%
cases:1.33%
controls:0.15%
cases:2.32%
controls:0.25%
44
75
4015
40514
34
54
4026
40545
12
26
4047
40573
—
17
23
4028
40479
51
59
3783
38935
72
78
3034
31704
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
6.2e-01
8.9e-01
2.1e+00
4.4e+00
2.2e+00
9.1e-01
5.1e-01
cases:3.10%
controls:1.69%
cases:2.14%
controls:0.89%
cases:0.99%
controls:0.13%
cases:0.96%
controls:0.01%
cases:1.41%
controls:0.16%
cases:2.61%
controls:1.07%
cases:5.51%
controls:3.37%
126
686
3933
39903
87
362
3973
40237
40
51
4019
40548
39
5
4020
40594
57
64
3988
40438
100
417
3734
38577
171
1071
2935
30711
Haemorrhage of anus and rectum
K62.5 [45596339]
9.2e-01
1.8e+00
3.4e+00
1.0e+50
3.0e+00
1.4e+00
8.8e-01
cases:1.08%
controls:0.44%
cases:1.18%
controls:0.19%
cases:0.69%
controls:0.02%
cases:0.39%
controls:0.00%
cases:0.25%
controls:0.01%
cases:0.52%
controls:0.13%
cases:1.67%
controls:0.70%
44
177
4015
40412
48
78
4012
40521
28
9
4031
40590
16
0
4043
40599
10
5
4035
40497
20
49
3814
38945
52
222
3054
31560
Differential panel, method unspecified - Blood
69738-3 [42870588]
7.0e-01
1.2e+00
2.1e+00
3.1e+00
2.0e+00
1.3e+00
1.2e+00
cases:15.00%
controls:8.03%
cases:13.62%
controls:4.67%
cases:6.85%
controls:0.91%
cases:0.76%
controls:0.03%
cases:6.40%
controls:0.95%
cases:15.36%
controls:4.68%
cases:26.85%
controls:10.35%
609
3260
3450
37329
553
1898
3507
38701
278
368
3781
40231
31
14
4028
40585
259
383
3786
40119
589
1825
3245
37169
834
3289
2272
28493
Osmolality of Urine
2695-5 [3026782]
5.4e-01
8.3e-01
1.8e+00
4.7e+00
1.8e+00
1.0e+00
7.8e-01
cases:8.57%
controls:5.17%
cases:4.48%
controls:2.00%
cases:1.55%
controls:0.26%
cases:1.58%
controls:0.01%
cases:1.53%
controls:0.26%
cases:4.80%
controls:1.81%
cases:10.82%
controls:5.29%
348
2100
3711
38489
182
812
3878
39787
63
106
3996
40493
64
6
3995
40593
62
106
3983
40396
184
707
3650
38287
336
1681
2770
30101
Base excess in Venous blood by calculation
1927-3 [3002032]
6.1e-01
9.0e-01
2.0e+00
4.3e+00
2.2e+00
8.9e-01
5.0e-01
cases:3.08%
controls:1.70%
cases:2.12%
controls:0.87%
cases:0.94%
controls:0.13%
cases:0.91%
controls:0.01%
cases:1.36%
controls:0.16%
cases:2.53%
controls:1.06%
cases:5.34%
controls:3.30%
125
689
3934
39900
86
353
3974
40246
38
52
4021
40547
37
5
4022
40594
55
63
3990
40439
97
412
3737
38582
166
1049
2940
30733
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
8.7e-01
2.4e+00
3.5e+00
—
2.9e+00
1.1e+00
6.4e-01
cases:11.11%
controls:4.99%
cases:15.15%
controls:1.65%
cases:4.88%
controls:0.15%
—
—
cases:2.94%
controls:0.16%
cases:4.49%
controls:1.58%
cases:11.82%
controls:6.59%
451
2025
3608
38564
615
670
3445
39929
198
62
3861
40537
—
119
65
3926
40437
172
618
3662
38376
367
2093
2739
29689
pH of Venous blood
2746-6 [3012544]
6.0e-01
8.7e-01
2.0e+00
4.3e+00
2.2e+00
8.9e-01
4.9e-01
cases:3.15%
controls:1.75%
cases:2.17%
controls:0.92%
cases:0.96%
controls:0.13%
cases:0.94%
controls:0.01%
cases:1.36%
controls:0.16%
cases:2.53%
controls:1.06%
cases:5.44%
controls:3.42%
128
711
3931
39878
88
372
3972
40227
39
52
4020
40547
38
5
4021
40594
55
63
3990
40439
97
413
3737
38581
169
1087
2937
30695
prednisolone; oral, parenteral
H02AB06 [21602734]
8.5e-01
1.1e+00
1.3e+00
3.5e+00
2.1e+00
1.3e+00
1.1e+00
cases:23.65%
controls:11.67%
cases:14.31%
controls:5.16%
cases:3.67%
controls:1.01%
cases:0.91%
controls:0.03%
cases:7.79%
controls:0.98%
cases:17.14%
controls:5.31%
cases:29.07%
controls:12.33%
960
4735
3099
35854
581
2094
3479
38505
149
409
3910
40190
37
11
4022
40588
315
398
3730
40104
657
2069
3177
36925
903
3918
2203
27864
prednisolone
A07EA01 [21600653]
8.5e-01
1.1e+00
1.3e+00
3.5e+00
2.1e+00
1.3e+00
1.1e+00
cases:23.70%
controls:11.72%
cases:14.31%
controls:5.18%
cases:3.70%
controls:1.01%
cases:0.91%
controls:0.03%
cases:7.81%
controls:0.99%
cases:17.16%
controls:5.32%
cases:29.20%
controls:12.40%
962
4756
3097
35833
581
2102
3479
38497
150
409
3909
40190
37
11
4022
40588
316
400
3729
40102
658
2073
3176
36921
907
3940
2199
27842
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
8.4e-01
1.2e+00
2.8e+00
1.0e+50
3.1e+00
1.7e+00
1.7e+00
cases:1.13%
controls:0.49%
cases:0.62%
controls:0.19%
cases:0.37%
controls:0.02%
cases:0.17%
controls:0.00%
cases:0.49%
controls:0.02%
cases:0.83%
controls:0.16%
cases:1.77%
controls:0.33%
46
199
4013
40390
25
77
4035
40522
15
9
4044
40590
7
0
4052
40599
20
9
4025
40493
32
61
3802
38933
55
106
3051
31676
Bacteria [Presence] in Urine
87829-8 [36304419]
5.2e-01
8.7e-01
1.8e+00
4.8e+00
1.7e+00
9.2e-01
7.2e-01
cases:10.15%
controls:6.28%
cases:6.77%
controls:2.95%
cases:2.61%
controls:0.42%
cases:2.51%
controls:0.02%
cases:2.25%
controls:0.44%
cases:7.17%
controls:3.00%
cases:16.00%
controls:8.51%
412
2549
3647
38040
275
1198
3785
39401
106
172
3953
40427
102
9
3957
40590
91
178
3954
40324
275
1168
3559
37826
497
2704
2609
29078
Base excess in Blood by calculation
11555-0 [3012501]
8.3e-01
1.2e+00
2.8e+00
1.0e+50
3.1e+00
1.7e+00
1.7e+00
cases:1.11%
controls:0.49%
cases:0.59%
controls:0.19%
cases:0.37%
controls:0.02%
cases:0.17%
controls:0.00%
cases:0.49%
controls:0.02%
cases:0.83%
controls:0.15%
cases:1.74%
controls:0.33%
45
198
4014
40391
24
76
4036
40523
15
9
4044
40590
7
0
4052
40599
20
9
4025
40493
32
60
3802
38934
54
106
3052
31676
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
8.2e-01
1.2e+00
2.8e+00
1.0e+50
3.1e+00
1.7e+00
1.7e+00
cases:1.11%
controls:0.49%
cases:0.59%
controls:0.19%
cases:0.37%
controls:0.02%
cases:0.17%
controls:0.00%
cases:0.49%
controls:0.02%
cases:0.83%
controls:0.15%
cases:1.74%
controls:0.33%
45
199
4014
40390
24
76
4036
40523
15
9
4044
40590
7
0
4052
40599
20
9
4025
40493
32
60
3802
38934
54
106
3052
31676
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
4.8e-01
9.8e-01
1.9e+00
4.1e+00
1.7e+00
1.2e+00
9.7e-01
cases:22.49%
controls:15.28%
cases:21.26%
controls:9.18%
cases:12.22%
controls:2.13%
cases:5.15%
controls:0.09%
cases:10.14%
controls:2.05%
cases:24.07%
controls:8.84%
cases:39.50%
controls:19.79%
913
6204
3146
34385
863
3725
3197
36874
496
864
3563
39735
209
37
3850
40562
410
831
3635
39671
923
3449
2911
35545
1227
6291
1879
25491
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
3.8e-01
1.1e+00
2.1e+00
4.1e+00
1.8e+00
9.3e-01
6.9e-01
cases:44.64%
controls:35.58%
cases:45.59%
controls:22.35%
cases:27.30%
controls:4.33%
cases:14.58%
controls:0.27%
cases:21.21%
controls:4.13%
cases:42.98%
controls:22.94%
cases:65.13%
controls:48.38%
1812
14440
2247
26149
1851
9074
2209
31525
1108
1758
2951
38841
592
109
3467
40490
858
1671
3187
38831
1648
8945
2186
30049
2023
15375
1083
16407
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.4e+00
1.6e+00
2.3e+00
—
2.0e+00
2.0e+00
1.8e+00
cases:1.06%
controls:0.27%
cases:0.79%
controls:0.17%
cases:0.30%
controls:0.03%
—
—
cases:0.47%
controls:0.06%
cases:1.07%
controls:0.14%
cases:1.26%
controls:0.20%
43
108
4016
40481
32
68
4028
40531
12
12
4047
40587
—
19
25
4026
40477
41
56
3793
38938
39
64
3067
31718
Emergency Medicine
93 [38004510]
4.6e-01
8.4e-01
1.8e+00
5.3e+00
1.3e+00
8.4e-01
5.0e-01
cases:24.39%
controls:16.98%
cases:18.62%
controls:8.99%
cases:7.54%
controls:1.30%
cases:9.78%
controls:0.05%
cases:4.47%
controls:1.29%
cases:19.04%
controls:9.23%
cases:37.06%
controls:26.30%
990
6890
3069
33699
756
3650
3304
36949
306
528
3753
40071
397
21
3662
40578
181
522
3864
39980
730
3600
3104
35394
1151
8360
1955
23422
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
5.2e-01
8.8e-01
1.8e+00
4.7e+00
1.6e+00
8.9e-01
6.8e-01
cases:10.35%
controls:6.41%
cases:7.17%
controls:3.10%
cases:2.71%
controls:0.46%
cases:2.66%
controls:0.02%
cases:2.37%
controls:0.48%
cases:7.49%
controls:3.21%
cases:16.36%
controls:9.05%
420
2603
3639
37986
291
1259
3769
39340
110
188
3949
40411
108
10
3951
40589
96
196
3949
40306
287
1253
3547
37741
508
2875
2598
28907
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
5.2e-01
8.4e-01
1.6e+00
4.3e+00
2.0e+00
1.0e+00
7.8e-01
cases:8.18%
controls:5.05%
cases:4.73%
controls:2.11%
cases:1.33%
controls:0.27%
cases:0.91%
controls:0.01%
cases:1.61%
controls:0.23%
cases:4.98%
controls:1.85%
cases:11.78%
controls:5.75%
332
2051
3727
38538
192
855
3868
39744
54
108
4005
40491
37
5
4022
40594
65
92
3980
40410
191
722
3643
38272
366
1826
2740
29956
Proteinase 3 Ab [Units/volume] in Serum
6968-2 [3009445]
1.0e+00
1.2e+00
3.0e+00
—
2.9e+00
1.5e+00
1.4e+00
cases:1.90%
controls:0.70%
cases:1.03%
controls:0.31%
cases:0.34%
controls:0.02%
—
—
cases:0.47%
controls:0.03%
cases:1.12%
controls:0.24%
cases:3.41%
controls:0.85%
77
286
3982
40303
42
124
4018
40475
14
7
4045
40592
—
19
11
4026
40491
43
94
3791
38900
106
270
3000
31512
Monocytes/Leukocytes in Blood
26485-3 [3019069]
5.6e-01
1.1e+00
2.0e+00
3.1e+00
2.0e+00
1.3e+00
1.1e+00
cases:19.14%
controls:11.89%
cases:17.93%
controls:6.89%
cases:8.80%
controls:1.30%
cases:1.11%
controls:0.05%
cases:8.45%
controls:1.25%
cases:20.24%
controls:6.74%
cases:34.90%
controls:15.72%
777
4825
3282
35764
728
2797
3332
37802
357
527
3702
40072
45
21
4014
40578
342
508
3703
39994
776
2627
3058
36367
1084
4996
2022
26786
Tissue Pathology biopsy report
66121-5 [40768804]
3.2e-01
7.7e-01
1.6e+00
5.1e+00
1.6e+00
8.5e-01
7.0e-01
cases:13.48%
controls:10.14%
cases:7.44%
controls:3.59%
cases:2.00%
controls:0.40%
cases:2.39%
controls:0.01%
cases:1.71%
controls:0.34%
cases:7.17%
controls:3.20%
cases:19.22%
controls:10.56%
547
4115
3512
36474
302
1459
3758
39140
81
163
3978
40436
97
6
3962
40593
69
138
3976
40364
275
1247
3559
37747
597
3356
2509
28426
Examination and observation for other specified reasons
Z04.8 [45552063]
8.6e-01
1.8e+00
3.4e+00
—
2.3e+00
1.6e+00
9.3e-01
cases:4.04%
controls:1.75%
cases:3.52%
controls:0.57%
cases:1.53%
controls:0.05%
—
—
cases:0.62%
controls:0.06%
cases:2.66%
controls:0.53%
cases:4.86%
controls:1.98%
164
710
3895
39879
143
232
3917
40367
62
21
3997
40578
—
25
25
4020
40477
102
205
3732
38789
151
628
2955
31154
tacrolimus; oral, parenteral
L04AD02 [21603925]
1.8e+00
1.8e+00
1.8e+00
—
2.2e+00
1.6e+00
1.7e+00
cases:0.69%
controls:0.12%
cases:0.74%
controls:0.12%
cases:0.32%
controls:0.05%
—
—
cases:0.32%
controls:0.03%
cases:0.68%
controls:0.13%
cases:0.68%
controls:0.12%
28
48
4031
40541
30
49
4030
40550
13
21
4046
40578
—
13
14
4032
40488
26
52
3808
38942
21
39
3085
31743
Basophils/Leukocytes in Blood
30180-4 [3022096]
5.6e-01
1.1e+00
2.0e+00
3.0e+00
2.0e+00
1.3e+00
1.1e+00
cases:19.04%
controls:11.84%
cases:18.03%
controls:6.86%
cases:8.82%
controls:1.29%
cases:1.06%
controls:0.05%
cases:8.41%
controls:1.24%
cases:20.27%
controls:6.75%
cases:34.90%
controls:15.78%
773
4807
3286
35782
732
2785
3328
37814
358
524
3701
40075
43
21
4016
40578
340
504
3705
39998
777
2631
3057
36363
1084
5015
2022
26767
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
5.6e-01
1.1e+00
2.0e+00
3.1e+00
2.0e+00
1.3e+00
1.1e+00
cases:19.09%
controls:11.88%
cases:17.98%
controls:6.88%
cases:8.80%
controls:1.29%
cases:1.08%
controls:0.05%
cases:8.31%
controls:1.25%
cases:20.19%
controls:6.74%
cases:34.96%
controls:15.72%
775
4823
3284
35766
730
2795
3330
37804
357
524
3702
40075
44
21
4015
40578
336
508
3709
39994
774
2627
3060
36367
1086
4997
2020
26785
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
5.4e-01
1.0e+00
2.0e+00
3.1e+00
2.1e+00
1.2e+00
9.0e-01
cases:7.79%
controls:4.70%
cases:7.07%
controls:2.62%
cases:3.40%
controls:0.46%
cases:0.39%
controls:0.02%
cases:3.34%
controls:0.41%
cases:8.24%
controls:2.70%
cases:15.94%
controls:7.13%
316
1908
3743
38681
287
1063
3773
39536
138
187
3921
40412
16
7
4043
40592
135
168
3910
40334
316
1053
3518
37941
495
2265
2611
29517
Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7852-7 [3010130]
8.1e-01
1.5e+00
2.6e+00
—
2.9e+00
1.7e+00
1.3e+00
cases:0.71%
controls:0.32%
cases:0.69%
controls:0.15%
cases:0.17%
controls:0.01%
—
—
cases:0.27%
controls:0.01%
cases:0.60%
controls:0.11%
cases:1.22%
controls:0.33%
29
130
4030
40459
28
61
4032
40538
7
5
4052
40594
—
11
6
4034
40496
23
43
3811
38951
38
105
3068
31677
Tacrolimus [Mass/volume] in Blood
11253-2 [3026250]
1.7e+00
1.7e+00
2.2e+00
—
2.2e+00
1.6e+00
1.5e+00
cases:0.59%
controls:0.10%
cases:0.49%
controls:0.09%
cases:0.30%
controls:0.03%
—
—
cases:0.32%
controls:0.03%
cases:0.52%
controls:0.10%
cases:0.55%
controls:0.13%
24
42
4035
40547
20
38
4040
40561
12
14
4047
40585
—
13
14
4032
40488
20
40
3814
38954
17
40
3089
31742
Stomach Pathology biopsy report
66114-0 [40768797]
7.1e-01
1.6e+00
2.5e+00
1.0e+50
3.3e+00
1.7e+00
1.1e+00
cases:5.72%
controls:2.89%
cases:4.19%
controls:0.87%
cases:0.99%
controls:0.08%
cases:1.43%
controls:0.00%
cases:1.24%
controls:0.05%
cases:4.07%
controls:0.79%
cases:8.89%
controls:3.07%
232
1173
3827
39416
170
354
3890
40245
40
33
4019
40566
58
0
4001
40599
50
19
3995
40483
156
309
3678
38685
276
977
2830
30805
clidinium and psycholeptics
A03CA02 [21600204]
1.4e+00
1.8e+00
2.3e+00
—
2.4e+00
1.6e+00
1.5e+00
cases:3.30%
controls:0.86%
cases:1.95%
controls:0.33%
cases:0.34%
controls:0.03%
—
—
cases:0.42%
controls:0.04%
cases:1.51%
controls:0.32%
cases:3.67%
controls:0.85%
134
351
3925
40238
79
134
3981
40465
14
14
4045
40585
—
17
16
4028
40486
58
124
3776
38870
114
271
2992
31511
Smooth muscle Ab [Titer] in Serum
8095-2 [3007566]
4.5e-01
1.4e+00
2.7e+00
—
3.6e+00
1.7e+00
1.5e+00
cases:0.79%
controls:0.50%
cases:0.62%
controls:0.15%
cases:0.25%
controls:0.02%
—
—
cases:0.44%
controls:0.01%
cases:0.94%
controls:0.17%
cases:2.38%
controls:0.56%
32
204
4027
40385
25
59
4035
40540
10
7
4049
40592
—
18
5
4027
40497
36
66
3798
38928
74
179
3032
31603
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
5.2e-01
8.2e-01
1.7e+00
4.6e+00
1.6e+00
9.2e-01
7.5e-01
cases:8.01%
controls:4.94%
cases:4.68%
controls:2.12%
cases:1.65%
controls:0.30%
cases:1.68%
controls:0.02%
cases:1.46%
controls:0.31%
cases:5.03%
controls:2.07%
cases:11.75%
controls:5.91%
325
2005
3734
38584
190
861
3870
39738
67
122
3992
40477
68
7
3991
40592
59
125
3986
40377
193
809
3641
38185
365
1878
2741
29904
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
5.4e-01
1.1e+00
2.0e+00
3.1e+00
2.0e+00
1.2e+00
1.0e+00
cases:19.36%
controls:12.23%
cases:18.15%
controls:7.07%
cases:8.75%
controls:1.33%
cases:1.13%
controls:0.05%
cases:8.58%
controls:1.28%
cases:20.21%
controls:7.02%
cases:34.93%
controls:16.51%
786
4966
3273
35623
737
2871
3323
37728
355
539
3704
40060
46
21
4013
40578
347
517
3698
39985
775
2736
3059
36258
1085
5246
2021
26536
Outpatient Hospital
22 [8756]
5.3e-01
7.9e-01
1.2e+00
5.1e+00
1.6e+00
8.6e-01
7.7e-01
cases:35.72%
controls:24.72%
cases:13.20%
controls:6.44%
cases:2.51%
controls:0.76%
cases:4.09%
controls:0.03%
cases:3.56%
controls:0.76%
cases:11.89%
controls:5.41%
cases:27.62%
controls:15.04%
1450
10033
2609
30556
536
2616
3524
37983
102
309
3957
40290
166
11
3893
40588
144
306
3901
40196
456
2108
3378
36886
858
4779
2248
27003
Eosinophils [#/volume] in Blood
26449-9 [3013115]
5.2e-01
1.1e+00
2.0e+00
3.0e+00
1.9e+00
1.3e+00
1.0e+00
cases:20.35%
controls:13.14%
cases:19.36%
controls:7.63%
cases:9.73%
controls:1.47%
cases:1.16%
controls:0.06%
cases:8.58%
controls:1.34%
cases:22.01%
controls:7.44%
cases:37.96%
controls:18.01%
826
5334
3233
35255
786
3096
3274
37503
395
597
3664
40002
47
24
4012
40575
347
544
3698
39958
844
2903
2990
36091
1179
5725
1927
26057
Monocytes [#/volume] in Blood
26484-6 [3001604]
5.3e-01
1.1e+00
2.0e+00
3.0e+00
1.9e+00
1.3e+00
1.0e+00
cases:19.59%
controls:12.52%
cases:18.67%
controls:7.32%
cases:9.19%
controls:1.39%
cases:1.08%
controls:0.06%
cases:8.36%
controls:1.30%
cases:21.49%
controls:7.20%
cases:37.06%
controls:17.39%
795
5081
3264
35508
758
2970
3302
37629
373
563
3686
40036
44
23
4015
40576
338
525
3707
39977
824
2809
3010
36185
1151
5527
1955
26255
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
4.7e-01
8.4e-01
1.8e+00
4.9e+00
1.4e+00
8.4e-01
5.9e-01
cases:13.55%
controls:8.90%
cases:9.21%
controls:4.19%
cases:3.20%
controls:0.55%
cases:2.83%
controls:0.02%
cases:2.18%
controls:0.57%
cases:9.15%
controls:4.18%
cases:20.93%
controls:12.82%
550
3611
3509
36978
374
1700
3686
38899
130
225
3929
40374
115
9
3944
40590
88
230
3957
40272
351
1630
3483
37364
650
4073
2456
27709
Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7853-5 [3015635]
7.8e-01
1.5e+00
2.6e+00
—
3.0e+00
1.5e+00
1.3e+00
cases:0.79%
controls:0.36%
cases:0.71%
controls:0.16%
cases:0.17%
controls:0.01%
—
—
cases:0.30%
controls:0.01%
cases:0.57%
controls:0.12%
cases:1.26%
controls:0.36%
32
147
4027
40442
29
63
4031
40536
7
5
4052
40594
—
12
6
4033
40496
22
48
3812
38946
39
115
3067
31667
Basophils [#/volume] in Blood
26444-0 [3006315]
5.3e-01
1.1e+00
2.0e+00
3.0e+00
1.9e+00
1.3e+00
1.0e+00
cases:19.61%
controls:12.57%
cases:18.77%
controls:7.33%
cases:9.14%
controls:1.39%
cases:1.08%
controls:0.06%
cases:8.31%
controls:1.30%
cases:21.44%
controls:7.22%
cases:37.12%
controls:17.44%
796
5101
3263
35488
762
2975
3298
37624
371
564
3688
40035
44
23
4015
40576
336
525
3709
39977
822
2814
3012
36180
1153
5542
1953
26240
Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22246-3 [3017918]
7.9e-01
1.6e+00
2.6e+00
—
3.0e+00
1.5e+00
1.2e+00
cases:0.81%
controls:0.37%
cases:0.76%
controls:0.16%
cases:0.17%
controls:0.01%
—
—
cases:0.30%
controls:0.01%
cases:0.57%
controls:0.13%
cases:1.26%
controls:0.38%
33
150
4026
40439
31
63
4029
40536
7
5
4052
40594
—
12
6
4033
40496
22
50
3812
38944
39
121
3067
31661
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.0e-01
9.8e-01
1.7e+00
3.9e+00
1.9e+00
1.0e+00
7.6e-01
cases:17.37%
controls:11.27%
cases:13.94%
controls:5.74%
cases:5.05%
controls:0.93%
cases:1.85%
controls:0.04%
cases:5.64%
controls:0.91%
cases:14.16%
controls:5.71%
cases:27.24%
controls:14.93%
705
4574
3354
36015
566
2332
3494
38267
205
376
3854
40223
75
16
3984
40583
228
368
3817
40134
543
2227
3291
36767
846
4744
2260
27038
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
5.2e-01
1.1e+00
2.0e+00
3.0e+00
1.9e+00
1.2e+00
1.0e+00
cases:20.28%
controls:13.10%
cases:19.36%
controls:7.58%
cases:9.41%
controls:1.44%
cases:1.11%
controls:0.06%
cases:8.45%
controls:1.33%
cases:21.78%
controls:7.49%
cases:37.48%
controls:18.10%
823
5319
3236
35270
786
3077
3274
37522
382
584
3677
40015
45
23
4014
40576
342
540
3703
39962
835
2920
2999
36074
1164
5751
1942
26031
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
8.6e-01
1.4e+00
2.6e+00
—
3.3e+00
1.5e+00
1.1e+00
cases:13.25%
controls:6.05%
cases:6.90%
controls:1.72%
cases:2.59%
controls:0.20%
—
—
cases:3.81%
controls:0.15%
cases:6.89%
controls:1.66%
cases:13.81%
controls:5.21%
538
2457
3521
38132
280
699
3780
39900
105
82
3954
40517
—
154
61
3891
40441
264
649
3570
38345
429
1656
2677
30126
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.3e-01
8.4e-01
1.8e+00
4.7e+00
1.6e+00
8.3e-01
5.8e-01
cases:21.02%
controls:14.70%
cases:15.34%
controls:7.27%
cases:5.54%
controls:0.99%
cases:4.21%
controls:0.04%
cases:4.23%
controls:0.92%
cases:14.68%
controls:6.97%
cases:31.39%
controls:20.45%
853
5967
3206
34622
623
2952
3437
37647
225
400
3834
40199
171
17
3888
40582
171
373
3874
40129
563
2716
3271
36278
975
6498
2131
25284
Hypokalaemia
E87.6 [45537991]
6.4e-01
1.8e+00
3.3e+00
1.0e+50
2.7e+00
1.8e+00
9.3e-01
cases:0.52%
controls:0.27%
cases:0.74%
controls:0.12%
cases:0.42%
controls:0.01%
cases:0.30%
controls:0.00%
cases:0.22%
controls:0.01%
cases:0.78%
controls:0.13%
cases:1.16%
controls:0.46%
21
111
4038
40478
30
48
4030
40551
17
6
4042
40593
12
0
4047
40599
9
6
4036
40496
30
49
3804
38945
36
147
3070
31635
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
4.9e-01
8.6e-01
1.6e+00
4.6e+00
1.5e+00
8.6e-01
6.2e-01
cases:11.60%
controls:7.46%
cases:8.20%
controls:3.63%
cases:2.86%
controls:0.57%
cases:2.71%
controls:0.03%
cases:2.65%
controls:0.58%
cases:8.61%
controls:3.83%
cases:18.51%
controls:10.86%
471
3026
3588
37563
333
1472
3727
39127
116
230
3943
40369
110
11
3949
40588
107
235
3938
40267
330
1494
3504
37500
575
3453
2531
28329
Pharmacy visit
OMOP4822462 [581458]
1.4e+00
1.6e+00
9.2e-01
1.9e+00
1.2e+00
1.8e+00
1.8e+00
cases:99.04%
controls:96.35%
cases:97.32%
controls:88.27%
cases:72.70%
controls:51.45%
cases:16.14%
controls:2.80%
cases:77.95%
controls:51.46%
cases:98.02%
controls:88.70%
cases:99.48%
controls:96.83%
4020
39108
39
1481
3951
35838
109
4761
2951
20890
1108
19709
655
1136
3404
39463
3153
20843
892
19659
3758
34587
76
4407
3090
30776
16
1006
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
5.4e-01
1.0e+00
2.0e+00
3.0e+00
1.9e+00
1.2e+00
9.9e-01
cases:18.85%
controls:11.95%
cases:17.49%
controls:6.94%
cases:8.60%
controls:1.30%
cases:0.94%
controls:0.05%
cases:8.06%
controls:1.26%
cases:19.74%
controls:6.86%
cases:34.16%
controls:16.21%
765
4852
3294
35737
710
2819
3350
37780
349
526
3710
40073
38
20
4021
40579
326
510
3719
39992
757
2674
3077
36320
1061
5153
2045
26629
Benign neoplasm: Colon, unspecified
D12.6 [45576377]
8.3e-01
1.6e+00
2.7e+00
1.0e+50
2.9e+00
1.6e+00
9.3e-01
cases:1.18%
controls:0.52%
cases:0.89%
controls:0.18%
cases:0.34%
controls:0.02%
cases:0.67%
controls:0.00%
cases:0.35%
controls:0.02%
cases:0.89%
controls:0.17%
cases:1.51%
controls:0.60%
48
210
4011
40379
36
75
4024
40524
14
9
4045
40590
27
0
4032
40599
14
8
4031
40494
34
68
3800
38926
47
192
3059
31590
Celiac disease serology panel - Serum
94494-2 [36660697]
9.1e-01
2.3e+00
2.9e+00
—
2.9e+00
1.0e+00
5.6e-01
cases:3.94%
controls:1.63%
cases:4.95%
controls:0.54%
cases:1.16%
controls:0.06%
—
—
cases:1.11%
controls:0.06%
cases:1.25%
controls:0.45%
cases:3.70%
controls:2.15%
160
662
3899
39927
201
221
3859
40378
47
26
4012
40573
—
45
25
4000
40477
48
174
3786
38820
115
682
2991
31100
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
4.7e-01
8.5e-01
1.7e+00
4.5e+00
1.5e+00
8.5e-01
6.7e-01
cases:13.55%
controls:8.90%
cases:8.99%
controls:4.06%
cases:3.08%
controls:0.60%
cases:2.86%
controls:0.03%
cases:2.77%
controls:0.60%
cases:9.18%
controls:4.16%
cases:20.57%
controls:11.72%
550
3613
3509
36976
365
1649
3695
38950
125
242
3934
40357
116
13
3943
40586
112
245
3933
40257
352
1622
3482
37372
639
3725
2467
28057
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
4.6e-01
7.9e-01
1.5e+00
4.1e+00
1.8e+00
1.1e+00
7.5e-01
cases:11.36%
controls:7.50%
cases:6.33%
controls:2.97%
cases:1.68%
controls:0.36%
cases:1.18%
controls:0.02%
cases:2.13%
controls:0.35%
cases:6.94%
controls:2.46%
cases:15.52%
controls:8.00%
461
3043
3598
37546
257
1205
3803
39394
68
148
3991
40451
48
8
4011
40591
86
142
3959
40360
266
958
3568
38036
482
2542
2624
29240
Secondary malignant neoplasm of lung
C78.0 [45537839]
1.8e+00
2.3e+00
2.6e+00
—
2.3e+00
1.6e+00
8.2e-01
cases:0.39%
controls:0.06%
cases:0.57%
controls:0.06%
cases:0.44%
controls:0.03%
—
—
cases:0.35%
controls:0.03%
cases:0.47%
controls:0.10%
cases:0.42%
controls:0.19%
16
26
4043
40563
23
23
4037
40576
18
14
4041
40585
—
14
14
4031
40488
18
39
3816
38955
13
59
3093
31723
Metastasis to lung
OMOP4999962 [36770283]
1.8e+00
2.3e+00
2.6e+00
—
2.3e+00
1.6e+00
8.2e-01
cases:0.39%
controls:0.06%
cases:0.57%
controls:0.06%
cases:0.44%
controls:0.03%
—
—
cases:0.35%
controls:0.03%
cases:0.47%
controls:0.10%
cases:0.42%
controls:0.19%
16
26
4043
40563
23
23
4037
40576
18
14
4041
40585
—
14
14
4031
40488
18
39
3816
38955
13
59
3093
31723
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
7.6e-01
1.4e+00
2.8e+00
—
2.6e+00
1.6e+00
1.3e+00
cases:3.55%
controls:1.70%
cases:3.10%
controls:0.77%
cases:1.18%
controls:0.07%
—
—
cases:1.36%
controls:0.10%
cases:3.10%
controls:0.67%
cases:6.95%
controls:2.00%
144
689
3915
39900
126
314
3934
40285
48
29
4011
40570
—
55
40
3990
40462
119
260
3715
38734
216
636
2890
31146
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
6.6e-01
1.4e+00
2.5e+00
—
2.6e+00
1.8e+00
1.4e+00
cases:2.24%
controls:1.18%
cases:1.92%
controls:0.47%
cases:0.54%
controls:0.04%
—
—
cases:0.84%
controls:0.06%
cases:2.53%
controls:0.42%
cases:5.41%
controls:1.37%
91
477
3968
40112
78
191
3982
40408
22
18
4037
40581
—
34
25
4011
40477
97
162
3737
38832
168
436
2938
31346
Other and unspecified abdominal pain
R10.4 [45568113]
8.9e-01
1.8e+00
3.0e+00
—
2.3e+00
1.5e+00
9.9e-01
cases:13.72%
controls:6.13%
cases:9.80%
controls:1.76%
cases:3.84%
controls:0.20%
—
—
cases:1.85%
controls:0.19%
cases:7.20%
controls:1.77%
cases:15.00%
controls:6.15%
557
2489
3502
38100
398
716
3662
39883
156
80
3903
40519
—
75
78
3970
40424
276
689
3558
38305
466
1954
2640
29828
Normoblasts [#/volume] in Blood
715-3 [3021589]
4.4e-01
8.4e-01
1.9e+00
3.8e+00
1.7e+00
9.4e-01
8.1e-01
cases:15.96%
controls:10.93%
cases:17.66%
controls:8.47%
cases:11.09%
controls:1.86%
cases:3.89%
controls:0.09%
cases:9.00%
controls:1.80%
cases:19.67%
controls:8.75%
cases:30.88%
controls:16.64%
648
4435
3411
36154
717
3437
3343
37162
450
754
3609
39845
158
37
3901
40562
364
728
3681
39774
754
3411
3080
35583
959
5288
2147
26494
Leukocytes [#/volume] in Urine
30405-5 [3018095]
4.8e-01
8.7e-01
1.6e+00
4.6e+00
1.5e+00
8.3e-01
5.4e-01
cases:12.93%
controls:8.41%
cases:9.88%
controls:4.38%
cases:3.28%
controls:0.69%
cases:2.86%
controls:0.03%
cases:2.92%
controls:0.69%
cases:10.20%
controls:4.70%
cases:20.64%
controls:13.10%
525
3412
3534
37177
401
1780
3659
38819
133
282
3926
40317
116
12
3943
40587
118
279
3927
40223
391
1833
3443
37161
641
4165
2465
27617
Neutrophils [#/volume] in Blood
26499-4 [3017732]
5.0e-01
1.1e+00
2.1e+00
3.3e+00
1.9e+00
9.0e-01
5.3e-01
cases:2.41%
controls:1.47%
cases:2.51%
controls:0.89%
cases:1.26%
controls:0.16%
cases:0.39%
controls:0.01%
cases:1.21%
controls:0.18%
cases:2.53%
controls:1.05%
cases:6.12%
controls:3.68%
98
598
3961
39991
102
361
3958
40238
51
66
4008
40533
16
6
4043
40593
49
73
3996
40429
97
409
3737
38585
190
1171
2916
30611
Abdominal CT examination
JN3AD [2001305554]
7.4e-01
1.5e+00
3.1e+00
—
2.0e+00
1.7e+00
1.1e+00
cases:2.09%
controls:1.01%
cases:2.27%
controls:0.49%
cases:1.58%
controls:0.07%
—
—
cases:0.57%
controls:0.08%
cases:3.03%
controls:0.57%
cases:6.34%
controls:2.15%
85
409
3974
40180
92
200
3968
40399
64
29
3995
40570
—
23
31
4022
40471
116
221
3718
38773
197
682
2909
31100
Tissue transglutaminase IgG Ab [Units/volume] in Serum
32998-7 [3046870]
9.7e-01
2.6e+00
2.2e+00
—
3.2e+00
7.7e-01
4.9e-01
cases:1.72%
controls:0.66%
cases:3.47%
controls:0.28%
cases:0.34%
controls:0.04%
—
—
cases:0.67%
controls:0.03%
cases:0.70%
controls:0.33%
cases:2.48%
controls:1.53%
70
268
3989
40321
141
113
3919
40486
14
15
4045
40584
—
27
11
4018
40491
27
128
3807
38866
77
486
3029
31296
Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
83084-4 [42529201]
7.5e-01
1.6e+00
2.6e+00
—
2.3e+00
1.7e+00
1.3e+00
cases:0.69%
controls:0.33%
cases:0.94%
controls:0.19%
cases:0.34%
controls:0.02%
—
—
cases:0.30%
controls:0.03%
cases:0.89%
controls:0.17%
cases:1.48%
controls:0.43%
28
133
4031
40456
38
76
4022
40523
14
10
4045
40589
—
12
12
4033
40490
34
66
3800
38928
46
136
3060
31646
General Surgery
2 [38004447]
5.1e-01
7.5e-01
1.4e+00
4.8e+00
1.3e+00
7.3e-01
5.6e-01
cases:23.87%
controls:15.86%
cases:9.33%
controls:4.65%
cases:2.46%
controls:0.60%
cases:2.71%
controls:0.02%
cases:2.15%
controls:0.57%
cases:7.96%
controls:4.00%
cases:18.13%
controls:11.21%
969
6438
3090
34151
379
1886
3681
38713
100
245
3959
40354
110
9
3949
40590
87
230
3958
40272
305
1560
3529
37434
563
3563
2543
28219
Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
38917-1 [3042194]
7.1e-01
1.1e+00
2.6e+00
—
2.9e+00
1.4e+00
1.3e+00
cases:0.81%
controls:0.40%
cases:0.62%
controls:0.20%
cases:0.17%
controls:0.01%
—
—
cases:0.22%
controls:0.01%
cases:0.73%
controls:0.17%
cases:1.96%
controls:0.53%
33
163
4026
40426
25
81
4035
40518
7
5
4052
40594
—
9
5
4036
40497
28
68
3806
38926
61
168
3045
31614
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.5e-01
9.2e-01
1.6e+00
3.7e+00
1.8e+00
9.0e-01
6.9e-01
cases:18.43%
controls:12.57%
cases:15.25%
controls:6.72%
cases:5.27%
controls:1.09%
cases:1.77%
controls:0.04%
cases:6.25%
controls:1.04%
cases:15.13%
controls:6.73%
cases:30.01%
controls:17.74%
748
5104
3311
35485
619
2728
3441
37871
214
444
3845
40155
72
18
3987
40581
253
421
3792
40081
580
2625
3254
36369
932
5638
2174
26144
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
7.1e-01
1.7e+00
2.9e+00
—
2.6e+00
1.5e+00
6.5e-01
cases:5.84%
controls:2.95%
cases:5.74%
controls:1.09%
cases:3.01%
controls:0.16%
—
—
cases:2.10%
controls:0.16%
cases:4.88%
controls:1.15%
cases:6.47%
controls:3.48%
237
1198
3822
39391
233
444
3827
40155
122
66
3937
40533
—
85
64
3960
40438
187
450
3647
38544
201
1105
2905
30677
pH of Blood
11558-4 [3010421]
7.3e-01
1.3e+00
2.6e+00
1.0e+50
2.9e+00
1.4e+00
1.3e+00
cases:1.16%
controls:0.56%
cases:0.81%
controls:0.23%
cases:0.44%
controls:0.03%
cases:0.22%
controls:0.00%
cases:0.67%
controls:0.04%
cases:1.04%
controls:0.26%
cases:2.32%
controls:0.67%
47
227
4012
40362
33
95
4027
40504
18
14
4041
40585
9
0
4050
40599
27
15
4018
40487
40
101
3794
38893
72
213
3034
31569
Chronic kidney disease, unspecified
N18.9 [45553438]
7.7e-01
1.1e+00
1.4e+00
3.6e+00
1.4e+00
1.0e+00
8.0e-01
cases:1.50%
controls:0.70%
cases:1.31%
controls:0.46%
cases:0.52%
controls:0.13%
cases:0.54%
controls:0.01%
cases:0.52%
controls:0.12%
cases:1.41%
controls:0.51%
cases:2.48%
controls:1.13%
61
285
3998
40304
53
185
4007
40414
21
53
4038
40546
22
6
4037
40593
21
50
4024
40452
54
197
3780
38797
77
358
3029
31424
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
8.0e-01
1.5e+00
2.9e+00
—
2.6e+00
1.3e+00
9.7e-01
cases:3.89%
controls:1.79%
cases:3.35%
controls:0.75%
cases:1.18%
controls:0.06%
—
—
cases:0.94%
controls:0.07%
cases:2.76%
controls:0.77%
cases:6.12%
controls:2.41%
158
725
3901
39864
136
306
3924
40293
48
26
4011
40573
—
38
29
4007
40473
106
302
3728
38692
190
765
2916
31017
pH of Serum or Plasma
2753-2 [3018418]
4.7e-01
9.8e-01
1.7e+00
3.3e+00
2.0e+00
9.9e-01
6.3e-01
cases:10.89%
controls:7.08%
cases:9.26%
controls:3.67%
cases:3.25%
controls:0.62%
cases:0.67%
controls:0.02%
cases:3.93%
controls:0.57%
cases:9.10%
controls:3.58%
cases:17.48%
controls:10.15%
442
2875
3617
37714
376
1492
3684
39107
132
252
3927
40347
27
10
4032
40589
159
230
3886
40272
349
1396
3485
37598
543
3227
2563
28555
General Practice
1 [38004446]
5.1e-01
7.5e-01
1.6e+00
4.5e+00
1.3e+00
7.6e-01
5.8e-01
cases:21.51%
controls:14.13%
cases:11.28%
controls:5.67%
cases:3.94%
controls:0.80%
cases:3.52%
controls:0.04%
cases:3.26%
controls:0.89%
cases:11.84%
controls:5.92%
cases:25.79%
controls:16.36%
873
5737
3186
34852
458
2302
3602
38297
160
323
3899
40276
143
17
3916
40582
132
361
3913
40141
454
2310
3380
36684
801
5198
2305
26584
Band form neutrophils/Leukocytes in Blood
26508-2 [3004809]
9.8e-01
1.0e+00
2.2e+00
—
3.2e+00
1.7e+00
9.6e-01
cases:0.79%
controls:0.30%
cases:0.39%
controls:0.15%
cases:0.20%
controls:0.02%
—
—
cases:0.47%
controls:0.02%
cases:0.73%
controls:0.13%
cases:1.06%
controls:0.41%
32
121
4027
40468
16
59
4044
40540
8
9
4051
40590
—
19
8
4026
40494
28
52
3806
38942
33
130
3073
31652
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
1.0e+00
1.1e+00
2.5e+00
1.0e+50
2.6e+00
1.5e+00
1.3e+00
cases:2.69%
controls:0.97%
cases:0.91%
controls:0.31%
cases:0.30%
controls:0.02%
cases:0.30%
controls:0.00%
cases:0.37%
controls:0.03%
cases:1.36%
controls:0.32%
cases:3.28%
controls:0.94%
109
394
3950
40195
37
124
4023
40475
12
10
4047
40589
12
0
4047
40599
15
11
4030
40491
52
124
3782
38870
102
298
3004
31484
Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
63459-2 [40766189]
7.0e-01
1.9e+00
3.7e+00
—
2.3e+00
1.4e+00
6.1e-01
cases:1.48%
controls:0.74%
cases:1.08%
controls:0.16%
cases:0.57%
controls:0.01%
—
—
cases:0.20%
controls:0.02%
cases:0.44%
controls:0.11%
cases:1.00%
controls:0.55%
60
301
3999
40288
44
65
4016
40534
23
6
4036
40593
—
8
8
4037
40494
17
43
3817
38951
31
174
3075
31608
Change in bowel habit
R19.4 [45573017]
1.6e+00
3.3e+00
4.2e+00
1.0e+50
—
1.2e+00
8.0e-01
cases:1.03%
controls:0.21%
cases:2.39%
controls:0.09%
cases:1.01%
controls:0.01%
cases:0.20%
controls:0.00%
—
—
cases:0.31%
controls:0.10%
cases:0.77%
controls:0.35%
42
86
4017
40503
97
35
3963
40564
41
6
4018
40593
8
0
4051
40599
—
12
38
3822
38956
24
111
3082
31671
Irritable bowel syndrome without diarrhoea
K58.9 [45538539]
9.7e-01
2.5e+00
2.8e+00
1.0e+50
—
2.4e+00
1.3e+00
cases:0.84%
controls:0.32%
cases:0.84%
controls:0.07%
cases:0.20%
controls:0.01%
cases:0.17%
controls:0.00%
—
—
cases:0.60%
controls:0.06%
cases:0.93%
controls:0.25%
34
130
4025
40459
34
28
4026
40571
8
5
4051
40594
7
0
4052
40599
—
23
22
3811
38972
29
79
3077
31703
Gas panel - Central venous blood
97535-9 [1616796]
7.5e-01
9.5e-01
2.4e+00
1.0e+50
3.0e+00
1.5e+00
1.3e+00
cases:0.86%
controls:0.41%
cases:0.57%
controls:0.22%
cases:0.27%
controls:0.02%
cases:0.20%
controls:0.00%
cases:0.59%
controls:0.03%
cases:0.81%
controls:0.18%
cases:1.96%
controls:0.53%
35
166
4024
40423
23
89
4037
40510
11
10
4048
40589
8
0
4051
40599
24
12
4021
40490
31
70
3803
38924
61
170
3045
31612
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
5.1e-01
7.9e-01
1.6e+00
4.6e+00
1.4e+00
6.4e-01
4.3e-01
cases:5.15%
controls:3.15%
cases:3.72%
controls:1.72%
cases:1.38%
controls:0.29%
cases:1.18%
controls:0.01%
cases:1.26%
controls:0.32%
cases:3.76%
controls:2.02%
cases:8.92%
controls:5.98%
209
1278
3850
39311
151
699
3909
39900
56
117
4003
40482
48
5
4011
40594
51
128
3994
40374
144
788
3690
38206
277
1902
2829
29880
Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
88928-7 [36305771]
1.8e+00
3.2e+00
—
—
—
3.0e+00
1.9e+00
cases:0.59%
controls:0.10%
cases:1.06%
controls:0.04%
—
—
—
—
—
—
cases:0.68%
controls:0.03%
cases:0.93%
controls:0.15%
24
40
4035
40549
43
17
4017
40582
—
—
—
26
13
3808
38981
29
47
3077
31735
Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
92687-3 [37020937]
1.8e+00
3.2e+00
—
—
—
3.0e+00
1.9e+00
cases:0.59%
controls:0.10%
cases:1.06%
controls:0.04%
—
—
—
—
—
—
cases:0.68%
controls:0.03%
cases:0.93%
controls:0.15%
24
40
4035
40549
43
17
4017
40582
—
—
—
26
13
3808
38981
29
47
3077
31735
Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
92689-9 [37020300]
1.7e+00
3.3e+00
—
—
1.0e+50
3.1e+00
1.8e+00
cases:0.30%
controls:0.05%
cases:0.59%
controls:0.02%
—
—
—
—
cases:0.44%
controls:0.00%
cases:0.29%
controls:0.01%
cases:0.58%
controls:0.10%
12
21
4047
40568
24
9
4036
40590
—
—
18
0
4027
40502
11
5
3823
38989
18
32
3088
31750
nintedanib; oral
L01EX09 [947759]
2.6e+00
2.3e+00
2.5e+00
—
2.1e+00
2.6e+00
—
cases:0.22%
controls:0.02%
cases:0.20%
controls:0.02%
cases:0.17%
controls:0.01%
—
—
cases:0.12%
controls:0.01%
cases:0.23%
controls:0.02%
—
—
9
7
4050
40582
8
8
4052
40591
7
6
4052
40593
—
5
6
4040
40496
9
7
3825
38987
—
Inpatient Visit
IP [9201]
3.5e-01
6.7e-01
1.6e+00
3.9e+00
1.7e+00
1.0e+00
6.2e-01
cases:9.02%
controls:6.52%
cases:6.03%
controls:3.19%
cases:1.63%
controls:0.35%
cases:1.36%
controls:0.03%
cases:1.98%
controls:0.36%
cases:8.03%
controls:3.01%
cases:16.65%
controls:9.68%
366
2647
3693
37942
245
1294
3815
39305
66
141
3993
40458
55
11
4004
40588
80
144
3965
40358
308
1174
3526
37820
517
3076
2589
28706
Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
70242-3 [42868716]
1.6e+00
3.4e+00
—
1.0e+50
—
2.8e+00
2.1e+00
cases:1.18%
controls:0.24%
cases:2.00%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.83%
controls:0.05%
cases:1.51%
controls:0.19%
48
98
4011
40491
81
28
3979
40571
—
14
0
4045
40599
—
32
20
3802
38974
47
59
3059
31723
MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
72872-5 [43534045]
7.9e-01
2.6e+00
3.6e+00
1.0e+50
2.9e+00
6.1e-01
3.0e-01
cases:2.54%
controls:1.17%
cases:4.38%
controls:0.34%
cases:0.81%
controls:0.02%
cases:0.12%
controls:0.00%
cases:0.40%
controls:0.02%
cases:0.52%
controls:0.28%
cases:1.51%
controls:1.12%
103
473
3956
40116
178
137
3882
40462
33
9
4026
40590
5
0
4054
40599
16
9
4029
40493
20
111
3814
38883
47
356
3059
31426
Intravenous
ZX120 [2001311495]
1.1e+00
1.6e+00
1.9e+00
—
2.0e+00
1.7e+00
1.5e+00
cases:3.67%
controls:1.22%
cases:2.17%
controls:0.45%
cases:0.69%
controls:0.10%
—
—
cases:0.82%
controls:0.11%
cases:2.14%
controls:0.40%
cases:4.28%
controls:0.98%
149
496
3910
40093
88
183
3972
40416
28
41
4031
40558
—
33
43
4012
40459
82
156
3752
38838
133
312
2973
31470
Vibrio sp identified in Specimen by Organism specific culture
6581-3 [3005988]
1.6e+00
3.4e+00
—
1.0e+50
—
2.7e+00
2.1e+00
cases:1.21%
controls:0.24%
cases:1.97%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.83%
controls:0.06%
cases:1.51%
controls:0.18%
49
98
4010
40491
80
27
3980
40572
—
14
0
4045
40599
—
32
22
3802
38972
47
57
3059
31725
Yersinia sp identified in Specimen by Organism specific culture
701-3 [3025468]
1.6e+00
3.4e+00
—
1.0e+50
—
2.7e+00
2.2e+00
cases:1.21%
controls:0.24%
cases:1.95%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.81%
controls:0.06%
cases:1.51%
controls:0.17%
49
98
4010
40491
79
27
3981
40572
—
14
0
4045
40599
—
31
22
3803
38972
47
55
3059
31727
Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
82198-3 [21493466]
1.6e+00
3.4e+00
—
1.0e+50
—
2.7e+00
2.1e+00
cases:1.21%
controls:0.24%
cases:1.95%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.83%
controls:0.06%
cases:1.51%
controls:0.18%
49
98
4010
40491
79
27
3981
40572
—
14
0
4045
40599
—
32
22
3802
38972
47
57
3059
31725
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
3.0e-01
6.4e-01
1.4e+00
4.5e+00
1.6e+00
8.5e-01
6.1e-01
cases:14.29%
controls:10.99%
cases:8.25%
controls:4.54%
cases:2.14%
controls:0.56%
cases:1.48%
controls:0.02%
cases:2.42%
controls:0.48%
cases:8.40%
controls:3.77%
cases:20.80%
controls:12.50%
580
4459
3479
36130
335
1842
3725
38757
87
227
3972
40372
60
7
3999
40592
98
195
3947
40307
322
1470
3512
37524
646
3973
2460
27809
IgG [Mass/volume] in Serum or Plasma
2465-3 [3005719]
7.0e-01
1.3e+00
2.3e+00
—
2.6e+00
1.6e+00
1.3e+00
cases:3.18%
controls:1.60%
cases:2.96%
controls:0.80%
cases:0.89%
controls:0.09%
—
—
cases:1.38%
controls:0.11%
cases:3.63%
controls:0.75%
cases:6.95%
controls:1.95%
129
649
3930
39940
120
326
3940
40273
36
37
4023
40562
—
56
43
3989
40459
139
292
3695
38702
216
620
2890
31162
Acute renal failure, unspecified
N17.9 [45567829]
6.1e-01
1.4e+00
3.5e+00
1.0e+50
1.9e+00
1.6e+00
1.3e+00
cases:0.52%
controls:0.28%
cases:0.47%
controls:0.11%
cases:0.42%
controls:0.01%
cases:0.22%
controls:0.00%
cases:0.17%
controls:0.02%
cases:0.73%
controls:0.15%
cases:1.51%
controls:0.42%
21
114
4038
40475
19
45
4041
40554
17
5
4042
40594
9
0
4050
40599
7
10
4038
40492
28
58
3806
38936
47
133
3059
31649
Microscopic observation [Identifier] in Isolate by Gram stain
87975-9 [36305247]
8.5e-01
1.1e+00
2.6e+00
—
2.7e+00
1.3e+00
1.2e+00
cases:1.01%
controls:0.43%
cases:0.54%
controls:0.18%
cases:0.20%
controls:0.01%
—
—
cases:0.37%
controls:0.02%
cases:0.63%
controls:0.16%
cases:1.80%
controls:0.55%
41
176
4018
40413
22
73
4038
40526
8
6
4051
40593
—
15
10
4030
40492
24
64
3810
38930
56
176
3050
31606
Campylobacter sp identified in Specimen by Organism specific culture
6332-1 [3012568]
1.6e+00
3.4e+00
—
1.0e+50
—
2.7e+00
2.1e+00
cases:1.21%
controls:0.25%
cases:2.02%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.83%
controls:0.06%
cases:1.55%
controls:0.19%
49
100
4010
40489
82
28
3978
40571
—
14
0
4045
40599
—
32
22
3802
38972
48
61
3058
31721
Salmonella sp identified in Specimen by Organism specific culture
17563-8 [3024522]
1.6e+00
3.4e+00
—
1.0e+50
—
2.7e+00
2.1e+00
cases:1.21%
controls:0.24%
cases:2.00%
controls:0.07%
—
—
cases:0.34%
controls:0.00%
—
—
cases:0.83%
controls:0.06%
cases:1.45%
controls:0.19%
49
98
4010
40491
81
28
3979
40571
—
14
0
4045
40599
—
32
22
3802
38972
45
60
3061
31722
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
9.1e-01
1.2e+00
2.5e+00
—
2.5e+00
1.6e+00
1.1e+00
cases:1.58%
controls:0.64%
cases:0.79%
controls:0.24%
cases:0.27%
controls:0.02%
—
—
cases:0.17%
controls:0.01%
cases:0.89%
controls:0.18%
cases:2.06%
controls:0.72%
64
261
3995
40328
32
97
4028
40502
11
9
4048
40590
—
7
6
4038
40496
34
71
3800
38923
64
228
3042
31554
ursodeoxycholic acid; oral
A05AA02 [21600513]
1.7e+00
1.6e+00
1.3e+00
—
2.2e+00
2.2e+00
2.1e+00
cases:0.94%
controls:0.18%
cases:0.74%
controls:0.15%
cases:0.25%
controls:0.06%
—
—
cases:0.40%
controls:0.04%
cases:1.10%
controls:0.13%
cases:1.55%
controls:0.20%
38
73
4021
40516
30
61
4030
40538
10
26
4049
40573
—
16
17
4029
40485
42
50
3792
38944
48
63
3058
31719
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 [3000620]
9.1e-01
1.2e+00
2.5e+00
—
2.5e+00
1.6e+00
1.1e+00
cases:1.63%
controls:0.66%
cases:0.79%
controls:0.25%
cases:0.27%
controls:0.02%
—
—
cases:0.17%
controls:0.01%
cases:0.89%
controls:0.18%
cases:2.16%
controls:0.72%
66
268
3993
40321
32
101
4028
40498
11
9
4048
40590
—
7
6
4038
40496
34
72
3800
38922
67
230
3039
31552
Melaena
K92.1 [45533624]
5.9e-01
1.7e+00
3.0e+00
—
2.3e+00
1.8e+00
8.3e-01
cases:0.84%
controls:0.47%
cases:0.69%
controls:0.13%
cases:0.57%
controls:0.03%
—
—
cases:0.35%
controls:0.03%
cases:0.76%
controls:0.12%
cases:1.42%
controls:0.62%
34
190
4025
40399
28
53
4032
40546
23
11
4036
40588
—
14
14
4031
40488
29
47
3805
38947
44
197
3062
31585
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
3.3e-01
7.6e-01
1.5e+00
4.5e+00
1.4e+00
6.5e-01
5.0e-01
cases:10.27%
controls:7.62%
cases:8.23%
controls:4.01%
cases:2.81%
controls:0.64%
cases:1.77%
controls:0.02%
cases:2.42%
controls:0.61%
cases:7.96%
controls:4.30%
cases:17.45%
controls:11.40%
417
3093
3642
37496
334
1630
3726
38969
114
258
3945
40341
72
8
3987
40591
98
246
3947
40256
305
1676
3529
37318
542
3623
2564
28159
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
8.6e-01
1.4e+00
2.3e+00
—
2.4e+00
1.5e+00
1.2e+00
cases:4.24%
controls:1.84%
cases:3.18%
controls:0.82%
cases:1.21%
controls:0.12%
—
—
cases:1.43%
controls:0.13%
cases:3.29%
controls:0.74%
cases:7.37%
controls:2.40%
172
748
3887
39841
129
333
3931
40266
49
49
4010
40550
—
58
54
3987
40448
126
287
3708
38707
229
763
2877
31019
Short blood count panel - Blood
55429-5 [40758558]
4.4e-01
7.1e-01
1.6e+00
4.0e+00
1.5e+00
7.1e-01
6.7e-01
cases:9.90%
controls:6.59%
cases:6.58%
controls:3.36%
cases:3.30%
controls:0.70%
cases:1.92%
controls:0.03%
cases:2.99%
controls:0.70%
cases:6.78%
controls:3.45%
cases:15.07%
controls:8.32%
402
2673
3657
37916
267
1364
3793
39235
134
283
3925
40316
78
14
3981
40585
121
282
3924
40220
260
1346
3574
37648
468
2645
2638
29137
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
5.0e-01
1.3e+00
2.0e+00
2.4e+00
1.6e+00
9.4e-01
8.4e-01
cases:32.74%
controls:22.80%
cases:30.84%
controls:11.16%
cases:10.25%
controls:1.51%
cases:0.76%
controls:0.07%
cases:6.92%
controls:1.46%
cases:24.54%
controls:11.26%
cases:48.33%
controls:28.74%
1329
9253
2730
31336
1252
4532
2808
36067
416
614
3643
39985
31
27
4028
40572
280
591
3765
39911
941
4392
2893
34602
1501
9135
1605
22647
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
7.5e-01
1.5e+00
2.5e+00
—
2.7e+00
1.1e+00
9.0e-01
cases:1.68%
controls:0.80%
cases:1.48%
controls:0.33%
cases:0.37%
controls:0.03%
—
—
cases:0.44%
controls:0.03%
cases:0.94%
controls:0.31%
cases:2.74%
controls:1.13%
68
323
3991
40266
60
134
4000
40465
15
12
4044
40587
—
18
12
4027
40490
36
119
3798
38875
85
358
3021
31424
Ankylosing spondylitis
M45 [45591841]
1.2e+00
1.4e+00
1.9e+00
—
2.1e+00
1.5e+00
1.5e+00
cases:0.94%
controls:0.29%
cases:0.62%
controls:0.16%
cases:0.20%
controls:0.03%
—
—
cases:0.25%
controls:0.03%
cases:0.73%
controls:0.17%
cases:1.22%
controls:0.28%
38
119
4021
40470
25
63
4035
40536
8
12
4051
40587
—
10
12
4035
40490
28
66
3806
38928
38
90
3068
31692
Liver transplant status
Z94.4 [45566478]
2.1e+00
2.2e+00
—
1.0e+50
—
2.8e+00
2.4e+00
cases:0.22%
controls:0.03%
cases:0.22%
controls:0.02%
—
—
cases:0.17%
controls:0.00%
—
—
cases:0.29%
controls:0.02%
cases:0.32%
controls:0.03%
9
11
4050
40578
9
10
4051
40589
—
7
0
4052
40599
—
11
7
3823
38987
10
9
3096
31773
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
3.2e-01
9.0e-01
1.6e+00
4.2e+00
1.4e+00
5.7e-01
5.1e-01
cases:23.04%
controls:17.86%
cases:17.61%
controls:7.96%
cases:4.68%
controls:0.96%
cases:2.09%
controls:0.03%
cases:3.44%
controls:0.90%
cases:13.46%
controls:8.07%
cases:34.22%
controls:23.80%
935
7248
3124
33341
715
3233
3345
37366
190
391
3869
40208
85
13
3974
40586
139
364
3906
40138
516
3146
3318
35848
1063
7564
2043
24218
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
3.8e-01
7.4e-01
1.5e+00
4.2e+00
1.3e+00
6.7e-01
6.1e-01
cases:26.34%
controls:19.65%
cases:18.15%
controls:9.61%
cases:6.33%
controls:1.44%
cases:4.34%
controls:0.07%
cases:5.36%
controls:1.50%
cases:17.48%
controls:9.82%
cases:37.99%
controls:24.95%
1069
7977
2990
32612
737
3901
3323
36698
257
583
3802
40016
176
27
3883
40572
217
608
3828
39894
670
3828
3164
35166
1180
7931
1926
23851
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
5.9e-01
1.3e+00
2.6e+00
—
3.4e+00
1.3e+00
8.4e-01
cases:0.94%
controls:0.52%
cases:0.91%
controls:0.26%
cases:0.34%
controls:0.02%
—
—
cases:0.96%
controls:0.03%
cases:1.10%
controls:0.31%
cases:2.12%
controls:0.93%
38
212
4021
40377
37
105
4023
40494
14
10
4045
40589
—
39
13
4006
40489
42
119
3792
38875
66
295
3040
31487
prednisone
A07EA03 [21600655]
1.2e+00
1.4e+00
1.9e+00
—
1.8e+00
1.7e+00
1.4e+00
cases:4.68%
controls:1.46%
cases:2.19%
controls:0.55%
cases:0.49%
controls:0.07%
—
—
cases:0.87%
controls:0.15%
cases:2.66%
controls:0.48%
cases:4.48%
controls:1.10%
190
593
3869
39996
89
222
3971
40377
20
30
4039
40569
—
35
61
4010
40441
102
186
3732
38808
139
351
2967
31431
prednisone; oral
H02AB07 [21602735]
1.2e+00
1.4e+00
1.9e+00
—
1.8e+00
1.7e+00
1.4e+00
cases:4.68%
controls:1.46%
cases:2.19%
controls:0.55%
cases:0.49%
controls:0.07%
—
—
cases:0.87%
controls:0.15%
cases:2.66%
controls:0.48%
cases:4.48%
controls:1.10%
190
593
3869
39996
89
222
3971
40377
20
30
4039
40569
—
35
61
4010
40441
102
186
3732
38808
139
351
2967
31431
Pancreatic steatorrhoea
K90.3 [45552957]
1.4e+00
2.7e+00
—
1.0e+50
—
3.2e+00
2.1e+00
cases:0.39%
controls:0.09%
cases:0.44%
controls:0.03%
—
—
cases:0.20%
controls:0.00%
—
—
cases:0.57%
controls:0.02%
cases:0.90%
controls:0.12%
16
38
4043
40551
18
12
4042
40587
—
8
0
4051
40599
—
22
9
3812
38985
28
37
3078
31745
Oxygen content in Capillary blood by calculation
64799-0 [40767503]
7.8e-01
1.0e+00
2.6e+00
1.0e+50
2.4e+00
1.3e+00
1.3e+00
cases:0.89%
controls:0.41%
cases:0.44%
controls:0.16%
cases:0.32%
controls:0.02%
cases:0.17%
controls:0.00%
cases:0.32%
controls:0.03%
cases:0.63%
controls:0.16%
cases:1.80%
controls:0.48%
36
166
4023
40423
18
66
4042
40533
13
10
4046
40589
7
0
4052
40599
13
12
4032
40490
24
64
3810
38930
56
152
3050
31630
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
3.6e-01
7.2e-01
1.5e+00
4.2e+00
1.4e+00
6.1e-01
5.0e-01
cases:9.76%
controls:6.99%
cases:6.77%
controls:3.41%
cases:2.27%
controls:0.49%
cases:1.48%
controls:0.02%
cases:1.88%
controls:0.47%
cases:6.55%
controls:3.66%
cases:16.45%
controls:10.64%
396
2838
3663
37751
275
1383
3785
39216
92
199
3967
40400
60
9
3999
40590
76
191
3969
40311
251
1429
3583
37565
511
3381
2595
28401
Lactate [Moles/volume] in Capillary blood
19239-3 [3028271]
7.7e-01
1.0e+00
3.0e+00
—
2.5e+00
1.8e+00
1.3e+00
cases:0.71%
controls:0.33%
cases:0.27%
controls:0.10%
cases:0.25%
controls:0.01%
—
—
cases:0.17%
controls:0.01%
cases:0.55%
controls:0.09%
cases:1.22%
controls:0.32%
29
135
4030
40454
11
39
4049
40560
10
5
4049
40594
—
7
6
4038
40496
21
36
3813
38958
38
102
3068
31680
Immunohistochemistry procedure
117617002 [4035726]
6.5e-01
1.2e+00
1.9e+00
1.0e+50
3.0e+00
1.5e+00
1.1e+00
cases:3.20%
controls:1.70%
cases:2.34%
controls:0.71%
cases:0.37%
controls:0.05%
cases:0.30%
controls:0.00%
cases:0.62%
controls:0.03%
cases:1.72%
controls:0.41%
cases:3.57%
controls:1.25%
130
691
3929
39898
95
288
3965
40311
15
22
4044
40577
12
0
4047
40599
25
12
4020
40490
66
159
3768
38835
111
396
2995
31386
methoxy polyethylene glycol-epoetin beta; parenteral
B03XA03 [21601135]
2.3e+00
2.4e+00
—
—
2.5e+00
2.2e+00
1.2e+00
cases:0.30%
controls:0.03%
cases:0.30%
controls:0.03%
—
—
—
—
cases:0.15%
controls:0.01%
cases:0.31%
controls:0.04%
cases:0.26%
controls:0.08%
12
12
4047
40577
12
11
4048
40588
—
—
6
5
4039
40497
12
14
3822
38980
8
25
3098
31757
Hematology
82 [38004501]
6.2e-01
7.4e-01
1.1e+00
3.6e+00
1.5e+00
1.0e+00
6.6e-01
cases:2.22%
controls:1.20%
cases:1.72%
controls:0.83%
cases:0.91%
controls:0.30%
cases:0.47%
controls:0.01%
cases:1.14%
controls:0.25%
cases:2.22%
controls:0.82%
cases:2.83%
controls:1.49%
90
487
3969
40102
70
338
3990
40261
37
120
4022
40479
19
5
4040
40594
46
102
3999
40400
85
320
3749
38674
88
474
3018
31308
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
6.7e-01
1.4e+00
2.4e+00
—
2.4e+00
1.4e+00
9.9e-01
cases:10.15%
controls:5.47%
cases:9.21%
controls:2.44%
cases:3.67%
controls:0.33%
—
—
cases:3.07%
controls:0.30%
cases:10.30%
controls:2.70%
cases:19.77%
controls:8.40%
412
2220
3647
38369
374
991
3686
39608
149
136
3910
40463
—
124
120
3921
40382
395
1052
3439
37942
614
2671
2492
29111
Abdominal pain/cramps general
D01 [2002000300]
7.0e-01
1.6e+00
2.6e+00
1.0e+50
2.6e+00
8.4e-01
8.6e-01
cases:3.18%
controls:1.60%
cases:2.49%
controls:0.49%
cases:0.54%
controls:0.04%
cases:0.27%
controls:0.00%
cases:0.57%
controls:0.04%
cases:1.33%
controls:0.58%
cases:4.51%
controls:1.95%
129
648
3930
39941
101
198
3959
40401
22
17
4037
40582
11
0
4048
40599
23
17
4022
40485
51
225
3783
38769
140
620
2966
31162
saccharomyces boulardii; oral
A07FA02 [21600670]
7.9e-01
1.8e+00
2.0e+00
—
2.2e+00
1.5e+00
9.8e-01
cases:2.04%
controls:0.94%
cases:1.85%
controls:0.31%
cases:0.34%
controls:0.05%
—
—
cases:0.32%
controls:0.04%
cases:1.23%
controls:0.28%
cases:2.90%
controls:1.11%
83
381
3976
40208
75
127
3985
40472
14
19
4045
40580
—
13
15
4032
40487
47
110
3787
38884
90
353
3016
31429
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
6.1e-01
1.3e+00
2.1e+00
—
2.7e+00
1.5e+00
9.6e-01
cases:5.44%
controls:3.03%
cases:4.90%
controls:1.44%
cases:1.72%
controls:0.21%
—
—
cases:3.09%
controls:0.20%
cases:5.66%
controls:1.29%
cases:9.88%
controls:4.05%
221
1231
3838
39358
199
585
3861
40014
70
87
3989
40512
—
125
83
3920
40419
217
504
3617
38490
307
1287
2799
30495
Thoracal epidural anesthesia
WX302 [2001310795]
1.3e+00
1.7e+00
—
—
2.2e+00
2.5e+00
1.5e+00
cases:1.97%
controls:0.52%
cases:0.74%
controls:0.14%
—
—
—
—
cases:0.15%
controls:0.02%
cases:1.10%
controls:0.09%
cases:1.48%
controls:0.34%
80
212
3979
40377
30
57
4030
40542
—
—
6
7
4039
40495
42
36
3792
38958
46
107
3060
31675
Nausea and vomiting
R11 [45539317]
8.7e-01
1.6e+00
2.2e+00
—
2.5e+00
1.2e+00
8.8e-01
cases:2.54%
controls:1.07%
cases:1.48%
controls:0.32%
cases:0.44%
controls:0.05%
—
—
cases:0.30%
controls:0.02%
cases:1.04%
controls:0.33%
cases:2.90%
controls:1.22%
103
436
3956
40153
60
128
4000
40471
18
21
4041
40578
—
12
10
4033
40492
40
128
3794
38866
90
387
3016
31395
Kidney transplant status
Z94.0 [45566477]
1.2e+00
1.3e+00
1.6e+00
—
2.3e+00
1.3e+00
1.4e+00
cases:0.49%
controls:0.15%
cases:0.57%
controls:0.15%
cases:0.27%
controls:0.05%
—
—
cases:0.42%
controls:0.04%
cases:0.55%
controls:0.16%
cases:0.64%
controls:0.16%
20
61
4039
40528
23
60
4037
40539
11
22
4048
40577
—
17
17
4028
40485
21
61
3813
38933
20
51
3086
31731
Retinol [Moles/volume] in Serum or Plasma
14905-4 [3013005]
1.6e+00
2.0e+00
—
—
—
3.0e+00
2.5e+00
cases:0.34%
controls:0.07%
cases:0.27%
controls:0.04%
—
—
—
—
—
—
cases:0.31%
controls:0.02%
cases:0.87%
controls:0.08%
14
29
4045
40560
11
15
4049
40584
—
—
—
12
6
3822
38988
27
24
3079
31758
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
8.4e-01
1.2e+00
2.2e+00
—
2.3e+00
1.3e+00
1.2e+00
cases:2.93%
controls:1.29%
cases:3.10%
controls:0.95%
cases:1.48%
controls:0.17%
—
—
cases:1.76%
controls:0.17%
cases:3.86%
controls:1.04%
cases:7.63%
controls:2.55%
119
523
3940
40066
126
386
3934
40213
60
70
3999
40529
—
71
70
3974
40432
148
406
3686
38588
237
810
2869
30972
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
8.5e-01
1.2e+00
2.1e+00
—
2.3e+00
1.3e+00
1.2e+00
cases:2.61%
controls:1.14%
cases:2.86%
controls:0.87%
cases:1.31%
controls:0.16%
—
—
cases:1.51%
controls:0.16%
cases:3.60%
controls:0.96%
cases:7.41%
controls:2.34%
106
462
3953
40127
116
353
3944
40246
53
64
4006
40535
—
61
63
3984
40439
138
376
3696
38618
230
745
2876
31037
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
8.6e-01
1.2e+00
2.2e+00
—
2.3e+00
1.3e+00
1.2e+00
cases:2.83%
controls:1.22%
cases:3.03%
controls:0.92%
cases:1.40%
controls:0.17%
—
—
cases:1.58%
controls:0.17%
cases:3.78%
controls:1.02%
cases:7.41%
controls:2.45%
115
494
3944
40095
123
372
3937
40227
57
67
4002
40532
—
64
67
3981
40435
145
396
3689
38598
230
779
2876
31003
Treatment plan or consultation
WZC00 [2001310885]
4.4e-01
8.5e-01
1.3e+00
4.1e+00
7.1e-01
1.0e+00
5.8e-01
cases:9.63%
controls:6.42%
cases:5.42%
controls:2.39%
cases:1.16%
controls:0.33%
cases:0.76%
controls:0.01%
cases:0.69%
controls:0.34%
cases:5.66%
controls:2.16%
cases:12.43%
controls:7.35%
391
2607
3668
37982
220
971
3840
39628
47
135
4012
40464
31
5
4028
40594
28
139
4017
40363
217
842
3617
38152
386
2335
2720
29447
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
2.3e-01
7.9e-01
1.7e+00
3.7e+00
1.4e+00
6.1e-01
4.7e-01
cases:46.32%
controls:40.77%
cases:48.52%
controls:30.05%
cases:24.32%
controls:5.34%
cases:8.23%
controls:0.22%
cases:18.12%
controls:5.02%
cases:45.88%
controls:31.61%
cases:68.64%
controls:57.86%
1880
16550
2179
24039
1970
12199
2090
28400
987
2169
3072
38430
334
89
3725
40510
733
2035
3312
38467
1759
12326
2075
26668
2132
18389
974
13393
Bacteria identified in Urine by Culture
630-4 [3026008]
3.5e-01
6.0e-01
1.2e+00
4.1e+00
1.5e+00
7.0e-01
4.8e-01
cases:10.35%
controls:7.53%
cases:6.53%
controls:3.67%
cases:1.77%
controls:0.52%
cases:1.33%
controls:0.02%
cases:2.08%
controls:0.48%
cases:7.49%
controls:3.86%
cases:16.71%
controls:11.03%
420
3058
3639
37531
265
1492
3795
39107
72
213
3987
40386
54
9
4005
40590
84
194
3961
40308
287
1506
3547
37488
519
3504
2587
28278
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.5e-01
7.3e-01
1.4e+00
3.9e+00
1.2e+00
6.6e-01
6.1e-01
cases:26.95%
controls:20.57%
cases:19.26%
controls:10.29%
cases:5.84%
controls:1.48%
cases:2.91%
controls:0.06%
cases:5.02%
controls:1.50%
cases:18.39%
controls:10.44%
cases:39.70%
controls:26.34%
1094
8348
2965
32241
782
4177
3278
36422
237
600
3822
39999
118
24
3941
40575
203
606
3842
39896
705
4071
3129
34923
1233
8371
1873
23411
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.8e-01
6.7e-01
1.6e+00
3.8e+00
1.4e+00
6.1e-01
5.4e-01
cases:36.07%
controls:29.95%
cases:38.62%
controls:24.42%
cases:20.77%
controls:5.15%
cases:10.86%
controls:0.27%
cases:17.65%
controls:4.84%
cases:39.05%
controls:25.83%
cases:58.37%
controls:44.98%
1464
12155
2595
28434
1568
9916
2492
30683
843
2090
3216
38509
441
108
3618
40491
714
1962
3331
38540
1497
10074
2337
28920
1813
14295
1293
17487
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
8.4e-01
1.4e+00
1.8e+00
—
2.3e+00
1.7e+00
8.6e-01
cases:2.56%
controls:1.12%
cases:1.43%
controls:0.34%
cases:0.39%
controls:0.06%
—
—
cases:0.42%
controls:0.04%
cases:1.85%
controls:0.34%
cases:2.77%
controls:1.19%
104
456
3955
40133
58
139
4002
40460
16
26
4043
40573
—
17
18
4028
40484
71
134
3763
38860
86
377
3020
31405
Asthma, unspecified
J45.9 [45562456]
5.2e-01
6.0e-01
1.1e+00
4.5e+00
9.6e-01
6.9e-01
5.5e-01
cases:6.26%
controls:3.81%
cases:3.20%
controls:1.79%
cases:1.06%
controls:0.36%
cases:1.31%
controls:0.01%
cases:0.99%
controls:0.38%
cases:3.65%
controls:1.86%
cases:7.92%
controls:4.71%
254
1545
3805
39044
130
726
3930
39873
43
146
4016
40453
53
6
4006
40593
40
155
4005
40347
140
726
3694
38268
246
1496
2860
30286
immunoglobulins, normal human, for extravascular adm.
J06BA01 [21601256]
1.6e+00
2.0e+00
2.6e+00
—
—
2.1e+00
2.2e+00
cases:0.17%
controls:0.03%
cases:0.20%
controls:0.03%
cases:0.20%
controls:0.01%
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.29%
controls:0.03%
7
14
4052
40575
8
11
4052
40588
8
6
4051
40593
—
—
8
10
3826
38984
9
10
3097
31772
immunoglobulins, normal human, for intravascular adm.
J06BA02 [21601257]
1.6e+00
2.0e+00
2.6e+00
—
—
2.1e+00
2.2e+00
cases:0.17%
controls:0.03%
cases:0.20%
controls:0.03%
cases:0.20%
controls:0.01%
—
—
—
—
cases:0.21%
controls:0.03%
cases:0.29%
controls:0.03%
7
14
4052
40575
8
11
4052
40588
8
6
4051
40593
—
—
8
10
3826
38984
9
10
3097
31772
racecadotril
A07XA04 [21600677]
2.2e+00
3.1e+00
—
—
—
1.9e+00
1.7e+00
cases:1.55%
controls:0.18%
cases:1.48%
controls:0.07%
—
—
—
—
—
—
cases:0.37%
controls:0.05%
cases:1.09%
controls:0.20%
63
74
3996
40515
60
28
4000
40571
—
—
—
14
21
3820
38973
34
62
3072
31720
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
8.4e-01
1.3e+00
1.7e+00
—
2.6e+00
1.7e+00
1.6e+00
cases:0.32%
controls:0.14%
cases:0.34%
controls:0.10%
cases:0.20%
controls:0.04%
—
—
cases:0.40%
controls:0.03%
cases:0.52%
controls:0.09%
cases:0.55%
controls:0.11%
13
56
4046
40533
14
40
4046
40559
8
15
4051
40584
—
16
12
4029
40490
20
37
3814
38957
17
35
3089
31747
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
7.0e-01
1.4e+00
2.3e+00
1.0e+50
2.2e+00
1.3e+00
8.2e-01
cases:4.73%
controls:2.39%
cases:3.72%
controls:0.90%
cases:1.08%
controls:0.11%
cases:0.54%
controls:0.00%
cases:1.06%
controls:0.11%
cases:3.23%
controls:0.87%
cases:6.12%
controls:2.79%
192
972
3867
39617
151
366
3909
40233
44
46
4015
40553
22
0
4037
40599
43
46
4002
40456
124
338
3710
38656
190
887
2916
30895
Infectious Disease
44 [38004484]
7.5e-01
1.3e+00
2.2e+00
—
2.2e+00
1.3e+00
1.0e+00
cases:3.97%
controls:1.91%
cases:2.54%
controls:0.73%
cases:0.81%
controls:0.09%
—
—
cases:1.26%
controls:0.14%
cases:2.56%
controls:0.68%
cases:5.18%
controls:1.89%
161
777
3898
39812
103
298
3957
40301
33
37
4026
40562
—
51
55
3994
40447
98
267
3736
38727
161
602
2945
31180
Fractional oxyhemoglobin in Capillary blood
2715-1 [3022806]
8.1e-01
1.3e+00
3.1e+00
—
2.3e+00
1.9e+00
1.7e+00
cases:0.67%
controls:0.30%
cases:0.27%
controls:0.07%
cases:0.27%
controls:0.01%
—
—
cases:0.12%
controls:0.01%
cases:0.44%
controls:0.06%
cases:1.00%
controls:0.19%
27
120
4032
40469
11
30
4049
40569
11
5
4048
40594
—
5
5
4040
40497
17
25
3817
38969
31
60
3075
31722
Fever, unspecified
R50.9 [45582716]
6.7e-01
1.2e+00
2.5e+00
—
2.1e+00
1.3e+00
9.8e-01
cases:3.25%
controls:1.68%
cases:1.87%
controls:0.55%
cases:0.69%
controls:0.06%
—
—
cases:0.49%
controls:0.06%
cases:2.14%
controls:0.58%
cases:4.86%
controls:1.88%
132
683
3927
39906
76
223
3984
40376
28
24
4031
40575
—
20
24
4025
40478
82
227
3752
38767
151
599
2955
31183
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
3.0e-01
7.3e-01
1.4e+00
4.2e+00
1.2e+00
5.6e-01
3.7e-01
cases:16.70%
controls:12.92%
cases:13.74%
controls:7.14%
cases:4.34%
controls:1.11%
cases:2.24%
controls:0.03%
cases:3.61%
controls:1.09%
cases:13.07%
controls:7.88%
cases:28.82%
controls:21.91%
678
5246
3381
35343
558
2900
3502
37699
176
449
3883
40150
91
14
3968
40585
146
443
3899
40059
501
3072
3333
35922
895
6965
2211
24817
Bacterial infection, unspecified
A49.9 [45590816]
6.6e-01
1.4e+00
2.3e+00
—
2.4e+00
1.2e+00
7.7e-01
cases:2.12%
controls:1.11%
cases:1.67%
controls:0.42%
cases:0.81%
controls:0.08%
—
—
cases:0.72%
controls:0.06%
cases:1.59%
controls:0.47%
cases:3.09%
controls:1.46%
86
450
3973
40139
68
171
3992
40428
33
34
4026
40565
—
29
26
4016
40476
61
183
3773
38811
96
463
3010
31319
Blasts/Leukocytes in Blood
26446-5 [3025159]
8.8e-01
1.2e+00
2.1e+00
—
2.2e+00
1.3e+00
1.1e+00
cases:2.64%
controls:1.11%
cases:2.96%
controls:0.93%
cases:1.45%
controls:0.18%
—
—
cases:1.56%
controls:0.18%
cases:3.73%
controls:1.04%
cases:7.24%
controls:2.52%
107
452
3952
40137
120
379
3940
40220
59
73
4000
40526
—
63
72
3982
40430
143
405
3691
38589
225
800
2881
30982
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
3.0e-01
7.3e-01
1.4e+00
4.1e+00
1.2e+00
5.7e-01
3.8e-01
cases:16.21%
controls:12.55%
cases:13.52%
controls:7.00%
cases:4.36%
controls:1.08%
cases:2.22%
controls:0.04%
cases:3.58%
controls:1.08%
cases:12.88%
controls:7.73%
cases:28.49%
controls:21.50%
658
5094
3401
35495
549
2842
3511
37757
177
437
3882
40162
90
15
3969
40584
145
439
3900
40063
494
3014
3340
35980
885
6832
2221
24950
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
2.1e-01
6.7e-01
1.6e+00
3.8e+00
1.4e+00
5.9e-01
4.4e-01
cases:48.12%
controls:42.95%
cases:51.16%
controls:34.83%
cases:28.63%
controls:7.28%
cases:14.31%
controls:0.38%
cases:23.46%
controls:6.95%
cases:50.52%
controls:36.11%
cases:70.19%
controls:60.28%
1953
17431
2106
23158
2077
14139
1983
26460
1162
2956
2897
37643
581
153
3478
40446
949
2816
3096
37686
1937
14079
1897
24915
2180
19157
926
12625
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
4.5e-01
9.2e-01
1.7e+00
2.2e+00
1.8e+00
9.3e-01
7.3e-01
cases:14.73%
controls:9.94%
cases:13.30%
controls:5.75%
cases:4.07%
controls:0.78%
cases:0.27%
controls:0.03%
cases:4.00%
controls:0.69%
cases:14.42%
controls:6.25%
cases:29.27%
controls:16.62%
598
4035
3461
36554
540
2334
3520
38265
165
315
3894
40284
11
12
4048
40587
162
278
3883
40224
553
2438
3281
36556
909
5281
2197
26501
Benign neoplasm: Sigmoid colon
D12.5 [45552326]
6.6e-01
1.4e+00
3.3e+00
1.0e+50
2.3e+00
1.7e+00
4.1e-01
cases:0.74%
controls:0.38%
cases:0.54%
controls:0.14%
cases:0.34%
controls:0.01%
cases:0.54%
controls:0.00%
cases:0.30%
controls:0.03%
cases:0.60%
controls:0.11%
cases:0.71%
controls:0.47%
30
156
4029
40433
22
55
4038
40544
14
5
4045
40594
22
0
4037
40599
12
12
4033
40490
23
43
3811
38951
22
150
3084
31632
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 [3049804]
1.0e+00
1.4e+00
3.0e+00
—
—
1.8e+00
1.5e+00
cases:1.36%
controls:0.50%
cases:0.74%
controls:0.19%
cases:0.25%
controls:0.01%
—
—
—
—
cases:0.97%
controls:0.16%
cases:2.35%
controls:0.53%
55
203
4004
40386
30
76
4030
40523
10
5
4049
40594
—
—
37
62
3797
38932
73
169
3033
31613
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
3.0e-01
7.2e-01
1.4e+00
4.1e+00
1.2e+00
5.7e-01
3.7e-01
cases:16.38%
controls:12.70%
cases:13.57%
controls:7.08%
cases:4.31%
controls:1.10%
cases:2.22%
controls:0.04%
cases:3.66%
controls:1.10%
cases:13.02%
controls:7.84%
cases:28.78%
controls:21.82%
665
5156
3394
35433
551
2874
3509
37725
175
447
3884
40152
90
15
3969
40584
148
446
3897
40056
499
3056
3335
35938
894
6934
2212
24848
Benign neoplasm: Rectum
D12.8 [45595734]
6.5e-01
1.7e+00
3.0e+00
1.0e+50
2.0e+00
1.3e+00
4.8e-01
cases:0.84%
controls:0.44%
cases:0.64%
controls:0.12%
cases:0.30%
controls:0.01%
cases:0.44%
controls:0.00%
cases:0.22%
controls:0.03%
cases:0.52%
controls:0.14%
cases:0.58%
controls:0.36%
34
179
4025
40410
26
48
4034
40551
12
6
4047
40593
18
0
4041
40599
9
12
4036
40490
20
54
3814
38940
18
114
3088
31668
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.3e-01
7.0e-01
1.4e+00
3.9e+00
1.4e+00
5.2e-01
4.3e-01
cases:45.45%
controls:39.72%
cases:46.90%
controls:30.42%
cases:20.77%
controls:5.83%
cases:14.12%
controls:0.34%
cases:19.68%
controls:5.44%
cases:43.64%
controls:31.46%
cases:65.87%
controls:55.54%
1845
16122
2214
24467
1904
12352
2156
28247
843
2365
3216
38234
573
137
3486
40462
796
2205
3249
38297
1673
12267
2161
26727
2046
17653
1060
14129
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.3e-01
7.0e-01
1.4e+00
3.9e+00
1.4e+00
5.2e-01
4.4e-01
cases:45.60%
controls:40.00%
cases:47.17%
controls:30.75%
cases:20.92%
controls:5.93%
cases:14.07%
controls:0.33%
cases:19.93%
controls:5.60%
cases:43.97%
controls:31.81%
cases:66.19%
controls:55.82%
1851
16235
2208
24354
1915
12486
2145
28113
849
2407
3210
38192
571
134
3488
40465
806
2267
3239
38235
1686
12403
2148
26591
2056
17740
1050
14042
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
7.6e-01
1.8e+00
2.8e+00
—
2.7e+00
7.4e-01
5.8e-01
cases:1.65%
controls:0.78%
cases:1.21%
controls:0.21%
cases:0.37%
controls:0.02%
—
—
cases:0.22%
controls:0.01%
cases:0.57%
controls:0.27%
cases:1.55%
controls:0.87%
67
315
3992
40274
49
84
4011
40515
15
9
4044
40590
—
9
6
4036
40496
22
107
3812
38887
48
278
3058
31504
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
7.4e-01
1.4e+00
2.0e+00
—
2.3e+00
1.2e+00
9.1e-01
cases:4.71%
controls:2.29%
cases:4.78%
controls:1.18%
cases:1.68%
controls:0.22%
—
—
cases:1.98%
controls:0.19%
cases:3.55%
controls:1.14%
cases:7.44%
controls:3.13%
191
931
3868
39658
194
480
3866
40119
68
89
3991
40510
—
80
78
3965
40424
136
446
3698
38548
231
996
2875
30786
Microorganisms panel - Urine sediment
58435-9 [40761536]
7.2e-01
1.2e+00
2.3e+00
—
2.0e+00
1.3e+00
1.2e+00
cases:4.48%
controls:2.23%
cases:3.10%
controls:0.95%
cases:1.33%
controls:0.13%
—
—
cases:1.06%
controls:0.15%
cases:3.21%
controls:0.94%
cases:6.86%
controls:2.25%
182
905
3877
39684
126
384
3934
40215
54
54
4005
40545
—
43
61
4002
40441
123
365
3711
38629
213
714
2893
31068
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
9.8e-01
1.2e+00
1.5e+00
—
2.1e+00
1.7e+00
1.1e+00
cases:1.26%
controls:0.47%
cases:0.86%
controls:0.27%
cases:0.32%
controls:0.07%
—
—
cases:0.49%
controls:0.06%
cases:1.33%
controls:0.24%
cases:1.80%
controls:0.62%
51
192
4008
40397
35
108
4025
40491
13
28
4046
40571
—
20
25
4025
40477
51
95
3783
38899
56
197
3050
31585
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
7.5e-01
1.5e+00
2.9e+00
—
2.0e+00
1.4e+00
6.7e-01
cases:1.16%
controls:0.55%
cases:1.18%
controls:0.25%
cases:0.57%
controls:0.03%
—
—
cases:0.32%
controls:0.04%
cases:0.70%
controls:0.17%
cases:0.90%
controls:0.46%
47
223
4012
40366
48
103
4012
40496
23
13
4036
40586
—
13
18
4032
40484
27
67
3807
38927
28
147
3078
31635
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
6.6e-01
1.1e+00
2.4e+00
—
2.5e+00
1.2e+00
6.9e-01
cases:2.61%
controls:1.36%
cases:1.82%
controls:0.64%
cases:0.84%
controls:0.08%
—
—
cases:1.19%
controls:0.10%
cases:2.37%
controls:0.70%
cases:4.64%
controls:2.38%
106
553
3953
40036
74
258
3986
40341
34
31
4025
40568
—
48
40
3997
40462
91
274
3743
38720
144
755
2962
31027
Other psoriatic arthropathies
M07.3*L40.5 [2000503010]
8.5e-01
1.1e+00
2.5e+00
1.0e+50
2.0e+00
1.3e+00
7.9e-01
cases:0.74%
controls:0.32%
cases:0.54%
controls:0.18%
cases:0.32%
controls:0.03%
cases:0.25%
controls:0.00%
cases:0.30%
controls:0.04%
cases:0.70%
controls:0.19%
cases:0.77%
controls:0.35%
30
129
4029
40460
22
72
4038
40527
13
11
4046
40588
10
0
4049
40599
12
16
4033
40486
27
75
3807
38919
24
112
3082
31670
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
4.7e-01
7.8e-01
1.9e+00
1.8e+00
1.7e+00
1.0e+00
8.4e-01
cases:14.83%
controls:9.85%
cases:10.57%
controls:5.15%
cases:3.89%
controls:0.58%
cases:0.30%
controls:0.05%
cases:2.47%
controls:0.48%
cases:13.95%
controls:5.43%
cases:30.65%
controls:16.06%
602
3999
3457
36590
429
2089
3631
38510
158
237
3901
40362
12
19
4047
40580
100
196
3945
40306
535
2119
3299
36875
952
5103
2154
26679
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
6.8e-01
1.1e+00
1.9e+00
—
2.5e+00
1.4e+00
9.8e-01
cases:1.92%
controls:0.98%
cases:1.40%
controls:0.49%
cases:0.49%
controls:0.08%
—
—
cases:0.84%
controls:0.07%
cases:2.16%
controls:0.53%
cases:3.73%
controls:1.43%
78
399
3981
40190
57
197
4003
40402
20
31
4039
40568
—
34
28
4011
40474
83
205
3751
38789
116
456
2990
31326
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
7.4e-01
1.1e+00
2.0e+00
—
2.5e+00
1.2e+00
8.9e-01
cases:3.67%
controls:1.78%
cases:2.61%
controls:0.86%
cases:1.11%
controls:0.15%
—
—
cases:1.48%
controls:0.13%
cases:2.82%
controls:0.84%
cases:5.47%
controls:2.32%
149
723
3910
39866
106
348
3954
40251
45
59
4014
40540
—
60
51
3985
40451
108
327
3726
38667
170
737
2936
31045
Cathetrisation of vein
TPH04 [2001309597]
7.5e-01
1.1e+00
2.4e+00
—
2.3e+00
1.1e+00
7.9e-01
cases:6.48%
controls:3.16%
cases:3.50%
controls:1.19%
cases:1.13%
controls:0.11%
—
—
cases:1.29%
controls:0.13%
cases:3.42%
controls:1.11%
cases:7.60%
controls:3.59%
263
1281
3796
39308
142
484
3918
40115
46
43
4013
40556
—
52
51
3993
40451
131
433
3703
38561
236
1141
2870
30641
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 [3035797]
6.7e-01
1.2e+00
1.8e+00
—
2.6e+00
1.2e+00
9.0e-01
cases:1.11%
controls:0.57%
cases:0.86%
controls:0.26%
cases:0.25%
controls:0.04%
—
—
cases:0.35%
controls:0.02%
cases:0.78%
controls:0.23%
cases:1.61%
controls:0.66%
45
231
4014
40358
35
104
4025
40495
10
16
4049
40583
—
14
10
4031
40492
30
89
3804
38905
50
210
3056
31572
Clostridioides difficile [Presence] in Stool by Organism specific culture
562-9 [3013566]
2.0e+00
4.0e+00
1.0e+50
—
—
—
2.5e+00
cases:0.42%
controls:0.06%
cases:0.67%
controls:0.01%
cases:0.20%
controls:0.00%
—
—
—
—
—
—
cases:0.42%
controls:0.03%
17
23
4042
40566
27
5
4033
40594
8
0
4051
40599
—
—
—
13
11
3093
31771
Platelets [#/volume] in Blood
26515-7 [3007461]
1.7e-01
6.5e-01
1.6e+00
3.7e+00
1.4e+00
5.7e-01
3.4e-01
cases:50.90%
controls:46.62%
cases:54.29%
controls:38.34%
cases:32.00%
controls:8.34%
cases:15.20%
controls:0.44%
cases:25.66%
controls:7.95%
cases:53.89%
controls:39.89%
cases:72.22%
controls:64.95%
2066
18923
1993
21666
2204
15564
1856
25035
1299
3387
2760
37212
617
177
3442
40422
1038
3218
3007
37284
2066
15556
1768
23438
2243
20642
863
11140
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 [3029338]
6.8e-01
1.2e+00
1.7e+00
—
2.7e+00
1.3e+00
8.6e-01
cases:1.01%
controls:0.51%
cases:0.81%
controls:0.25%
cases:0.22%
controls:0.04%
—
—
cases:0.37%
controls:0.02%
cases:0.76%
controls:0.21%
cases:1.48%
controls:0.63%
41
209
4018
40380
33
100
4027
40499
9
16
4050
40583
—
15
10
4030
40492
29
83
3805
38911
46
201
3060
31581
MCH [Entitic mass]
28539-5 [3035941]
1.7e-01
6.4e-01
1.6e+00
3.7e+00
1.4e+00
5.6e-01
3.3e-01
cases:50.90%
controls:46.68%
cases:54.26%
controls:38.41%
cases:32.00%
controls:8.35%
cases:15.20%
controls:0.44%
cases:25.66%
controls:7.95%
cases:53.89%
controls:39.92%
cases:72.22%
controls:65.04%
2066
18947
1993
21642
2203
15595
1857
25004
1299
3390
2760
37209
617
177
3442
40422
1038
3218
3007
37284
2066
15566
1768
23428
2243
20670
863
11112
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.7e-01
6.4e-01
1.6e+00
3.7e+00
1.4e+00
5.6e-01
3.4e-01
cases:51.00%
controls:46.77%
cases:54.36%
controls:38.46%
cases:32.05%
controls:8.38%
cases:15.27%
controls:0.44%
cases:25.64%
controls:7.97%
cases:53.94%
controls:40.01%
cases:72.31%
controls:65.08%
2070
18982
1989
21607
2207
15616
1853
24983
1301
3402
2758
37197
620
178
3439
40421
1037
3230
3008
37272
2068
15603
1766
23391
2246
20684
860
11098
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.7e-01
6.4e-01
1.6e+00
3.7e+00
1.4e+00
5.7e-01
3.3e-01
cases:50.95%
controls:46.74%
cases:54.29%
controls:38.45%
cases:32.05%
controls:8.39%
cases:15.20%
controls:0.44%
cases:25.66%
controls:7.96%
cases:53.94%
controls:39.95%
cases:72.25%
controls:65.07%
2068
18970
1991
21619
2204
15611
1856
24988
1301
3408
2758
37191
617
177
3442
40422
1038
3224
3007
37278
2068
15580
1766
23414
2244
20680
862
11102
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.7e-01
6.4e-01
1.6e+00
3.7e+00
1.4e+00
5.6e-01
3.3e-01
cases:50.90%
controls:46.73%
cases:54.29%
controls:38.42%
cases:32.00%
controls:8.36%
cases:15.20%
controls:0.44%
cases:25.66%
controls:7.96%
cases:53.89%
controls:39.96%
cases:72.22%
controls:65.06%
2066
18969
1993
21620
2204
15597
1856
25002
1299
3393
2760
37206
617
177
3442
40422
1038
3222
3007
37280
2066
15582
1768
23412
2243
20678
863
11104
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.7e-01
6.4e-01
1.6e+00
3.7e+00
1.4e+00
5.6e-01
3.3e-01
cases:50.92%
controls:46.73%
cases:54.29%
controls:38.45%
cases:32.03%
controls:8.37%
cases:15.20%
controls:0.44%
cases:25.66%
controls:7.96%
cases:53.91%
controls:39.99%
cases:72.25%
controls:65.08%
2067
18968
1992
21621
2204
15611
1856
24988
1300
3399
2759
37200
617
177
3442
40422
1038
3222
3007
37280
2067
15592
1767
23402
2244
20685
862
11097
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
7.7e-01
1.2e+00
1.6e+00
1.0e+50
2.2e+00
1.6e+00
1.0e+00
cases:1.90%
controls:0.89%
cases:0.91%
controls:0.27%
cases:0.22%
controls:0.05%
cases:0.20%
controls:0.00%
cases:0.40%
controls:0.04%
cases:1.04%
controls:0.21%
cases:1.67%
controls:0.59%
77
361
3982
40228
37
109
4023
40490
9
19
4050
40580
8
0
4051
40599
16
17
4029
40485
40
83
3794
38911
52
189
3054
31593
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.7e-01
6.4e-01
1.6e+00
3.7e+00
1.4e+00
5.6e-01
3.3e-01
cases:50.97%
controls:46.79%
cases:54.26%
controls:38.51%
cases:32.03%
controls:8.39%
cases:15.27%
controls:0.44%
cases:25.69%
controls:7.97%
cases:53.99%
controls:40.06%
cases:72.28%
controls:65.15%
2069
18993
1990
21596
2203
15634
1857
24965
1300
3407
2759
37192
620
177
3439
40422
1039
3230
3006
37272
2070
15620
1764
23374
2245
20706
861
11076
INR in Blood by Coagulation assay
34714-6 [3032080]
4.2e-01
7.4e-01
1.1e+00
3.5e+00
1.1e+00
8.6e-01
7.5e-01
cases:17.42%
controls:12.19%
cases:13.18%
controls:6.78%
cases:5.96%
controls:2.13%
cases:4.48%
controls:0.14%
cases:5.86%
controls:2.10%
cases:14.01%
controls:6.42%
cases:27.30%
controls:15.12%
707
4946
3352
35643
535
2754
3525
37845
242
864
3817
39735
182
56
3877
40543
237
852
3808
39650
537
2503
3297
36491
848
4806
2258
26976
Body CT examination
JN4AD [2001310897]
8.5e-01
1.4e+00
2.4e+00
—
1.9e+00
1.2e+00
7.1e-01
cases:1.92%
controls:0.83%
cases:2.36%
controls:0.59%
cases:0.86%
controls:0.08%
—
—
cases:0.64%
controls:0.10%
cases:2.11%
controls:0.64%
cases:3.35%
controls:1.67%
78
338
3981
40251
96
238
3964
40361
35
33
4024
40566
—
26
41
4019
40461
81
248
3753
38746
104
531
3002
31251
CBC panel - Blood by Automated count
58410-2 [40761511]
2.1e-01
6.1e-01
1.6e+00
3.7e+00
1.4e+00
5.4e-01
3.9e-01
cases:44.52%
controls:39.36%
cases:38.99%
controls:25.77%
cases:18.99%
controls:4.70%
cases:8.30%
controls:0.23%
cases:15.77%
controls:4.38%
cases:37.01%
controls:25.57%
cases:60.82%
controls:51.22%
1807
15974
2252
24615
1583
10462
2477
30137
771
1910
3288
38689
337
92
3722
40507
638
1776
3407
38726
1419
9972
2415
29022
1889
16280
1217
15502
Body temperature
8310-5 [3020891]
6.1e-01
9.4e-01
2.6e+00
—
2.6e+00
1.1e+00
5.5e-01
cases:1.28%
controls:0.70%
cases:0.81%
controls:0.32%
cases:0.39%
controls:0.03%
—
—
cases:0.57%
controls:0.04%
cases:0.99%
controls:0.34%
cases:2.29%
controls:1.34%
52
283
4007
40306
33
129
4027
40470
16
12
4043
40587
—
23
17
4022
40485
38
131
3796
38863
71
425
3035
31357
Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50797-0 [3029379]
6.8e-01
1.2e+00
1.7e+00
—
2.6e+00
1.3e+00
8.5e-01
cases:1.01%
controls:0.51%
cases:0.79%
controls:0.24%
cases:0.22%
controls:0.04%
—
—
cases:0.35%
controls:0.02%
cases:0.73%
controls:0.20%
cases:1.35%
controls:0.58%
41
209
4018
40380
32
97
4028
40502
9
16
4050
40583
—
14
10
4031
40492
28
79
3806
38915
42
185
3064
31597
Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
92690-7 [37021247]
2.0e+00
2.2e+00
—
1.0e+50
—
2.3e+00
1.8e+00
cases:0.57%
controls:0.08%
cases:0.30%
controls:0.03%
—
—
cases:0.20%
controls:0.00%
—
—
cases:0.29%
controls:0.03%
cases:0.58%
controls:0.10%
23
31
4036
40558
12
13
4048
40586
—
8
0
4051
40599
—
11
11
3823
38983
18
31
3088
31751
Astrovirus RNA [Presence] in Stool by NAA with probe detection
92691-5 [37020445]
2.0e+00
2.2e+00
—
1.0e+50
—
2.3e+00
1.8e+00
cases:0.57%
controls:0.08%
cases:0.30%
controls:0.03%
—
—
cases:0.20%
controls:0.00%
—
—
cases:0.29%
controls:0.03%
cases:0.58%
controls:0.10%
23
31
4036
40558
12
13
4048
40586
—
8
0
4051
40599
—
11
11
3823
38983
18
31
3088
31751
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
2.4e-01
6.1e-01
1.4e+00
4.0e+00
1.2e+00
4.7e-01
3.8e-01
cases:13.43%
controls:10.85%
cases:9.63%
controls:5.46%
cases:3.18%
controls:0.81%
cases:1.77%
controls:0.03%
cases:2.60%
controls:0.80%
cases:8.97%
controls:5.81%
cases:22.12%
controls:16.30%
545
4405
3514
36184
391
2218
3669
38381
129
329
3930
40270
72
13
3987
40586
105
324
3940
40178
344
2266
3490
36728
687
5182
2419
26600
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
6.8e-01
1.4e+00
1.7e+00
—
2.6e+00
1.2e+00
8.1e-01
cases:2.96%
controls:1.52%
cases:2.93%
controls:0.76%
cases:0.59%
controls:0.11%
—
—
cases:1.06%
controls:0.08%
cases:2.45%
controls:0.78%
cases:5.44%
controls:2.50%
120
615
3939
39974
119
307
3941
40292
24
46
4035
40553
—
43
32
4002
40470
94
305
3740
38689
169
796
2937
30986
mercaptopurine
L01BB02 [21601428]
3.2e+00
—
—
—
1.0e+50
—
5.0e+00
cases:0.57%
controls:0.02%
—
—
—
—
—
—
cases:0.20%
controls:0.00%
—
—
cases:2.38%
controls:0.02%
23
9
4036
40580
—
—
—
8
0
4037
40502
—
74
5
3032
31777
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
6.9e-01
1.1e+00
1.9e+00
—
2.4e+00
1.1e+00
1.1e+00
cases:5.37%
controls:2.77%
cases:2.96%
controls:0.98%
cases:0.67%
controls:0.10%
—
—
cases:0.87%
controls:0.08%
cases:2.97%
controls:0.99%
cases:9.24%
controls:3.40%
218
1125
3841
39464
120
398
3940
40201
27
40
4032
40559
—
35
33
4010
40469
114
385
3720
38609
287
1080
2819
30702
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
8.6e-01
1.2e+00
2.1e+00
—
2.1e+00
1.2e+00
8.6e-01
cases:1.92%
controls:0.83%
cases:1.40%
controls:0.44%
cases:0.64%
controls:0.08%
—
—
cases:0.82%
controls:0.10%
cases:1.72%
controls:0.54%
cases:3.48%
controls:1.50%
78
335
3981
40254
57
180
4003
40419
26
33
4033
40566
—
33
39
4012
40463
66
210
3768
38784
108
477
2998
31305
Iron deficiency anaemia, unspecified
D50.9 [45605373]
7.2e-01
1.4e+00
1.9e+00
—
1.8e+00
1.4e+00
1.0e+00
cases:1.87%
controls:0.92%
cases:1.87%
controls:0.45%
cases:0.34%
controls:0.05%
—
—
cases:0.35%
controls:0.06%
cases:1.85%
controls:0.45%
cases:3.41%
controls:1.28%
76
374
3983
40215
76
182
3984
40417
14
21
4045
40578
—
14
24
4031
40478
71
175
3763
38819
106
407
3000
31375
Nephrology
39 [38004479]
8.6e-01
8.8e-01
1.2e+00
2.2e+00
1.3e+00
9.2e-01
8.8e-01
cases:2.14%
controls:0.92%
cases:1.82%
controls:0.76%
cases:0.94%
controls:0.28%
cases:0.39%
controls:0.04%
cases:0.94%
controls:0.27%
cases:1.90%
controls:0.77%
cases:2.93%
controls:1.24%
87
374
3972
40215
74
310
3986
40289
38
114
4021
40485
16
17
4043
40582
38
108
4007
40394
73
300
3761
38694
91
393
3015
31389
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
6.1e-01
1.3e+00
2.3e+00
1.0e+50
2.4e+00
1.2e+00
1.0e+00
cases:0.54%
controls:0.30%
cases:0.37%
controls:0.10%
cases:0.17%
controls:0.02%
cases:0.17%
controls:0.00%
cases:0.20%
controls:0.02%
cases:0.39%
controls:0.12%
cases:1.00%
controls:0.36%
22
120
4037
40469
15
42
4045
40557
7
7
4052
40592
7
0
4052
40599
8
7
4037
40495
15
45
3819
38949
31
116
3075
31666
Adalimumab Ab [Units/volume] in Serum or Plasma
87742-3 [36304052]
2.1e+00
—
—
—
—
2.5e+00
3.6e+00
cases:0.25%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.18%
controls:0.02%
cases:0.84%
controls:0.02%
10
12
4049
40577
—
—
—
—
7
6
3827
38988
26
7
3080
31775
Other specified special examinations
Z01.8 [45581003]
5.3e-01
1.4e+00
2.4e+00
1.0e+50
2.1e+00
1.2e+00
6.8e-01
cases:5.54%
controls:3.33%
cases:3.65%
controls:0.93%
cases:1.28%
controls:0.12%
cases:0.32%
controls:0.00%
cases:0.82%
controls:0.10%
cases:3.05%
controls:0.95%
cases:6.79%
controls:3.57%
225
1351
3834
39238
148
379
3912
40220
52
50
4007
40549
13
0
4046
40599
33
41
4012
40461
117
371
3717
38623
211
1134
2895
30648
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.4e-01
5.5e-01
1.6e+00
3.8e+00
1.4e+00
5.6e-01
2.6e-01
cases:32.82%
controls:29.80%
cases:34.85%
controls:23.60%
cases:20.72%
controls:5.18%
cases:10.47%
controls:0.27%
cases:17.01%
controls:4.95%
cases:35.99%
controls:24.40%
cases:49.74%
controls:43.35%
1332
12096
2727
28493
1415
9580
2645
31019
841
2104
3218
38495
425
108
3634
40491
688
2006
3357
38496
1380
9516
2454
29478
1545
13778
1561
18004
Hypothyroidism, unspecified
E03.9 [45537945]
3.6e-01
4.9e-01
9.6e-01
4.3e+00
1.0e+00
5.9e-01
5.1e-01
cases:3.67%
controls:2.59%
cases:2.04%
controls:1.27%
cases:0.62%
controls:0.24%
cases:1.06%
controls:0.01%
cases:0.62%
controls:0.23%
cases:2.61%
controls:1.46%
cases:5.83%
controls:3.57%
149
1051
3910
39538
83
515
3977
40084
25
96
4034
40503
43
6
4016
40593
25
92
4020
40410
100
569
3734
38425
181
1134
2925
30648
leflunomide; oral
L04AK01 [955035]
1.4e+00
1.8e+00
1.4e+00
—
2.2e+00
1.4e+00
1.3e+00
cases:1.16%
controls:0.29%
cases:0.99%
controls:0.16%
cases:0.17%
controls:0.04%
—
—
cases:0.22%
controls:0.02%
cases:0.65%
controls:0.15%
cases:1.00%
controls:0.27%
47
116
4012
40473
40
64
4020
40535
7
18
4052
40581
—
9
10
4036
40492
25
60
3809
38934
31
87
3075
31695
Adalimumab [Mass/volume] in Serum or Plasma
74117-3 [44786774]
2.0e+00
—
—
—
—
2.8e+00
3.4e+00
cases:0.27%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.39%
controls:0.02%
cases:1.16%
controls:0.04%
11
15
4048
40574
—
—
—
—
15
9
3819
38985
36
13
3070
31769
Nonfamilial hypogammaglobulinaemia
D80.1 [45533001]
1.8e+00
1.9e+00
—
—
—
2.2e+00
2.3e+00
cases:0.22%
controls:0.04%
cases:0.17%
controls:0.03%
—
—
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.39%
controls:0.04%
9
15
4050
40574
7
11
4053
40588
—
—
—
8
9
3826
38985
12
12
3094
31770
Temporomandibular joint-pain-dysfunction syndrome
K07.65 [2000502796]
1.5e+00
2.1e+00
—
—
—
2.6e+00
2.0e+00
cases:0.34%
controls:0.07%
cases:0.17%
controls:0.02%
—
—
—
—
—
—
cases:0.23%
controls:0.02%
cases:0.48%
controls:0.07%
14
30
4045
40559
7
9
4053
40590
—
—
—
9
7
3825
38987
15
21
3091
31761
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
6.9e-01
1.1e+00
2.0e+00
—
2.2e+00
1.2e+00
1.0e+00
cases:4.90%
controls:2.52%
cases:4.29%
controls:1.49%
cases:1.58%
controls:0.22%
—
—
cases:1.80%
controls:0.21%
cases:5.32%
controls:1.60%
cases:11.08%
controls:4.34%
199
1021
3860
39568
174
605
3886
39994
64
90
3995
40509
—
73
86
3972
40416
204
623
3630
38371
344
1378
2762
30404
Hepatitis B virus core and surface Ab and surface Ag panel - Serum
77190-7 [46237023]
4.2e-01
1.3e+00
2.0e+00
—
2.7e+00
1.1e+00
1.1e+00
cases:0.94%
controls:0.62%
cases:0.79%
controls:0.23%
cases:0.15%
controls:0.02%
—
—
cases:0.30%
controls:0.02%
cases:0.55%
controls:0.18%
cases:1.96%
controls:0.67%
38
251
4021
40338
32
92
4028
40507
6
8
4053
40591
—
12
8
4033
40494
21
72
3813
38922
61
214
3045
31568
fluocortolone
D07AC05 [21602124]
8.3e-01
1.0e+00
2.2e+00
—
2.1e+00
1.2e+00
7.7e-01
cases:1.60%
controls:0.70%
cases:0.59%
controls:0.22%
cases:0.17%
controls:0.02%
—
—
cases:0.25%
controls:0.03%
cases:0.60%
controls:0.18%
cases:1.45%
controls:0.68%
65
285
3994
40304
24
88
4036
40511
7
8
4052
40591
—
10
12
4035
40490
23
71
3811
38923
45
215
3061
31567
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
8.4e-01
9.5e-01
2.0e+00
—
2.5e+00
1.2e+00
5.3e-01
cases:1.08%
controls:0.47%
cases:1.08%
controls:0.42%
cases:0.49%
controls:0.06%
—
—
cases:0.77%
controls:0.06%
cases:1.75%
controls:0.51%
cases:3.03%
controls:1.81%
44
191
4015
40398
44
171
4016
40428
20
26
4039
40573
—
31
26
4014
40476
67
198
3767
38796
94
575
3012
31207
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 [3001334]
8.8e-01
9.9e-01
—
—
2.9e+00
1.7e+00
1.6e+00
cases:1.60%
controls:0.67%
cases:0.71%
controls:0.27%
—
—
—
—
cases:0.37%
controls:0.02%
cases:0.91%
controls:0.17%
cases:3.19%
controls:0.67%
65
272
3994
40317
29
108
4031
40491
—
—
15
8
4030
40494
35
65
3799
38929
99
214
3007
31568
Pauciarticular juvenile arthritis
M08.4 [45582020]
2.0e+00
2.0e+00
—
—
—
2.2e+00
1.9e+00
cases:0.27%
controls:0.04%
cases:0.22%
controls:0.03%
—
—
—
—
—
—
cases:0.21%
controls:0.02%
cases:0.23%
controls:0.03%
11
15
4048
40574
9
12
4051
40587
—
—
—
8
9
3826
38985
7
11
3099
31771
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
7.3e-01
1.2e+00
2.2e+00
—
1.8e+00
1.3e+00
8.6e-01
cases:8.11%
controls:4.08%
cases:4.73%
controls:1.44%
cases:1.48%
controls:0.17%
—
—
cases:1.29%
controls:0.22%
cases:4.54%
controls:1.28%
cases:9.21%
controls:4.13%
329
1657
3730
38932
192
583
3868
40016
60
68
3999
40531
—
52
90
3993
40412
174
499
3660
38495
286
1314
2820
30468
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
5.7e-01
8.3e-01
1.5e+00
2.4e+00
1.5e+00
6.8e-01
5.5e-01
cases:6.11%
controls:3.53%
cases:5.52%
controls:2.48%
cases:1.43%
controls:0.32%
cases:0.22%
controls:0.02%
cases:1.33%
controls:0.30%
cases:5.32%
controls:2.77%
cases:15.42%
controls:9.55%
248
1434
3811
39155
224
1008
3836
39591
58
130
4001
40469
9
8
4050
40591
54
121
3991
40381
204
1082
3630
37912
479
3035
2627
28747
Medical doctor
Z2221 [2001311556]
6.5e-01
1.2e+00
2.3e+00
—
1.5e+00
1.3e+00
1.1e+00
cases:9.56%
controls:5.22%
cases:4.61%
controls:1.48%
cases:1.75%
controls:0.18%
—
—
cases:0.84%
controls:0.18%
cases:4.23%
controls:1.23%
cases:8.47%
controls:2.86%
388
2117
3671
38472
187
602
3873
39997
71
72
3988
40527
—
34
74
4011
40428
162
479
3672
38515
263
910
2843
30872
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
3.8e-01
6.9e-01
1.5e+00
3.6e+00
1.1e+00
5.1e-01
2.9e-01
cases:6.16%
controls:4.30%
cases:3.92%
controls:2.00%
cases:1.23%
controls:0.28%
cases:0.69%
controls:0.02%
cases:0.96%
controls:0.31%
cases:3.36%
controls:2.05%
cases:8.31%
controls:6.34%
250
1744
3809
38845
159
813
3901
39786
50
114
4009
40485
28
8
4031
40591
39
126
4006
40376
129
798
3705
38196
258
2016
2848
29766
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
7.3e-01
9.2e-01
1.9e+00
—
2.4e+00
1.2e+00
1.0e+00
cases:0.89%
controls:0.43%
cases:0.57%
controls:0.23%
cases:0.22%
controls:0.03%
—
—
cases:0.42%
controls:0.04%
cases:0.70%
controls:0.22%
cases:1.45%
controls:0.53%
36
174
4023
40415
23
92
4037
40507
9
14
4050
40585
—
17
16
4028
40486
27
87
3807
38907
45
168
3061
31614
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
8.2e-01
1.3e+00
2.0e+00
1.0e+50
1.8e+00
1.4e+00
8.2e-01
cases:2.07%
controls:0.92%
cases:1.18%
controls:0.33%
cases:0.32%
controls:0.04%
cases:0.44%
controls:0.00%
cases:0.35%
controls:0.06%
cases:1.15%
controls:0.30%
cases:2.29%
controls:1.02%
84
374
3975
40215
48
133
4012
40466
13
18
4046
40581
18
0
4041
40599
14
24
4031
40478
44
116
3790
38878
71
324
3035
31458
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
4.2e-01
7.6e-01
1.4e+00
2.5e+00
1.5e+00
7.1e-01
6.6e-01
cases:11.36%
controls:7.77%
cases:7.54%
controls:3.66%
cases:2.32%
controls:0.55%
cases:0.25%
controls:0.02%
cases:2.22%
controls:0.50%
cases:7.30%
controls:3.73%
cases:18.19%
controls:10.33%
461
3152
3598
37437
306
1487
3754
39112
94
225
3965
40374
10
8
4049
40591
90
204
3955
40298
280
1455
3554
37539
565
3282
2541
28500
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
5.9e-01
8.4e-01
1.9e+00
—
2.6e+00
1.3e+00
8.9e-01
cases:4.14%
controls:2.33%
cases:2.19%
controls:0.96%
cases:0.57%
controls:0.09%
—
—
cases:1.26%
controls:0.10%
cases:2.63%
controls:0.75%
cases:6.28%
controls:2.67%
168
946
3891
39643
89
390
3971
40209
23
36
4036
40563
—
51
40
3994
40462
101
292
3733
38702
195
847
2911
30935
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
7.0e-01
1.0e+00
2.0e+00
—
2.1e+00
1.2e+00
9.6e-01
cases:5.40%
controls:2.76%
cases:4.33%
controls:1.60%
cases:1.63%
controls:0.23%
—
—
cases:1.93%
controls:0.23%
cases:5.58%
controls:1.73%
cases:11.56%
controls:4.76%
219
1122
3840
39467
176
650
3884
39949
66
93
3993
40506
—
78
93
3967
40409
214
676
3620
38318
359
1514
2747
30268
Gastritis, unspecified
K29.7 [45591583]
8.5e-01
1.5e+00
—
1.0e+50
2.8e+00
1.8e+00
1.1e+00
cases:0.69%
controls:0.30%
cases:0.52%
controls:0.11%
—
—
cases:0.25%
controls:0.00%
cases:0.20%
controls:0.01%
cases:0.47%
controls:0.08%
cases:0.93%
controls:0.33%
28
120
4031
40469
21
45
4039
40554
—
10
0
4049
40599
8
5
4037
40497
18
31
3816
38963
29
104
3077
31678
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
7.8e-01
8.9e-01
9.5e-01
1.9e+00
1.2e+00
1.1e+00
1.1e+00
cases:15.59%
controls:7.81%
cases:6.70%
controls:2.87%
cases:1.43%
controls:0.56%
cases:0.17%
controls:0.02%
cases:1.68%
controls:0.49%
cases:7.22%
controls:2.64%
cases:17.84%
controls:6.61%
633
3169
3426
37420
272
1167
3788
39432
58
226
4001
40373
7
10
4052
40589
68
199
3977
40303
277
1028
3557
37966
554
2101
2552
29681
Pain localized to upper abdomen
R10.1 [45568111]
7.6e-01
1.4e+00
2.3e+00
—
1.7e+00
9.4e-01
7.8e-01
cases:5.10%
controls:2.45%
cases:2.88%
controls:0.70%
cases:0.64%
controls:0.06%
—
—
cases:0.37%
controls:0.07%
cases:2.09%
controls:0.82%
cases:6.28%
controls:2.97%
207
996
3852
39593
117
286
3943
40313
26
25
4033
40574
—
15
27
4030
40475
80
321
3754
38673
195
944
2911
30838
Parkinson disease
G20 [45538098]
7.2e-01
9.0e-01
9.3e-01
3.5e+00
1.3e+00
9.4e-01
5.9e-01
cases:1.18%
controls:0.58%
cases:1.33%
controls:0.54%
cases:0.39%
controls:0.16%
cases:0.39%
controls:0.01%
cases:0.62%
controls:0.17%
cases:1.38%
controls:0.54%
cases:1.29%
controls:0.72%
48
235
4011
40354
54
221
4006
40378
16
63
4043
40536
16
5
4043
40594
25
67
4020
40435
53
212
3781
38782
40
228
3066
31554
Anaemia, unspecified
D64.9 [45600610]
5.5e-01
1.5e+00
1.8e+00
—
2.1e+00
1.3e+00
7.6e-01
cases:2.02%
controls:1.17%
cases:2.02%
controls:0.48%
cases:0.69%
controls:0.12%
—
—
cases:0.69%
controls:0.08%
cases:1.80%
controls:0.52%
cases:3.48%
controls:1.66%
82
476
3977
40113
82
193
3978
40406
28
47
4031
40552
—
28
34
4017
40468
69
202
3765
38792
108
527
2998
31255
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
6.7e-01
1.0e+00
2.0e+00
—
2.1e+00
1.2e+00
9.5e-01
cases:5.67%
controls:2.99%
cases:4.73%
controls:1.75%
cases:1.63%
controls:0.23%
—
—
cases:1.95%
controls:0.24%
cases:5.95%
controls:1.81%
cases:12.23%
controls:5.10%
230
1214
3829
39375
192
709
3868
39890
66
95
3993
40504
—
79
98
3966
40404
228
707
3606
38287
380
1621
2726
30161
pH of Urine
2756-5 [3015736]
2.7e-01
6.8e-01
1.2e+00
3.9e+00
1.1e+00
4.6e-01
2.4e-01
cases:12.98%
controls:10.23%
cases:9.66%
controls:5.16%
cases:2.69%
controls:0.79%
cases:1.18%
controls:0.02%
cases:2.47%
controls:0.80%
cases:8.56%
controls:5.57%
cases:20.35%
controls:16.69%
527
4153
3532
36436
392
2095
3668
38504
109
319
3950
40280
48
10
4011
40589
100
326
3945
40176
328
2171
3506
36823
632
5306
2474
26476
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
6.5e-01
9.1e-01
2.4e+00
—
2.0e+00
1.3e+00
6.5e-01
cases:1.53%
controls:0.81%
cases:1.03%
controls:0.42%
cases:0.47%
controls:0.04%
—
—
cases:0.42%
controls:0.05%
cases:1.15%
controls:0.33%
cases:2.54%
controls:1.35%
62
327
3997
40262
42
170
4018
40429
19
18
4040
40581
—
17
22
4028
40480
44
129
3790
38865
79
428
3027
31354
Anal abscess
K61.0 [45601183]
1.8e+00
2.0e+00
—
—
—
1.8e+00
2.2e+00
cases:0.52%
controls:0.09%
cases:0.22%
controls:0.03%
—
—
—
—
—
—
cases:0.29%
controls:0.05%
cases:0.77%
controls:0.08%
21
35
4038
40554
9
12
4051
40587
—
—
—
11
18
3823
38976
24
27
3082
31755
Pain localized to other parts of lower abdomen
R10.3 [45534426]
6.3e-01
1.2e+00
2.3e+00
—
1.7e+00
1.2e+00
8.2e-01
cases:6.55%
controls:3.59%
cases:4.26%
controls:1.28%
cases:1.18%
controls:0.12%
—
—
cases:0.74%
controls:0.14%
cases:3.57%
controls:1.16%
cases:9.05%
controls:4.19%
266
1459
3793
39130
173
520
3887
40079
48
47
4011
40552
—
30
56
4015
40446
137
452
3697
38542
281
1333
2825
30449
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
6.9e-01
9.7e-01
2.0e+00
—
2.2e+00
1.0e+00
9.7e-01
cases:2.22%
controls:1.13%
cases:1.33%
controls:0.51%
cases:0.57%
controls:0.08%
—
—
cases:0.67%
controls:0.07%
cases:1.41%
controls:0.51%
cases:3.77%
controls:1.46%
90
458
3969
40131
54
206
4006
40393
23
32
4036
40567
—
27
30
4018
40472
54
198
3780
38796
117
463
2989
31319
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
7.1e-01
9.4e-01
2.0e+00
—
2.1e+00
9.5e-01
1.1e+00
cases:1.65%
controls:0.82%
cases:0.86%
controls:0.34%
cases:0.44%
controls:0.06%
—
—
cases:0.37%
controls:0.04%
cases:0.86%
controls:0.34%
cases:2.41%
controls:0.82%
67
331
3992
40258
35
137
4025
40462
18
24
4041
40575
—
15
18
4030
40484
33
131
3801
38863
75
262
3031
31520
Medical Oncology
90 [38004507]
3.5e-01
6.8e-01
1.3e+00
3.2e+00
1.2e+00
6.9e-01
3.0e-01
cases:6.48%
controls:4.64%
cases:6.16%
controls:3.22%
cases:4.11%
controls:1.13%
cases:2.39%
controls:0.10%
cases:3.61%
controls:1.07%
cases:6.13%
controls:3.18%
cases:6.66%
controls:5.03%
263
1882
3796
38707
250
1309
3810
39290
167
460
3892
40139
97
39
3962
40560
146
434
3899
40068
235
1239
3599
37755
207
1598
2899
30184
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
5.9e-01
1.3e+00
1.6e+00
—
2.5e+00
1.1e+00
7.5e-01
cases:4.07%
controls:2.30%
cases:3.77%
controls:1.06%
cases:0.71%
controls:0.15%
—
—
cases:1.36%
controls:0.11%
cases:3.18%
controls:1.07%
cases:6.73%
controls:3.29%
165
934
3894
39655
153
432
3907
40167
29
61
4030
40538
—
55
46
3990
40456
122
416
3712
38578
209
1047
2897
30735
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
6.1e-01
1.1e+00
1.9e+00
—
2.3e+00
1.2e+00
6.8e-01
cases:3.77%
controls:2.09%
cases:3.00%
controls:1.05%
cases:0.89%
controls:0.14%
—
—
cases:1.51%
controls:0.15%
cases:3.65%
controls:1.11%
cases:7.31%
controls:3.84%
153
850
3906
39739
122
425
3938
40174
36
55
4023
40544
—
61
60
3984
40442
140
432
3694
38562
227
1222
2879
30560
Abdominal ultrasound examination
JN3AE [2001305555]
9.0e-01
1.7e+00
2.6e+00
1.0e+50
1.2e+00
1.5e+00
9.9e-01
cases:4.11%
controls:1.71%
cases:2.49%
controls:0.45%
cases:0.62%
controls:0.04%
cases:1.08%
controls:0.00%
cases:0.20%
controls:0.06%
cases:1.96%
controls:0.44%
cases:4.19%
controls:1.60%
167
693
3892
39896
101
181
3959
40418
25
18
4034
40581
44
0
4015
40599
8
24
4037
40478
75
173
3759
38821
130
509
2976
31273
Simple antiboidy therapy of methastized malignancy
WD405 [2001310688]
1.2e+00
1.7e+00
2.0e+00
—
1.5e+00
1.3e+00
5.8e-01
cases:0.71%
controls:0.21%
cases:0.69%
controls:0.13%
cases:0.42%
controls:0.06%
—
—
cases:0.25%
controls:0.05%
cases:0.44%
controls:0.12%
cases:0.39%
controls:0.22%
29
87
4030
40502
28
51
4032
40548
17
23
4042
40576
—
10
22
4035
40480
17
46
3817
38948
12
69
3094
31713
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
7.1e-01
1.0e+00
2.1e+00
—
2.2e+00
1.1e+00
6.7e-01
cases:4.78%
controls:2.41%
cases:3.47%
controls:1.29%
cases:1.18%
controls:0.15%
—
—
cases:1.53%
controls:0.17%
cases:4.12%
controls:1.44%
cases:8.98%
controls:4.80%
194
980
3865
39609
141
522
3919
40077
48
62
4011
40537
—
62
68
3983
40434
158
563
3676
38431
279
1526
2827
30256
duloxetine; oral
N06AX21 [21604749]
9.9e-01
1.4e+00
1.6e+00
—
1.3e+00
1.3e+00
1.1e+00
cases:4.71%
controls:1.81%
cases:3.87%
controls:1.02%
cases:1.65%
controls:0.33%
—
—
cases:1.46%
controls:0.39%
cases:3.70%
controls:1.06%
cases:5.96%
controls:2.02%
191
734
3868
39855
157
413
3903
40186
67
133
3992
40466
—
59
156
3986
40346
142
414
3692
38580
185
641
2921
31141
Atherosclerotic heart disease
I25.1 [45596196]
3.8e-01
5.8e-01
8.9e-01
4.0e+00
8.8e-01
5.2e-01
3.7e-01
cases:6.55%
controls:4.58%
cases:4.29%
controls:2.45%
cases:1.26%
controls:0.52%
cases:1.53%
controls:0.03%
cases:1.19%
controls:0.49%
cases:4.36%
controls:2.64%
cases:7.98%
controls:5.65%
266
1861
3793
38728
174
995
3886
39604
51
210
4008
40389
62
11
3997
40588
48
200
3997
40302
167
1028
3667
37966
248
1797
2858
29985
pH of Capillary blood
2745-8 [3009343]
6.9e-01
9.5e-01
1.9e+00
—
2.1e+00
1.1e+00
8.8e-01
cases:2.29%
controls:1.16%
cases:1.43%
controls:0.56%
cases:0.59%
controls:0.09%
—
—
cases:0.77%
controls:0.09%
cases:1.83%
controls:0.61%
cases:4.09%
controls:1.73%
93
470
3966
40119
58
227
4002
40372
24
36
4035
40563
—
31
38
4014
40464
70
236
3764
38758
127
550
2979
31232
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
7.6e-01
1.1e+00
1.4e+00
—
2.4e+00
1.1e+00
9.0e-01
cases:1.11%
controls:0.52%
cases:0.94%
controls:0.32%
cases:0.25%
controls:0.06%
—
—
cases:0.57%
controls:0.05%
cases:0.97%
controls:0.34%
cases:2.06%
controls:0.85%
45
211
4014
40378
38
130
4022
40469
10
25
4049
40574
—
23
20
4022
40482
37
132
3797
38862
64
270
3042
31512
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
5.8e-01
9.4e-01
1.6e+00
1.0e+50
2.3e+00
1.2e+00
9.9e-01
cases:4.14%
controls:2.37%
cases:2.46%
controls:0.98%
cases:0.76%
controls:0.16%
cases:0.94%
controls:0.00%
cases:1.51%
controls:0.15%
cases:3.00%
controls:0.90%
cases:6.31%
controls:2.44%
168
962
3891
39627
100
397
3960
40202
31
65
4028
40534
38
0
4021
40599
61
60
3984
40442
115
352
3719
38642
196
775
2910
31007
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
7.5e-01
1.1e+00
1.4e+00
—
2.4e+00
1.1e+00
9.0e-01
cases:1.11%
controls:0.52%
cases:0.94%
controls:0.32%
cases:0.25%
controls:0.06%
—
—
cases:0.57%
controls:0.05%
cases:0.97%
controls:0.34%
cases:2.06%
controls:0.85%
45
213
4014
40376
38
130
4022
40469
10
25
4049
40574
—
23
20
4022
40482
37
131
3797
38863
64
270
3042
31512
Cancer Ag 19-9 [Units/volume] in Serum or Plasma
24108-3 [3022914]
6.7e-01
1.4e+00
1.5e+00
—
1.9e+00
1.2e+00
9.5e-01
cases:1.13%
controls:0.58%
cases:1.23%
controls:0.32%
cases:0.25%
controls:0.05%
—
—
cases:0.42%
controls:0.06%
cases:0.97%
controls:0.29%
cases:1.96%
controls:0.77%
46
237
4013
40352
50
130
4010
40469
10
22
4049
40577
—
17
25
4028
40477
37
114
3797
38880
61
244
3045
31538

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1828
7536
3.59
307.65
1.8
1.5
2.34
2.39
g/l
0.34
1163
4599
2105
8762
3.91
307.65
1.5
1.3
1.27
1.60
u/ml
0.70
566
2384
2060
3642
10.43
307.65
1.7
1.2
—
—
—
0
0
965
1854
6.51
307.65
1.5
1.2
—
—
—
0
0
3003
16378
4.18
307.65
8.3
4.8
35.29
35.65
g/l
3.10
2890
15323
2461
4087
13.71
307.65
4.0
1.3
198.57
102.81
ug/g
21.17
2135
3123
726
1091
7.88
307.65
1.6
1.4
266.29
283.88
ug/g
1.17
467
637
3147
19321
3.78
287.90
9.0
6.5
10.15
11.46
umol/l
9.36
3018
18396
2241
11602
3.07
266.69
3.8
2.6
93.19
59.92
u/l
0.47
2120
10729
2981
18604
3.25
245.44
11.3
6.0
0.59
0.58
e9/l
1.73
2648
15867
3045
19241
3.32
245.27
11.6
6.3
0.19
0.19
e9/l
0.42
2739
16695
2985
18656
3.25
244.87
11.3
6.0
0.04
0.04
e9/l
0.02
2651
15900
3013
19057
3.24
239.42
11.4
6.1
1.90
1.93
e9/l
0.51
2730
16674
2814
17175
3.07
237.44
11.6
6.3
8.80
8.79
%
0.04
2702
16082
2805
17132
3.05
235.54
11.5
6.2
2.77
2.83
%
0.57
2683
16034
2806
17142
3.05
235.51
11.7
6.3
0.68
0.68
%
0.03
2684
16026
1928
9730
2.87
231.07
3.6
2.3
2.88
2.81
mg/l
0.67
1743
8399
2799
17252
3.00
227.63
11.2
6.1
58.04
57.18
%
3.55
2712
16473
2835
17608
3.01
227.04
11.5
6.2
27.26
27.96
%
2.80
2740
16663
3755
27770
5.58
224.31
15.5
7.9
78.03
79.54
u/l
1.46
3673
26326
3154
20991
3.24
218.74
14.7
9.5
4.21
4.09
e9/l
2.18
2826
18112
455
945
5.30
209.04
1.4
1.1
—
—
—
0
0
1234
5164
2.99
205.20
1.4
1.2
—
—
—
0
0
3591
26918
3.85
182.19
7.6
4.3
13.92
12.29
mm/h
9.09
3444
25182
1216
5384
2.80
178.46
3.3
2.6
21.89
22.42
%
0.60
1143
4997
1338
6289
2.68
173.85
3.3
2.6
12.46
12.99
umol/l
1.68
1265
5855
1275
5866
2.71
172.74
3.3
2.5
2.31
2.33
g/l
0.50
1186
5418
1813
9969
2.48
167.94
6.0
4.3
—
—
—
0
0
2632
17176
2.51
165.80
3.6
2.4
77.55
78.25
nmol/l
0.63
2456
15518
2580
16925
2.43
156.78
9.4
6.5
1.21
1.21
mmol/l
1.19
2431
15618
106
39
27.88
156.46
3.9
2.3
8.09
5.62
mg/l
2.00
85
27
765
2806
3.13
156.23
3.4
2.9
10.29
10.48
g/l
0.51
718
2589
2776
18850
2.49
155.60
10.2
7.1
1.21
1.22
mmol/l
0.46
2393
16301
2620
17650
2.36
144.49
4.7
3.1
133.79
116.49
ug/l
1.44
2484
16498
2520
16726
2.33
143.49
16.0
14.8
1.18
1.24
inr
9.03
2150
13889
635
2198
3.24
142.20
2.1
1.9
1.23
1.38
g/l
0.77
590
2017
543
1746
3.43
136.78
1.2
1.1
62.14
139.28
titre
—
7
47
841
3520
2.75
133.12
3.0
2.2
0.21
0.21
g/l
0.18
793
3296
853
3603
2.73
132.58
2.9
2.2
361.24
381.48
nmol/l
2.12
813
3335
1098
5282
2.48
130.12
1.6
1.4
531.74
543.19
titre
0.07
276
1140
759
3081
2.80
126.93
1.3
1.2
—
—
—
0
0
1218
6257
2.35
123.60
4.9
3.4
0.81
0.82
mmol/l
2.05
1141
5879
88
40
22.46
119.95
2.7
2.3
177.31
188.59
au/ml
—
15
10
1850
11472
2.12
115.92
5.7
4.1
7.40
7.40
ph
0.99
1388
8217
2385
16337
2.11
113.85
20.4
11.2
0.00
0.00
e9/l
0.03
2005
13198
1663
9980
2.13
112.75
4.2
3.2
2561.26
71.86
estimate
—
5
37
3164
24265
2.37
112.54
6.8
4.8
2630.46
1964.40
e6/l
0.12
24
325
2406
16594
2.10
112.00
2.7
2.1
95.55
96.90
pmol/l
0.69
1378
8540
1931
12297
2.09
111.33
4.5
3.2
35.74
34.06
u/l
0.21
1823
11615
2910
21658
2.21
109.83
7.6
4.9
6.55
6.66
mmol/l
2.02
2819
20492
1708
10469
2.09
108.34
4.4
3.3
0.47
0.43
e6/l
0.27
1339
7646
730
3136
2.62
107.76
6.1
4.2
0.67
0.73
%
0.23
277
920
1736
10786
2.06
105.33
2.0
1.7
21.05
20.58
nmol/l
0.59
1529
9140
3211
25062
2.33
104.90
6.7
4.7
1.86
2.95
0.81
13
28
1882
12097
2.03
103.38
4.5
3.4
48.61
76.41
e6/l
0.83
1513
9166
742
3290
2.54
102.12
6.5
4.4
0.81
0.86
%
0.23
279
972
1430
8359
2.10
101.46
3.4
2.7
6.15
6.22
e6/l
0.06
1333
7605
966
4903
2.27
97.56
7.6
5.9
1.04
1.05
mmol/l
0.54
916
4550
878
4283
2.34
97.37
3.9
2.8
7.70
7.95
umol/l
0.14
755
3758
1261
7120
2.12
97.32
3.7
2.9
502.22
521.60
mosm/kgh2o
2.61
1130
6237
711
3156
2.52
97.25
6.6
4.5
0.11
0.10
%
0.12
247
841
2063
13905
1.98
96.89
5.5
4.0
66.63
103.97
e6/l
2.61
1575
9666
782
3638
2.42
96.51
3.2
2.4
150.33
49.90
u/l
0.45
679
3055
89
65
13.98
96.44
2.6
1.3
9.63
9.49
mg/l
0.06
75
55
713
3183
2.50
96.27
7.0
4.7
0.39
0.20
%
0.22
236
787
1972
13289
1.94
90.56
3.7
3.5
2.35
2.36
mmol/l
3.45
1786
12096
835
4101
2.30
90.45
1.7
1.6
—
—
—
0
0
3067
24080
2.11
89.57
5.0
3.3
52.91
46.50
u/l
2.31
2899
22575
1514
9387
1.98
88.40
6.5
4.1
90.97
90.68
%
0.17
1478
9175
427
1529
3.00
88.27
1.7
1.5
3.96
17.01
iu/ml
1.40
16
31
2022
13823
1.92
88.08
5.2
3.8
31.24
90.83
ng/l
1.09
1445
9545
1111
6180
2.10
87.68
2.1
1.7
1237.04
1164.53
nmol/l
1.40
851
4712
1361
8152
2.01
87.58
7.9
4.5
—
—
—
0
0
2629
19664
1.95
86.48
5.5
4.0
6.14
4.26
estimate
0.21
716
4211
2607
19450
1.95
86.34
5.4
4.0
0.00
0.00
estimate
1.08
698
4083
2639
19786
1.95
85.91
5.5
4.0
0.00
0.09
estimate
0.57
691
3959
320
997
3.40
83.42
1.4
1.2
110.32
98.82
titre
0.11
31
85
3943
35156
4.96
81.54
32.7
15.7
21.51
23.79
mg/l
5.35
3669
28943
1804
12101
1.88
81.15
3.4
2.4
—
—
—
0
0
828
4240
2.20
80.03
3.2
2.7
1.77
1.81
%
0.54
744
3787
476
1915
2.68
78.73
1.2
1.1
14.58
1.41
u/ml
—
6
15
308
971
3.35
78.71
1.7
1.4
6.36
18.71
iu/ml
—
8
19
2099
14898
1.84
77.69
2.5
2.1
—
—
—
0
0
875
4632
2.13
77.42
4.0
3.2
4.32
4.50
e9/l
0.33
743
4013
311
997
3.29
77.33
1.4
1.2
298.57
1181.25
titre
—
7
32
1001
5578
2.05
77.19
1.7
1.7
—
—
—
0
0
363
1285
3.00
76.24
1.4
1.2
—
—
—
0
0
225
593
3.96
75.12
1.7
1.6
0.66
0.81
g/l
1.10
172
456
1751
11880
1.83
73.83
4.1
3.3
—
—
—
0
0
2162
15644
1.82
73.56
4.4
3.5
6.18
6.26
ph
2.59
1173
8671
674
3278
2.27
73.37
2.9
2.6
68.73
70.18
e9/l
0.46
494
2379
936
5214
2.03
71.53
2.6
2.0
—
—
—
0
0
63
45
14.20
69.03
2.1
1.2
88.75
145.90
au/ml
—
6
5
2319
17325
1.79
69.00
3.6
2.8
—
—
estimate
—
0
0
1699
11592
1.80
68.93
2.7
2.2
183.19
201.21
u/l
0.35
1632
10964
3945
35790
4.38
66.49
33.6
18.7
139.27
139.68
mmol/l
19.62
3905
35105
658
3295
2.19
66.14
10.2
7.3
9.90
9.62
mmol/l
0.43
633
3165
3388
28673
2.09
65.97
5.8
4.6
14.83
14.78
pmol/l
0.48
3189
26391
3945
35863
4.31
64.71
33.8
18.9
3.94
3.97
mmol/l
6.48
3904
35109
246
761
3.38
64.60
4.4
3.0
57.62
57.64
%
0.01
246
761
667
3391
2.16
64.39
8.2
7.4
1.32
1.33
mmol/l
0.04
654
3329
788
4307
2.03
62.54
2.2
1.7
—
—
—
0
0
1075
6565
1.87
61.19
2.0
1.9
—
—
—
0
0
1277
8256
1.80
60.15
2.4
1.8
1.23
1.26
mg/l
0.14
1008
6362
1570
10793
1.74
59.62
5.9
4.2
0.00
0.00
estimate
1.94
676
3827
217
661
3.41
58.34
1.3
1.3
264.98
262.14
u/ml
0.04
125
403
1211
7771
1.80
58.11
2.0
1.7
9311803.43
35816479.98
pmol/l
1.67
1031
6458
382
1610
2.51
56.75
2.0
1.9
7.30
7.41
iu/ml
0.02
67
369
304
1146
2.79
56.50
1.9
1.8
0.24
0.23
g/l
0.13
288
1094
502
2394
2.25
56.35
5.7
4.0
5.02
5.17
kpa
4.14
489
2292
492
2331
2.26
56.10
5.7
4.0
7.41
7.42
ph
0.19
425
1931
310
1190
2.74
55.63
1.9
1.8
1.20
1.19
g/l
0.17
296
1137
1571
10993
1.70
54.64
3.8
3.2
1431.15
1258.84
ng/l
0.98
1365
9465
576
2942
2.12
54.28
5.8
4.1
—
—
—
0
0
3722
33301
2.38
53.32
7.4
5.6
1.96
1.92
mu/l
0.16
3537
30929
1388
9501
1.70
51.69
3.5
2.7
341.37
336.53
umol/l
0.92
1237
8379
598
3151
2.05
51.68
2.8
2.7
65.77
66.39
g/l
1.03
551
2902
380
1668
2.41
51.53
1.8
1.8
1.62
1.55
g/l
0.77
335
1447
120
266
4.62
50.20
1.3
1.1
231.07
149.47
titre
0.47
28
38
120
266
4.62
50.20
1.3
1.1
295.00
270.00
titre
—
6
6
502
2508
2.14
49.87
1.6
1.3
225.71
195.21
u/ml
0.31
466
2328
605
3245
2.02
49.64
10.5
8.6
—
—
—
0
0
256
949
2.81
49.01
1.1
1.1
1.69
5.87
eliau/ml
1.78
22
117
333
1418
2.47
48.18
2.1
2.0
1.55
2.09
ug/l
0.48
306
1257
663
3715
1.94
47.81
6.1
3.8
5.70
5.83
kpa
2.71
637
3624
1159
7711
1.70
47.07
3.3
2.9
2.46
2.45
mmol/l
0.71
1047
6940
665
3752
1.92
46.90
6.0
3.8
7.37
7.38
ph
1.48
357
2134
282
1125
2.62
46.74
1.3
1.3
—
—
—
0
0
90
166
5.52
46.54
2.8
1.7
1.95
1.97
umol/l
0.07
83
149
647
3628
1.93
46.44
6.1
3.8
1.35
1.87
mmol/l
2.83
576
3183
1564
11280
1.63
46.22
9.6
6.3
—
—
—
0
0
1026
6632
1.73
46.15
1.4
1.3
9.50
11.45
u/ml
0.44
394
2559
1021
6599
1.73
45.90
3.8
2.9
1.17
1.17
e6/l
0.01
557
3463
343
1513
2.38
45.86
1.3
1.2
0.78
0.95
u/ml
0.13
20
117
950
6025
1.75
45.65
4.1
3.0
3.87
3.01
e6/l
0.92
486
2882
521
2758
2.02
44.02
1.4
1.4
—
—
—
0
0
557
3019
1.98
44.01
5.7
3.8
1.22
1.23
mmol/l
3.30
507
2597
208
730
2.95
43.99
5.2
4.3
2.67
2.71
mmol/l
0.09
150
501
443
2209
2.13
43.97
6.5
4.0
23.87
24.30
mmol/l
2.09
431
2188
1916
14626
1.59
43.95
5.4
3.9
0.05
0.23
estimate
0.58
604
3330
1077
7143
1.69
43.69
1.5
1.3
32.85
31.27
iu/ml
0.13
317
2174
1701
12665
1.59
43.17
4.4
3.6
0.40
0.73
—
5
30
176
568
3.19
43.03
3.4
3.7
1.53
1.50
%
0.04
161
518
217
789
2.85
43.02
3.9
3.9
—
—
—
0
0
296
1258
2.46
42.91
3.1
3.1
24.16
24.98
mmol/l
3.00
291
1237
752
4526
1.81
42.90
1.7
1.5
—
—
—
0
0
3957
37011
3.53
42.15
22.4
11.9
25.40
25.45
u/l
0.08
3914
35953
46
5
93.09
41.83
1.1
1.0
20.11
—
u/ml
—
9
0
131
359
3.74
41.29
1.2
1.2
51.21
59.36
u/l
1.11
117
313
3967
37270
3.59
39.71
38.5
20.5
79.16
75.54
umol/l
8.19
3949
36840
241
984
2.54
37.99
3.7
3.4
2.48
2.06
index
0.41
118
509
151
480
3.23
37.85
1.1
1.1
1.49
1.51
g/l
0.28
143
434
234
960
2.53
36.51
2.2
2.0
11.97
11.81
mg/l
0.10
214
895
547
3126
1.87
36.43
5.6
3.3
4.42
4.56
kpa
0.75
525
3043
1421
10453
1.55
36.24
4.7
3.4
0.10
0.20
estimate
0.33
587
3246
568
3290
1.84
36.23
1.6
1.4
—
—
—
0
0
378
1907
2.08
36.13
2.4
2.4
—
—
—
0
0
864
5646
1.67
36.07
3.1
2.2
29.98
29.56
s
1.07
834
5485
127
374
3.47
35.96
1.4
1.4
0.35
0.40
g/l
0.77
86
271
127
374
3.47
35.96
1.4
1.4
2.64
2.86
g/l
0.63
85
274
127
375
3.46
35.82
1.4
1.4
6.63
6.73
g/l
0.08
85
271
191
718
2.74
35.53
1.4
1.4
—
—
—
0
0
611
3659
1.79
34.82
2.7
2.1
0.05
0.01
estimate
0.54
110
786
124
368
3.44
34.70
1.5
1.4
—
—
—
0
0
175
641
2.81
34.20
1.5
1.4
159.54
147.59
au/ml
0.50
36
190
632
3875
1.75
33.07
4.2
4.2
11.03
21.43
ug/l
1.12
493
3120
680
4300
1.70
31.71
8.9
7.5
7.42
7.42
ph
0.65
358
2323
188
747
2.59
31.33
2.0
1.4
60.46
62.47
mmol/l
0.29
145
610
247
1118
2.29
30.92
5.1
4.1
1.61
1.51
mg/l
1.14
226
1020
297
1460
2.12
30.28
1.9
1.6
0.31
0.31
mg/l
0.05
133
664
35
6
58.81
30.09
1.1
1.0
—
—
—
0
0
279
1344
2.16
29.97
2.7
2.2
302.22
589.10
ug/l
1.04
258
1264
266
1259
2.19
29.87
3.6
3.5
264.90
52.88
mg/l
0.51
219
1088
289
1420
2.11
29.49
1.6
1.6
13.54
15.88
u/ml
0.43
47
316
44
63
7.05
29.23
1.9
2.0
—
—
—
0
0
264
1257
2.18
29.20
3.6
3.5
36.88
63.58
mg/l
1.32
216
1086
670
4309
1.66
29.08
8.9
7.4
12.38
12.45
kpa
0.15
641
4143
128
435
3.01
28.68
1.2
1.2
—
—
—
0
0
668
4309
1.66
28.62
9.0
7.4
4.97
5.11
kpa
3.41
641
4145
662
4273
1.66
28.26
8.9
7.4
0.42
0.96
mmol/l
2.38
548
3528
2872
25111
1.49
28.04
5.1
4.1
0.38
7491.87
—
8
55
604
3814
1.69
28.04
9.3
7.8
96.09
95.58
%
1.34
579
3685
1386
10564
1.47
27.99
3.6
3.0
0.07
0.03
0.23
14
256
107
334
3.26
27.68
2.3
2.4
1269.91
1209.46
e6/l
0.25
96
294
289
1456
2.06
27.57
2.9
2.4
2.95
2.92
g/l
0.14
265
1324
320
1678
1.98
27.30
1.3
1.2
—
—
—
0
0
200
873
2.36
27.22
1.3
1.2
—
—
—
0
0
236
1116
2.18
26.54
3.6
3.3
3.08
2.83
ratio
0.09
141
644
134
491
2.79
26.20
1.1
1.1
1.73
3.17
eliau/ml
1.51
49
214
497
3032
1.73
26.08
4.8
3.7
88.29
87.70
ng/l
0.05
434
2595
297
1549
1.99
25.71
2.9
2.4
3.55
3.70
g/l
1.17
272
1418
297
1550
1.99
25.66
2.9
2.4
4.19
4.22
g/l
0.21
273
1416
93
279
3.39
25.65
1.1
1.1
—
—
—
0
0
297
1551
1.99
25.62
2.9
2.4
7.49
7.42
g/l
0.24
273
1416
339
1854
1.90
25.52
2.8
2.1
0.01
0.42
estimate
0.50
98
608
199
893
2.29
25.41
2.8
2.3
127.17
128.39
g/l
0.27
147
709
120
423
2.89
25.22
2.6
3.3
4.10
18.55
nmol/l
0.57
114
407
309
1646
1.95
25.16
6.8
4.1
—
—
—
0
0
3591
33251
1.68
24.61
7.3
6.3
39.32
39.08
mmol/mol
0.81
3373
31134
239
1181
2.09
23.99
1.3
1.2
32.75
47.90
u/ml
0.36
11
64
987
7214
1.49
23.89
5.0
3.9
428.18
393.81
ng/l
0.06
741
5544
105
355
3.01
23.79
3.7
4.2
—
—
—
0
0
176
772
2.34
23.70
3.1
2.8
31.91
35.16
umol/l
0.88
164
700
554
3565
1.64
23.63
9.8
8.2
118.56
120.79
g/l
1.72
543
3479
3648
33987
1.71
23.57
5.9
5.2
5.90
5.90
mmol/l
0.01
3386
31291
3978
38195
2.88
23.43
46.0
24.1
261.02
253.91
e9/l
8.58
3944
37457
3978
38200
2.87
23.33
45.7
24.1
91.56
91.05
fl
9.71
3962
37803
3978
38201
2.87
23.31
45.6
24.0
30.31
30.27
pg
0.68
3961
37802
149
611
2.49
23.28
1.1
1.1
—
—
—
0
0
3978
38205
2.86
23.23
45.8
24.1
4.35
4.46
e12/l
41.16
3934
37342
3978
38205
2.86
23.23
46.8
24.6
39.42
40.35
%
6.51
3962
37790
3978
38210
2.86
23.13
45.9
24.2
7.01
6.73
e9/l
9.65
3938
37343
3978
38215
2.85
23.03
46.3
24.3
130.47
134.19
g/l
49.42
3961
37830
225
1106
2.09
22.90
1.3
1.3
4.29
5.48
u/ml
0.14
21
104
226
1114
2.09
22.83
4.0
2.7
3.66
3.55
g/l
0.48
219
1058
546
3539
1.63
22.56
5.1
4.4
7.36
7.35
ph
0.62
407
2510
224
1107
2.08
22.47
1.3
1.3
9.63
7.03
u/ml
0.16
25
167
256
1342
1.97
21.81
3.9
3.4
314.51
3311.95
u/ml
0.83
224
1145
102
357
2.90
21.76
3.4
3.8
58.45
57.68
%
0.13
88
314
60
151
4.02
21.43
39.7
40.8
6.88
7.38
ug/l
0.82
54
137
248
1304
1.96
20.94
7.5
4.2
24.28
24.87
mmol/l
2.29
233
1195
57
141
4.09
20.84
29.2
27.4
117.83
113.66
ug/l
0.15
47
116
425
2650
1.67
20.36
1.2
1.3
—
—
—
0
0
99
356
2.83
20.12
3.9
3.4
14.38
12.44
index
0.76
61
200
261
1418
1.90
19.99
3.5
2.2
21.69
21.00
s
0.50
232
1250
399
2461
1.69
19.90
3.8
3.4
4.27
4.48
pmol/l
4.73
353
2209
372
2252
1.72
19.87
10.5
9.2
23.83
24.35
mmol/l
2.22
362
2211
75
234
3.25
19.51
2.1
2.5
191.80
218.90
e6/l
0.70
64
199
29
42
6.95
19.08
2.1
1.4
—
—
—
0
0
238
1274
1.92
19.06
1.1
1.1
—
—
—
0
0
247
1345
1.89
18.78
2.8
2.4
10.36
10.24
g/l
0.14
219
1200
3217
29516
1.43
18.39
36.7
19.6
13.93
13.62
%
29.13
3204
29116
177
876
2.07
17.72
1.3
1.2
32.65
44.97
u/ml
0.61
23
100
71
229
3.14
17.52
2.1
2.4
569.95
529.04
e6/l
0.20
57
183
446
2939
1.58
16.98
2.7
2.3
6.63
6.90
ug/l
0.10
386
2599
118
505
2.38
16.88
2.7
2.1
0.82
0.90
%
0.93
89
343
342
2122
1.67
16.61
11.8
9.9
15.62
15.90
%
1.16
335
2042
215
1172
1.88
16.31
3.8
2.4
89.05
93.29
%
1.78
210
1130
689
5015
1.45
16.28
1.4
1.3
—
—
—
0
0
75
263
2.89
16.03
1.8
1.2
31.60
35.19
mmol/l
0.61
68
231
107
451
2.41
15.85
1.9
2.4
9.66
6.85
umol/l
0.59
82
332
107
459
2.37
15.26
2.6
3.0
—
—
—
0
0
29
53
5.50
15.23
1.4
1.6
25.94
45.05
pmol/l
0.77
24
46
155
774
2.04
15.18
4.5
3.3
325.96
760.48
u/ml
0.62
145
715
78
288
2.74
15.17
1.2
1.1
—
—
—
0
0
112
493
2.31
15.06
9.2
6.4
13.00
11.93
mg/l
1.31
101
459
133
630
2.15
14.97
1.1
1.1
—
—
—
0
0
155
780
2.03
14.87
1.7
1.6
—
—
—
0
0
440
2998
1.52
14.34
2.9
2.4
0.46
0.44
e6/l
0.07
421
2855
81
315
2.60
14.25
1.2
1.1
—
—
—
0
0
181
977
1.89
14.18
4.7
3.1
58.92
61.42
%
0.66
167
947
100
433
2.34
13.99
1.3
1.4
—
—
—
0
0
123
584
2.14
13.79
1.3
1.3
0.21
0.35
nmol/l
0.65
14
28
352
2304
1.58
13.73
5.4
3.2
124.41
128.95
g/l
3.40
344
2236
1522
12830
1.30
13.65
3.8
3.4
7.21
7.25
mmol/l
0.10
1286
10848
70
260
2.72
13.50
1.8
1.4
—
—
—
0
0
109
498
2.22
13.46
1.3
1.3
0.19
0.21
nmol/l
0.24
83
393
3699
35313
1.52
13.11
6.4
5.8
2.62
2.72
mmol/l
10.05
3464
32929
55
182
3.05
13.08
1.1
1.1
1489.04
1597.73
miu/ml
0.29
55
182
1443
12131
1.29
13.06
4.6
4.1
12.07
8.37
mg/mmol
1.95
918
7393
95
416
2.31
12.98
2.2
2.2
-0.06
0.76
mmol/l
1.04
87
400
1414
11934
1.28
12.19
3.8
3.5
59.41
45.74
mg/l
1.48
922
7457
48
155
3.12
11.93
2.6
2.2
127.88
136.89
umol/l
0.08
24
85
109
524
2.11
11.89
1.6
1.4
74.03
80.63
mu/l
0.09
101
466
96
439
2.22
11.87
3.2
2.2
37.93
22.64
mg/l
1.45
43
167
3485
33005
1.39
11.87
4.7
4.3
1.32
1.28
mmol/l
3.40
3235
30367
216
1302
1.70
11.72
2.8
2.2
5016.91
5490.94
u/l
0.08
84
518
95
438
2.20
11.53
1.4
1.5
274.46
277.71
mosm/kgh2o
0.52
69
331
196
1160
1.72
11.37
5.4
3.6
1.34
1.38
mmol/l
0.17
191
1143
43
134
3.23
11.34
1.3
1.2
0.33
0.29
g/l
1.80
31
109
3640
34801
1.44
11.12
5.7
5.1
4.56
4.67
mmol/l
8.44
3422
32575
130
687
1.92
10.93
1.8
1.9
4.87
5.01
mmol/24h
0.20
118
599
36
103
3.52
10.85
5.2
4.9
—
—
—
0
0
123
640
1.95
10.83
1.6
1.6
—
—
—
0
0
23
28
8.25
10.78
1.3
1.2
1.60
1.41
iu/ml
—
10
16
208
1270
1.67
10.77
4.3
3.4
240.17
418.42
mg/l
1.65
118
526
165
945
1.78
10.75
1.4
1.4
12.34
11.02
u/l
0.47
134
758
44
144
3.08
10.72
2.3
2.1
31.11
29.84
%
0.23
44
144
22
44
5.02
10.51
3.2
1.6
1.21
1.35
umol/l
0.46
17
29
3617
34597
1.41
10.49
5.6
5.0
1.47
1.49
mmol/l
1.58
3389
32188
38
116
3.30
10.38
3.1
2.6
0.61
0.62
mmol/l
0.22
38
116
1756
15420
1.24
10.27
2.1
1.9
1.40
1.35
mmol/l
1.64
1435
13000
97
476
2.06
10.08
1.3
1.3
—
—
nmol/l
—
0
0
98
487
2.04
9.85
1.4
1.3
—
—
—
0
0
74
330
2.27
9.79
1.2
1.2
—
—
—
0
0
57
226
2.54
9.76
1.4
1.3
—
—
—
0
0
146
843
1.76
9.30
6.1
2.8
59.99
61.61
%
0.35
146
838
78
364
2.17
9.26
1.1
1.1
—
—
—
0
0
370
2653
1.43
9.26
2.5
2.4
29.13
20.74
au/ml
0.53
31
267
90
446
2.04
9.15
2.5
2.2
0.99
1.28
g/24h
0.63
61
255
198
1246
1.62
9.15
2.4
2.5
—
—
—
0
0
34
106
3.23
9.02
2.4
2.1
0.30
0.26
e9/l
0.15
19
48
568
4393
1.34
8.98
5.5
5.0
33.19
32.80
%
0.38
402
2917
77
363
2.14
8.93
2.5
2.1
—
—
—
0
0
83
404
2.08
8.86
2.1
1.6
60.51
57.99
%
0.24
55
257
96
494
1.97
8.80
1.4
1.3
314.12
323.66
pmol/l
0.08
84
421
53
215
2.48
8.70
1.7
1.4
5.69
6.86
u/l
0.63
45
187
37
125
2.98
8.60
1.1
1.1
—
—
—
0
0
28
80
3.52
8.51
1.6
2.1
—
—
—
0
0
315
2235
1.44
8.35
9.2
6.4
24.01
24.54
mmol/l
1.58
305
2133
239
1606
1.52
8.32
5.2
3.3
24.68
25.40
mmol/l
2.20
230
1550
69
321
2.17
8.30
1.2
1.2
108.62
109.52
pmol/l
0.06
69
321
40
145
2.78
8.21
2.3
2.0
8.25
8.00
%
0.06
40
138
107
586
1.85
8.16
1.9
2.8
—
—
—
0
0
137
811
1.71
8.04
1.4
1.4
—
—
—
0
0
397
2961
1.38
7.91
2.9
2.7
5.91
6.10
ph
4.67
260
2000
154
947
1.65
7.84
1.2
1.2
—
—
—
0
0
1218
10510
1.23
7.82
1.5
1.5
—
—
—
0
0
102
560
1.84
7.74
1.4
1.2
4.45
4.82
u/ml
0.10
58
248
92
491
1.89
7.63
2.5
2.5
—
—
—
0
0
31
102
3.05
7.57
1.0
1.0
—
—
—
0
0
334
2440
1.40
7.53
1.3
1.3
55.40
49.47
au/ml
0.19
21
157
17
24
7.11
7.46
1.1
1.2
—
—
—
0
0
24
68
3.54
7.41
2.2
1.7
—
—
—
0
0
43
171
2.53
7.40
1.5
1.8
3.09
4.07
u/field
0.28
35
123
83
435
1.93
7.28
1.4
1.5
—
—
—
0
0
152
953
1.62
7.20
1.7
1.6
10959.24
12484.72
e6/l
0.20
119
660
30
100
3.01
7.18
1.1
1.1
—
—
—
0
0
16
22
7.30
7.18
1.4
1.3
0.22
0.28
iu/ml
—
7
13
78
403
1.95
7.14
4.5
5.0
6.97
7.36
mmol/l
0.52
67
344
120
710
1.71
7.10
2.1
2.1
1.10
0.85
nmol/l
2.24
98
605
90
489
1.86
7.09
1.7
1.4
—
—
—
0
0
90
489
1.86
7.09
1.7
1.4
—
—
—
0
0
90
489
1.86
7.09
1.7
1.4
—
—
—
0
0
90
489
1.86
7.09
1.7
1.4
—
—
—
0
0
188
1247
1.53
6.99
1.7
1.7
306.84
293.88
mu/l
0.21
169
1133
32
113
2.85
6.94
1.3
1.2
—
—
—
0
0
30
103
2.93
6.84
2.1
1.5
9.22
9.37
ug/l
0.07
30
103
156
998
1.59
6.81
1.3
1.4
503.01
540.79
mg/l
0.38
147
948
47
203
2.33
6.81
1.9
2.3
16.06
16.27
%
0.16
47
203
33
120
2.76
6.79
2.0
2.0
—
—
—
0
0
88
482
1.84
6.78
1.2
1.3
113.82
51.36
u/ml
—
9
24
36
138
2.62
6.70
1.9
2.3
911.27
988.10
e6/l
0.05
22
98
37
144
2.58
6.69
8.1
5.3
9835.64
71.51
mg/l
0.79
28
109
77
408
1.90
6.58
1.8
1.6
526.06
346.31
mu/l
1.17
64
326
253
1809
1.42
6.47
1.5
1.4
28.10
28.40
iu/l
0.05
220
1547
112
668
1.70
6.47
1.4
1.3
—
—
—
0
0
137
861
1.61
6.46
1.4
1.4
46.63
34.02
e6/l
0.19
109
633
60
293
2.06
6.46
1.2
1.2
0.81
1.62
u/ml
0.60
34
163
41
171
2.41
6.43
1.9
2.4
2026.20
1867.18
ml
0.41
35
153
67
342
1.98
6.39
1.2
1.1
—
—
—
0
0
76
406
1.89
6.35
2.5
2.3
—
—
—
0
0
91
515
1.78
6.33
2.1
1.9
—
6.89
—
0
9
1000
8621
1.21
6.24
5.5
4.2
1.02
1.19
kg/l
0.50
692
5763
50
232
2.17
6.15
3.6
3.3
23.63
23.99
mu/l
0.02
45
223
138
880
1.59
6.15
1.3
1.3
3.81
3.72
mmol/l
0.46
130
830
137
876
1.58
6.04
1.5
1.5
795.64
1259.32
e6/l
0.37
116
691
60
301
2.01
6.03
2.1
1.8
4.44
4.18
mg/l
0.15
60
293
107
644
1.68
6.00
1.1
1.1
18.51
18.62
au/ml
0.00
21
150
163
1088
1.52
5.94
6.0
5.7
1.30
1.27
mmol/l
0.15
145
955
357
2743
1.33
5.88
1.3
1.2
118.00
144.40
u/ml
0.66
113
998
38
160
2.39
5.87
2.1
1.3
3.93
3.81
%
0.02
14
27
70
376
1.88
5.78
1.2
1.2
—
—
—
0
0
19
56
3.40
5.58
1.6
1.3
—
—
—
0
0
73
403
1.83
5.55
2.4
2.4
31.15
34.29
iu/ml
0.05
12
43
32
128
2.51
5.52
1.9
1.7
4640.00
4496.00
titre
—
8
20
30
117
2.58
5.45
1.4
1.4
127.89
127.36
nmol/l
0.00
19
85
144
956
1.52
5.41
2.1
3.0
—
—
—
0
0
296
2242
1.35
5.38
2.9
3.7
46.33
70.93
u/ml
1.25
288
2163
34
142
2.41
5.37
1.1
1.1
9.88
7.82
u/ml
—
5
23
38
167
2.29
5.36
1.6
1.3
171.08
153.51
mmol/24h
0.53
38
167
16
43
3.73
5.36
5.3
5.9
28.56
60.59
ug/min
—
9
37
226
1645
1.40
5.27
5.7
4.8
1.52
1.59
%
0.64
212
1550
90
538
1.69
5.23
1.1
1.2
—
—
—
0
0
432
3462
1.28
5.21
1.9
1.8
—
—
—
0
0
25
91
2.76
5.19
1.7
1.4
22.55
25.13
g/l
0.35
16
71
305
2340
1.33
5.10
2.5
2.3
12.37
12.93
nmol/l
0.50
267
2115
137
914
1.52
5.06
1.9
1.9
—
—
—
0
0
16
45
3.57
5.04
1.0
1.1
—
—
—
0
0
103
647
1.61
4.96
1.3
1.2
36.75
35.50
u/l
0.03
91
555
52
268
1.95
4.91
1.3
1.2
—
—
—
0
0
58
311
1.88
4.88
2.1
1.5
24.61
33.84
%
1.20
39
193
29
118
2.47
4.87
1.9
2.0
2436.83
20400.52
e6/l
0.53
12
61
43
208
2.08
4.83
2.7
2.7
39.70
42.67
%
0.52
28
109
159
1106
1.46
4.80
2.1
2.0
5.87
9.05
iu/l
0.25
58
459
27
108
2.51
4.70
1.6
1.6
—
—
—
0
0
34
710
0.47
4.69
1.6
1.6
—
—
—
0
0
89
549
1.64
4.63
1.2
1.2
—
—
—
0
0
15
35
4.30
4.62
1.1
1.0
—
—
—
0
0
26
104
2.51
4.54
1.4
1.5
11.40
13.11
g/l
0.48
18
78
33
682
0.48
4.44
1.5
1.5
1.21
1.27
mm
0.27
25
486
34
694
0.49
4.42
1.6
1.5
—
—
—
0
0
16
50
3.21
4.33
1.2
1.4
5.87
648787.54
nmol/l
—
10
41
52
281
1.86
4.31
1.5
2.1
1.35
1.52
u/field
0.19
34
149
12
24
5.01
4.31
1.0
1.0
—
—
—
0
0
12
24
5.01
4.31
1.0
1.0
—
—
—
0
0
581
4923
1.21
4.22
3.2
3.3
0.73
0.75
ug/l
0.21
399
3197
933
8249
1.17
4.16
5.8
5.5
2.12
3.34
ug/l
1.54
844
7432
24
97
2.48
4.12
1.2
1.1
0.43
2.63
u/ml
0.70
15
53
174
1268
1.39
4.11
1.8
2.1
—
—
—
0
0
32
148
2.17
4.08
2.2
1.8
39.45
40.10
g/l
0.28
32
148
239
1832
1.32
4.07
2.4
2.0
—
—
—
0
0
242
1859
1.32
4.06
4.0
3.4
1.02
1.02
ratio
0.14
212
1671
29
129
2.26
4.05
1.3
1.6
67.14
348.21
nmol/24h
0.70
29
129
90
577
1.57
4.05
1.3
1.2
—
—
—
0
0
23
92
2.51
4.04
1.3
1.2
—
—
—
0
0
63
370
1.71
3.99
1.6
1.5
—
—
—
0
0
10
18
5.57
3.97
1.3
1.5
—
—
—
0
0
65
386
1.70
3.96
1.3
1.2
—
—
—
0
0
201
1510
1.35
3.94
6.0
5.0
0.85
0.88
%
0.42
189
1420
358
2908
1.25
3.89
3.5
3.0
198.88
192.48
ng/l
0.08
320
2658
68
411
1.67
3.89
2.7
2.4
—
—
—
0
0
83
529
1.58
3.85
1.5
1.4
23.59
28.64
u/l
0.82
69
440
42
221
1.91
3.81
1.0
1.1
0.56
17.41
u/ml
0.55
18
61
24
102
2.36
3.73
2.5
1.2
14.39
16.90
umol/l
1.81
19
87
64
387
1.66
3.67
1.5
1.6
—
—
—
0
0
149
1080
1.39
3.67
2.0
2.1
—
—
—
0
0
9
16
5.63
3.65
1.8
1.5
369.69
494.97
nmol/l
—
9
16
35
176
2.00
3.63
2.5
1.5
—
—
—
0
0
182
1368
1.35
3.58
1.8
2.1
—
—
—
0
0
17
62
2.75
3.58
1.1
1.1
—
—
—
0
0
17
62
2.75
3.58
1.1
1.1
—
—
—
0
0
17
62
2.75
3.58
1.1
1.1
—
—
—
0
0
181
1360
1.35
3.57
1.9
2.1
—
—
—
0
0
7
9
7.79
3.55
3.9
4.6
—
—
—
0
0
242
3061
0.78
3.55
1.3
1.3
—
—
—
0
0
14
46
3.05
3.52
16.7
12.6
5.39
5.57
mmol/l
0.07
14
46
79
510
1.56
3.50
5.6
5.5
343.36
364.77
umol/l
0.63
69
450
182
1376
1.34
3.46
1.9
2.1
—
—
—
0
0
43
237
1.82
3.42
1.9
1.5
82.40
79.22
umol/l
0.25
43
237
70
442
1.59
3.41
1.1
1.2
—
—
—
0
0
11
27
4.08
3.39
3.5
3.3
—
—
—
0
0
19
76
2.51
3.37
1.2
1.1
0.88
0.73
umol/24h
—
7
39
31
154
2.02
3.34
1.6
2.0
2.61
0.98
u/ml
—
6
47
45
255
1.77
3.29
1.2
1.3
12.35
11.15
u/l
0.29
40
234
23
103
2.24
3.22
1.3
1.2
42.61
38.89
g/l
0.76
11
49
76
497
1.54
3.21
1.5
1.5
32.69
32.46
g/l
0.06
69
452
49
288
1.71
3.17
1.0
1.1
269.33
259.46
mg/l
0.06
43
251
62
388
1.61
3.16
1.5
1.4
21767.93
65662.41
e6/l
1.53
30
212
41
229
1.80
3.15
1.1
1.1
1.12
3.72
u/ml
1.04
16
80
50
296
1.70
3.15
1.1
1.2
389.57
376.05
nmol/l
0.17
42
258
50
299
1.68
3.05
1.1
1.2
34.56
38.98
mg/l
0.56
39
249
176
1352
1.32
3.04
1.9
2.0
—
—
—
0
0
17
68
2.51
3.03
1.1
1.2
0.04
7.01
u/ml
0.53
12
44
19
81
2.35
2.98
1.2
1.1
482.86
275.43
pmol/l
0.60
14
61
38
212
1.80
2.95
1.9
1.6
—
—
—
0
0
14
52
2.70
2.88
1.2
1.2
71.36
67.54
ug/l
0.18
14
52
40
230
1.75
2.82
1.3
1.2
0.59
0.55
ratio
0.26
20
138
440
3779
1.18
2.79
1.5
1.5
—
—
—
0
0
57
362
1.58
2.78
1.6
1.6
—
—
—
0
0
83
573
1.46
2.75
1.1
1.1
177.58
1091.64
iu/ml
0.44
18
124
35
195
1.80
2.75
1.0
1.1
0.10
2.65
u/ml
0.85
15
47
13
48
2.71
2.71
1.4
1.1
43.19
78.87
ng/l
—
8
32
90
634
1.43
2.69
1.1
1.1
—
—
—
0
0
90
634
1.43
2.69
1.1
1.1
—
—
—
0
0
109
799
1.37
2.61
1.1
1.1
0.87
2.03
u/ml
1.56
55
430
24
120
2.01
2.60
1.3
1.2
28.42
28.57
s
0.03
24
120
151
1164
1.31
2.59
1.4
1.3
178.48
220.43
miu/ml
0.76
63
555
42
252
1.67
2.58
1.1
1.1
0.54
14.55
nmol/l
1.54
11
56
8
20
4.01
2.56
1.1
1.1
—
—
—
0
0
83
1165
0.71
2.56
1.1
1.1
0.55
0.63
ratio
—
10
149
42
253
1.67
2.54
1.3
1.4
118.00
515.50
titre
—
5
20
31
171
1.82
2.54
2.8
2.8
—
—
—
0
0
20
95
2.11
2.48
1.2
1.3
288.67
408.94
ug/l
0.11
13
42
43
263
1.64
2.47
1.2
1.2
—
—
—
0
0
230
2797
0.81
2.46
1.7
1.7
3.26
3.49
mmol/l
1.94
144
1915
23
116
1.99
2.45
1.1
1.1
—
—
—
0
0
14
57
2.46
2.44
3.9
2.2
0.64
1.51
mmol/l
—
9
36
17
76
2.24
2.44
1.4
1.1
—
—
—
0
0
204
1649
1.25
2.42
1.1
1.1
—
—
—
0
0
49
751
0.65
2.40
6.1
3.5
31.20
26.54
mg/l
0.46
37
520
35
204
1.72
2.40
1.2
1.2
—
—
—
0
0
61
893
0.68
2.39
1.5
1.5
66.01
58.89
ug/l
0.36
55
748
32
182
1.76
2.39
1.3
1.4
26.80
75.96
%
—
5
23
92
1248
0.73
2.33
1.2
1.1
1.50
1.55
g/l
0.79
92
1248
47
300
1.57
2.30
3.8
3.2
38.65
36.75
mg/l
0.03
36
222
19
93
2.05
2.21
1.1
1.8
—
2.00
—
0
5
43
272
1.59
2.19
1.6
1.5
0.99
1.20
promille
0.45
30
215
15
67
2.24
2.17
1.2
1.3
—
—
—
0
0
121
1560
0.77
2.17
1.5
1.6
1044.37
1000.89
mu/l
0.21
101
1306
55
370
1.49
2.15
1.3
1.4
6.84
6.46
mmol/l
0.40
50
352
43
274
1.58
2.14
1.1
1.1
4.23
9.08
iu/ml
1.25
12
82
81
588
1.39
2.12
1.6
1.5
0.29
0.39
nmol/l
1.10
61
454
63
444
1.43
1.97
1.5
1.5
1831.59
3979.17
e6/l
0.54
39
310
21
112
1.88
1.96
1.2
1.1
—
—
—
0
0
21
112
1.88
1.96
1.2
1.1
—
—
—
0
0
21
112
1.88
1.96
1.2
1.1
—
—
—
0
0
115
893
1.30
1.95
1.9
1.9
44.45
41.48
nmol/l
0.65
109
863
6
16
3.75
1.93
1.0
1.1
—
0.20
—
0
6
91
685
1.34
1.92
1.1
1.1
5.77
4.36
u/ml
0.36
46
373
40
258
1.56
1.92
1.1
1.0
—
—
—
0
0
32
196
1.64
1.89
1.2
1.3
140.91
134.05
nmol/l
0.27
32
196
23
129
1.79
1.85
1.9
1.9
0.13
0.05
estimate
0.27
23
129
33
207
1.60
1.79
2.2
2.1
7.72
8.58
mmol/l
0.76
33
207
97
746
1.31
1.79
7.8
6.7
11.56
11.18
mmol/l
0.62
90
665
97
747
1.31
1.77
7.8
6.7
104.02
105.14
mmol/l
1.11
90
666
14
67
2.09
1.75
2.4
3.2
115.93
2326.82
u/l
1.24
14
61
87
662
1.32
1.74
1.1
1.1
0.65
1.14
u/ml
0.77
39
291
84
637
1.33
1.72
1.1
1.1
1.19
1.58
u/ml
0.26
44
322
24
140
1.72
1.71
2.4
1.7
—
—
—
0
0
329
3745
0.87
1.71
1.9
1.9
3.38
3.44
ratio
0.45
234
2855
31
194
1.60
1.71
4.7
2.9
20.42
46.91
umol/l
—
5
22
23
133
1.73
1.69
1.4
2.0
—
—
—
0
0
6
19
3.16
1.66
1.0
1.1
0.04
0.04
u/ml
—
6
19
8
31
2.58
1.66
1.0
1.3
—
—
—
0
0
38
255
1.49
1.57
2.1
2.0
6.32
6.74
mmol/l
0.63
29
166
11
50
2.20
1.56
1.0
1.1
45.92
39.13
mg/l
—
6
43
31
199
1.56
1.56
1.2
1.4
7.41
7.42
ph
0.14
22
132
25
152
1.65
1.56
1.0
1.2
—
—
—
0
0
69
517
1.34
1.56
1.1
1.1
3.20
5.06
u/ml
0.65
30
230
43
297
1.45
1.55
1.3
1.4
9.34
8.80
mmol/l
0.30
43
283
98
772
1.28
1.55
2.9
2.3
42.73
105.26
ug/min
2.83
47
467
32
208
1.54
1.53
2.3
2.2
2.44
2.37
ug/l
0.05
27
175
31
201
1.55
1.51
2.7
2.1
527.76
494.25
min
1.67
21
152
11
51
2.16
1.50
2.1
1.4
—
—
—
0
0
53
385
1.38
1.47
3.0
2.7
—
—
—
0
0
6
22
2.73
1.43
1.3
2.2
—
—
—
0
0
47
336
1.40
1.43
1.5
1.4
116462.94
97234.53
e6/l
0.11
31
223
60
449
1.34
1.40
1.3
1.6
2.76
4.25
ug/l
1.24
54
381
28
181
1.55
1.39
1.8
1.4
176.15
215.11
pmol/l
0.30
28
181
20
119
1.68
1.37
1.5
1.5
9.66
7.63
mmol/l
0.71
20
119
9
41
2.20
1.37
1.0
1.1
0.04
0.03
u/ml
—
9
41
77
601
1.29
1.34
1.7
1.8
—
—
—
0
0
16
91
1.76
1.28
1.1
3.4
97.82
132.39
ng/l
—
9
41
10
48
2.09
1.27
1.5
1.1
—
—
—
0
0
15
84
1.79
1.27
1.2
1.1
—
—
—
0
0
72
564
1.28
1.24
1.1
1.1
1.00
4.45
u/ml
4.31
37
283
95
771
1.24
1.22
3.5
3.5
0.80
0.80
nmol/l
0.07
76
623
5
19
2.63
1.21
1.4
2.0
—
—
—
0
0
31
213
1.46
1.20
2.0
1.4
1.19
1.23
nmol/l
0.06
25
158
15
87
1.73
1.15
1.0
1.0
16.36
35.98
iu/ml
1.63
15
87
121
1017
1.20
1.12
1.1
1.1
—
—
—
0
0
7
30
2.34
1.12
1.4
1.2
—
—
—
0
0
7
31
2.26
1.10
2.0
2.6
0.14
0.74
u/field
—
7
31
26
176
1.48
1.10
3.7
3.5
—
—
—
0
0
20
129
1.55
1.05
1.1
1.2
1155.56
1048.15
titre
—
9
27
36
263
1.37
1.03
1.2
1.1
25.59
15.86
u/ml
0.93
15
111
36
263
1.37
1.03
1.0
1.0
773.50
719.24
ng/l
0.28
26
174
36
265
1.36
0.99
2.6
2.2
744.48
627.32
ml
1.10
23
179
48
370
1.30
0.98
1.5
1.5
—
—
—
0
0
12
200
0.60
0.98
1.3
1.4
5.51
5.81
mmol/l
0.49
12
190
28
198
1.42
0.97
1.4
1.8
6.97
8.05
nmol/l
0.08
23
156
7
36
1.95
0.97
1.0
1.2
—
—
—
0
0
18
117
1.54
0.93
1.0
1.0
7.60
13.25
u/ml
0.78
12
82
13
79
1.65
0.88
1.7
2.1
20.46
17.10
umol/l
0.34
13
79
35
263
1.33
0.87
1.0
1.0
276.81
321.31
ng/l
0.72
26
177
8
43
1.86
0.87
1.9
2.3
—
—
—
0
0
23
162
1.42
0.84
3.5
3.7
—
—
—
0
0
24
171
1.41
0.83
1.7
2.1
19.60
160.11
ug/min
—
5
44
22
155
1.42
0.81
1.2
1.1
30.14
362.08
ng/l
—
7
37
60
491
1.23
0.79
1.1
1.1
0.22
0.28
u/ml
0.20
19
168
6
33
1.82
0.79
1.3
1.4
34.00
15.48
%
—
6
23
35
447
0.78
0.73
1.2
1.3
7.26
7.31
mmol/l
0.05
35
396
7
40
1.75
0.71
1.1
1.2
1.55
1.79
umol/24h
—
7
40
79
684
1.16
0.61
2.0
1.9
192.19
202.66
pmol/l
0.35
74
645
196
1795
1.10
0.61
1.9
1.7
—
—
—
0
0
9
140
0.64
0.60
2.6
2.4
188.67
153.26
nmol/l
—
9
123
11
72
1.53
0.59
1.8
1.6
—
—
—
0
0
118
1054
1.12
0.59
1.4
1.3
—
—
—
0
0
43
356
1.21
0.56
4.6
5.2
8.55
68.43
u/ml
2.32
11
107
16
116
1.38
0.54
1.7
1.7
0.57
0.49
e9/l
0.61
16
116
11
77
1.43
0.45
2.4
2.5
4.18
49.83
ug/l
0.51
11
77
27
221
1.22
0.42
1.2
1.1
—
—
—
0
0
30
249
1.21
0.41
3.0
1.7
82.10
100.93
ng/l
0.82
30
249
5
33
1.52
0.41
1.4
1.3
5.98
5.88
mmol/l
—
5
33
23
187
1.23
0.39
1.4
1.7
—
—
—
0
0
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
9
67
1.34
0.38
1.3
1.1
—
—
—
0
0
5
37
1.35
0.37
1.0
1.1
64.00
94.27
titre
—
5
37
90
823
1.10
0.35
5.5
4.4
—
—
—
0
0
1389
13656
1.03
0.33
3.3
3.1
—
—
—
0
0
8
65
1.23
0.27
18.1
7.7
5.51
5.32
kpa
—
8
65
26
225
1.16
0.26
1.5
1.6
7.90
7.81
mmol/l
0.05
26
217
117
1106
1.06
0.23
12.1
9.8
—
—
—
0
0
12
97
1.24
0.23
1.2
1.4
54.67
33.27
%
—
6
67
5
42
1.19
0.21
1.4
1.0
—
—
—
0
0
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
0.09
—
0
8
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
2962
29486
1.02
0.18
36.5
20.4
330.81
331.81
g/l
7.38
2953
29325
56
523
1.07
0.17
1.2
1.2
—
—
—
0
0
8
71
1.13
0.16
2.8
3.0
—
—
—
0
0
10
83
1.21
0.15
1.3
1.4
—
—
—
0
0
15
132
1.14
0.13
1.3
1.1
—
—
—
0
0
19
177
1.07
0.06
1.2
1.2
14.11
9.63
mm/h
0.51
19
177
44
442
1.00
0.00
1.7
1.7
—
—
—
0
0
23
231
1.00
0.00
7.5
6.9
3.45
98.04
ug/l
0.66
16
141
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
32.87
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
77.32
—
0
5
0
7
0.00
-0.00
0.0
2.0
—
—
—
0
0
9
92
0.98
-0.00
1.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
3001.29
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
8.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
2.03
—
0
6
0
6
0.00
-0.00
0.0
1.5
—
2.35
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
1384.00
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
177.80
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: COLITCOLLAG – Collagenous colitis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).